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Abstract 
Background: Australia’s population health profile is characterized by rapidly growing 
numbers of people living with multiple chronic conditions. The challenges of delivering 
multimorbidity care are particularly salient for primary care as this is where the majority of 
chronic disease care is provided. Primary care practice tools that promote consistent 
evidence-based and patient-centred approaches to patient care are one component of the 
system-wide change needed to address this complex health systems challenge. Tools such 
as clinical practice guidelines, care plans and patient decision aids exist to support the 
management of single chronic diseases but their relevance and usefulness in the 
management of multiple conditions is unclear. 
Objectives: The overall aim of this thesis is to examine whether primary care practice tools 
developed to support the management of chronic disease in Australian primary care practice 
are transferable to the management of multiple chronic conditions. In answering this 
question the thesis considered:  
 What is known about living with multiple chronic conditions?  
 What is known about managing multimorbidity in primary care?  
 What primary care practice tools are currently in use to support chronic disease 
management?  
 What are the strengths and limitations of these primary care practice tools for 
supporting core components of multimorbidity care?  
 What are the implications of these findings for policy and practice? 
Design: Key elements of multimorbidity care in primary care practice were identified from 
the literature. The primary care practice tools themselves were identified through the 
published literature and in consultation with expert stakeholders to validate the selection of 
tools for analysis. Three tools identified as currently used or available to general practitioners 
in Australia were included for detailed review: clinical practice guidelines; care plans; and 
patient decision aids. Comprehensive searches of published and non-published sources 
were undertaken to identify existing tools relevant to multimorbidity care in each of these 
categories. Document analysis, directed by the framework approach, was used to 
systematically and rigorously assess the tools and to identify their strengths and 
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shortcomings in relation to multimorbidity care. The Appraisal of Guidelines, Research and 
Evaluation (AGREE II) instrument was also used to assess the quality of clinical practice 
guidelines. 
Results: The analysis revealed strengths and limitations with each of the identified tools in 
relation to the management of multiple conditions.  
Of the thirteen clinical practice guidelines reviewed, twelve included at least one core 
patient-preference recommendation, but more explicit acknowledgement of these 
recommendations is required. Although ten guidelines used consumer engagement 
processes during guideline development, these processes were generally limited. More 
extensive consumer engagement was generally linked to greater incorporation of patient-
preference recommendations.  
Care plan templates also demonstrated limitations in their ability to support multimorbidity 
care. None of the sixteen included care plan templates addressed all of the criteria identified 
as necessary for care planning in a multimorbidity context, but most addressed one or more 
to at least some extent. Patient preferences, was the most commonly addressed criterion. 
Substantially less emphasis was placed on priority setting and the review of individual 
management goals. None of the care plan templates identified conflicts and synergies. The 
analysis also revealed the majority of templates are pre-filled and are formatted to consider 
conditions individually, potentially limiting their ability to contribute to genuine care planning 
and patient-centred care.  
Twenty-one patient decision aids were identified and reviewed. Key methods used by patient 
decision aids to acknowledge multiple conditions included flagging potential complications, 
prompting discussion between the patient and clinician and identifying how further illness 
could be prevented. All of the patient decision aids reviewed contributed to shared decision-
making processes, but scope exists for more systematic presentation.  
Conclusion: Each of the three tools reviewed captures some elements of what is required 
to provide multimorbidity care but none was found to comprehensively incorporate the key 
components identified as integral to effective multimorbidity care. Adaptations are needed 
to improve the ability of each to contribute to patient-centred multimorbidity care. 
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Furthermore, the thesis proposes how these primary care practice tools could be integrated 
to enhance shared decision-making and the incorporation of patient preferences.   
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 Chapter 1 Introduction 
Traditionally centred on the treatment of acute and infectious diseases, Australia’s 
health system has made adaptations to address the longevity, severity and uncertainty 
of chronic disease. The health system has made significant shifts towards the care of 
patients with a chronic condition (1). The introduction of policies such as the National 
Chronic Disease Strategy (2), and the Enhanced Primary Care (EPC) strategy have 
been instrumental in this process (3,4), but there is increasing awareness that single 
chronic conditions are no longer the core concern. As Fortin and colleagues (5) note, 
multiple chronic conditions have become the “rule rather than the exception” for 
patients presenting to primary care, where the majority of chronic disease care is 
provided (6-11). Multiple long term conditions place a complex set of demands on 
patients and health practitioners, within a health system that is not designed to 
respond to such demands (12,13). 
In Australia, the bulk of clinical care for multiple long-term conditions takes place in 
primary care, with the majority of that care provided by general practitioners (GPs) 
(6,8,9,13-16). Yet, major challenges that limit the delivery of effective multimorbidity 
care are known to exist (12,17-28), and to some extent, reflect the challenges 
clinicians and policy makers have faced in shifting care from acute to chronic disease 
management. Problems commonly observed in routine primary care practice call for 
solutions that can be implemented on a wider scale (29,30). These solutions, or what 
Grol and Grimshaw, (30) refer to as “innovations” take a wide variety of forms ranging 
from macro-level policy, to professional-led clinical practice guidelines for best 
practice, to specific practice-level changes to improve processes of care. Evidence-
based clinical practice guidelines and care planning are two critical drivers of improved 
primary care for patients with chronic illness. Wagner et al. (31,32), argues for the 
importance of providing evidence-based medical care in a consistent and 
systematised manner, and that this can best be achieved through the use of 
“interventions” and “protocols” that act as effective behaviour change agents for 
clinicians. Operating “by protocol”, rather than relying on clinicians’, “rugged 
individualism”, aims to minimise variations in practice and maximise adherence to best 
practice guidelines for chronic illness care (32). The Royal Australian College of 
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General Practitioners (RACGP), in its position statement outlining the leadership role 
general practice must play in the management of multimorbidity (33) support this 
positiion arguing: “GPs need guidelines, tools and patient resources to assist them to 
better assess and manage patients with multimorbidity” (33). This highlights the need 
for investment in the development of tools that are relevant to the care of patients with 
multiple conditions (33).  
This thesis is concerned with primary care practice tools developed to support the 
management of chronic disease in Australian primary practice and their transferability 
to the management of multiple chronic conditions. Common to all such primary care 
practice tools is recognition of the need for standardisation of processes and 
procedures to improve consistency of care (30,31,34,35). Primary care practice tools 
can become a part of normal care provision and routine practice (34). Their ultimate 
goal is to improve patient care, with other desirable goals including increasing cost 
effectiveness, reducing inefficiencies, and assisting clinicians delivering care (30-
32,34,35). The development and implementation of new routines and improvements 
in patient care come as a result of emerging evidence and/or the reality that current 
care processes are not functioning well (34) 
In examining primary care practice tools, the thesis is not concerned with GPs’ actual 
use of the tools but rather their applicability. While understanding how primary care 
practice tools are used in the management of multiple chronic conditions is important, 
this understanding would seem superfluous without first establishing whether the tools 
themselves are fit for purpose. To this end, the thesis presents a detailed analysis of 
the primary care practice tools using a multimorbidity lens. By examining this issue, 
the thesis will contribute to an understanding of whether Australia’s primary care 
system is well positioned to manage multiple chronic conditions.  
In considering primary care practice tools, the thesis has sought to conduct an analysis 
embedded within Lindblom’s theory of incrementalism, which provides a conceptual 
framework for understanding change within health policy and practice (36-38). 
Incrementalism posits that since major structural reform is generally difficult and costly 
to achieve, most health system reform occurs through incremental changes to existing 
practice that may then culminate in broader system change (39,40). As such, 
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incremental changes to primary care practice tools, which have previously contributed 
to broader change for those managing single chronic conditions (4,41,42), may 
contribute to shifting Australia’s primary care system towards a more multimorbidity 
approach.  
In line with incrementalism, the thesis recognises that primary care practice tools are 
but one component of the wider context in which multimorbidity care takes place and 
that a combination of system-wide interventions are required to make meaningful and 
sustainable change (12,32). As Grol states: “it is unrealistic to expect that one 
approach can solve all the problems in healthcare delivery” (29). Rather the central 
proposition of the thesis is that good primary care practice tools, as one component of 
the implementation of new approaches to care, offer a potential catalyst for wider 
change by promoting consistent practice that is both evidence-based and patient-
centred.  
The thesis is firmly based in a patient-centred approach to care that values consumer 
perspectives and the lived experiences of health system users, including people living 
with multiple conditions. Capturing and incorporating consumer perspectives is 
increasingly recognised as essential at all levels of the health system – from health 
services and systems planning and development through to the delivery of individual 
care (34,43-45). For patients and clinicians to be truly supported in the management 
of multiple long term conditions, consideration of these issues needs to occur at a 
policy/system level to ensure meaningful change and engagement at the individual 
clinic level. 
This chapter provides the context of the study and the rationale for the research 
undertaken. Australia’s primary care system is described, key terms are defined and 
the significance of the research is established. The research questions are presented, 
along with a brief outline of the thesis structure. 
1.1 Primary care 
Primary care has long been considered the heart of a strong health care system 
(46,47). The Institute of Medicine as defines primary care as: 
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the provision of integrated, accessible health care services by clinicians who 
are accountable for addressing a large majority of personal health care 
needs, developing a sustained partnership with patients, and practicing in 
the context of family and community (48)  
In short, primary care reflects the core objectives of a health system through the 
provision of responsive, comprehensive and equitable care (49). There is an important 
distinction to be made between primary care and primary health care. Although often 
used interchangeably these terms have quite different, and often contested, meanings. 
Primary care is best understood as care, predominantly medical, delivered to 
individuals. In Australia the vast amount of primary care is delivered by fee-for-service 
general practitioners. Primary health care, in contrast, is a much broader concept. 
Originating from the World Health Organization’s Declaration of Alma-Ata (50) it 
encompasses an approach to improving the health of populations. The focus of this 
thesis is on primary care which can be considered one component of a comprehensive 
primary health care approach.  
Starfield (47) identifies four main features of primary care: first-contact access for each 
health need; long-term person (not disease) focused care; comprehensive care for 
most health needs; and coordination of care when input from other health 
professionals is required. In her work, comparing the distribution and provision of 
primary health care across eleven industrialised countries, Starfield (51) identified that 
countries with strong primary care, among them Australia, report: 
 Lower overall costs - attributed to: prevention and early management of health 
problems; reduced escalation and unnecessary hospitalisations; and 
corresponding reductions in the burden placed on the secondary and tertiary 
sectors (46,47,51). 
 Healthier populations - attributed to greater access to primary care clinicians 
(46,47,51). Countries (51), and populations within those countries (47), which 
had greater access to primary care clinicians tended to have better health 
outcomes. 
 5 
In Australia, primary care is generally a patient’s “first point of contact” with the health 
system (52). Primary care is made up of over 32, 000 general practitioners (GPs), who 
operate as private providers working in solo or group practices in the community 
(23,24,52,53). In 2014-15, approximately 85% of the Australian population visited a 
GP (53) to access direct care or obtain a referral to other health and medical providers 
(23,52). Other health professionals providing primary care include allied health 
professionals (e.g., physiotherapist and optometrists), dentists, pharmacists and 
Indigenous health (23,52). Primary care clinicians in Australia work on a fee-for-
service basis, with costs covered by patients and/or Medicare: Australia’s universal 
health insurance scheme (23,24,52). The appropriateness of this payment method in 
supporting the management of multiple chronic conditions has been questioned 
(23,24,39,54,55), as fee-for-service payments encourage short consultation times and 
an “additive sequential” (21) approach to illness management, in which conditions are 
considered sequentially and in isolation.  
As the core setting of care for multiple chronic conditions (6,8,9,13-16), this thesis 
focuses on the relationship between primary care clinicians and their patients. The 
terms ‘primary care clinician’ or ‘general practitioner’ are used interchangeably 
throughout this thesis to acknowledge the medical specialty most frequently identified 
at the centre of the primary medical care system (51). Patients with multiple conditions 
will often visit numerous disease-specific specialists and allied health professionals 
(56,57), but in the current Australian system, general practice is generally considered 
the main point of coordination and the area of medicine most equipped to oversee and 
provide holistic care (13,58,59). Primary care clinicians are also known for building 
long term relationships with their patients, acting as advocates and gatekeepers, and 
coordinating other health professionals around the patient’s health care needs (13,51). 
Primary care clinicians operate within a health system and policy context that can 
support or limit their capacity to deliver effective multimorbidity care. A number of key 
barriers relevant to the management of multiple conditions have been identified 
including limited system support for managing multiple chronic conditions. Australia’s 
health system, designed to address acute care needs, has been working to shift focus 
and acknowledge the increasing chronic disease profile of the population. Existing 
structures (e.g., fee-for-service and standard consultation times) policy (e.g., the 
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National Chronic Disease Strategies), and primary care practice tools (e.g., clinical 
practice guidelines) are directed towards the management of acute and single chronic 
conditions (17-22,54,60,61). However, the challenge has now become how to manage 
multiple chronic diseases (12,25), particularly given that current efforts which attempt 
to combine numerous single condition approaches can result in overly complex and 
potentially harmful care (62).  
1.2 Multimorbidity and comorbidity 
The terms ‘multimorbidity’ and ‘comorbidity’ are frequently used interchangeably to 
describe someone presenting with two or more conditions, but closer consideration 
reveals some key differences that have implications for approaching patient care. 
Comorbidity was first defined by Alvan Feinstein in 1970 as: “any distinct additional 
clinical entity that has existed or that may occur during the clinical course of a patient 
who has the index disease under study” (63).  
Feinstein defined the index condition as the focus or priority for clinical care (12,63). 
This aligns closely with the biomedical model, which focuses on a disease occurring 
within a body system isolated from other systems (64,65). In acknowledging the 
“additional clinical entity” Feinstein (63) recognises the presence of other conditions, 
but as illustrated in Figure 1.1, this is secondary to the principal or index condition 
which is the focus of clinical concern (12,66). Frequently applied in both research and 
policy the biomedical model has seen patients with complex comorbidities excluded 
from research studies, and the development of clinical practice guidelines and care 
plans which focus predominantly on single conditions (60,67,68). When comorbidities 
are acknowledged they are typically ‘concordant’ conditions that is, chronic conditions 
which share similar risk factors and management strategies to the index condition (69-
71). For example, hypertension, and peripheral vascular disease would be concordant 
to the index condition diabetes. In contrast ‘discordant’ conditions, share few risk 
factors or management strategies with the index condition and are rarely 
acknowledged (69-71). Asthma would be an example of a condition discordant from 
diabetes. In essence, a comorbidity approach is disease focused, with limited 
consideration of the cumulative burden and complexity faced by patients and clinicians 
managing multiple conditions (12,66).  
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Multimorbidity is defined as the presence of two or more conditions, without any 
condition necessarily being identified as more or less central as (see Figure 1.1) 
(12,72). Valderas et al. (66) claim the term multimorbidity emerged as “a modern 
alternative to comorbidity” that better reflects the reality of managing multiple 
conditions. Adopting a multimorbidity care approach requires clinicians to 
acknowledge that patients with multiple conditions rarely experience conditions in 
isolation; rather, each patient’s overall illness experience is a unique product of their 
conditions, preferences, beliefs, attitudes, symptoms, medications, functional 
capacity, and self-care activities (18,21,73). As such, the term aspires to a more 
patient-centred view, by attempting to capture the whole person not just the individual 
diseases they have, and acknowledging the importance of structuring care to meet the 
needs, values and preferences of patients. Like comorbidity, concordant and 
discordant conditions are also identified in a multimorbidity context; however 
similarities and differences in risk factors and management plans are identified across 
all conditions not just the index condition, capturing a more representative or holistic 
view of the patient (12,69,70,72).  
 
Figure 1.1 - Depiction of comorbidity and multimorbidity – adapted from Boyd and Fortin (12). 
The distinction between the terms comorbidity and multimorbidity has important 
implications for approaches to management and treatment (12,74). Recognising the 
importance of this distinction, throughout this thesis the terms multiple conditions and 
multimorbidity care are used. The term ‘multiple conditions’ refers to the presence of 
multiple chronic conditions or diseases in one individual. ‘Multimorbidity care’ 
describes an approach to managing multiple conditions, which focuses on viewing the 
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whole patient and respecting and incorporating their values and preferences for care. 
In essence, it is synonymous with patient-centred care as it acknowledges the 
importance of the patient experience and their role in managing care.  
1.3 Research issue  
For many years, Australia’s health care system has been under immense pressure 
from the demands of managing chronic disease. The Australian Institute of Health and 
Welfare (AIHW) (52) labels chronic disease: “Australia’s biggest health challenge”, as 
the leading contributor to mortality, morbidity and health system costs. Chronic 
disease can produce adverse consequences such as functional impairment and 
disability, and requires effective management to minimise further complications 
(41,52,75). Magnifying the impact of chronic disease is the high prevalence of multiple 
conditions.  
Prevalence and impact 
Determining the prevalence of patients with multiple long term conditions across both 
national and international literature is difficult, as varying methods, population 
samples, and morbidities are used (5,12,74,76-79). A review comparing the 
prevalence of multiple conditions in primary care from three different studies, found 
the prevalence rates differed by as much as 61% (80). Despite this, it is widely agreed 
the number of conditions co-occurring in an individual generally increases with age 
(5,76,79,81-87). In Australia, growth in the ageing population has and will continue to 
have a profound impact on the health system (85), but the presence of multiple 
conditions is not limited to the elderly. A Canadian population survey on self-reported 
multimorbidity among 5,010 adults aged 18 years and over found one in five people 
(936) reported the presence of two or more chronic conditions, and of these 70% (657) 
were under 65 years of age (81). Similarly, an Australian cohort study found 42% of 
participants with multiple conditions were under 60 years of age (88).  
Patients presenting in primary care practice with only one chronic disease are 
increasingly rare, leading Tinetti and colleagues (25) to describe multimorbidity as: 
“the most common chronic condition experienced by adults”. Multiple long term 
conditions are associated with a wide range of adverse outcomes for individuals and 
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the health system. These included: increased health service use (14,56,79,89-92), 
polypharmacy (56,90,93-96), hospital admissions (14,79,89,90,97,98), out-of-pocket 
expenses (99-103), and psychological distress (79,93,104-106), along with reductions 
in physical functioning (79,107-112), quality-of-life (14,79,113-117), employability 
(118-120),and continuity of care (56,93,121,122). 
Policy level 
Formulating an effective response to multimorbidity has presented a significant 
challenge to health policy makers in Australia and elsewhere in the world (8,12,60,61). 
A limited evidence-base informing the management of multiple conditions adds to this 
challenge (16,62,79,123). Steps to reform chronic illness care in Australia are being 
taken, a report released by the Primary Health Care Advisory Group (PHCAG) (54) 
late last year (2015) titled: “The Better outcomes for people with chronic and complex 
health conditions”, is set to “revolutionise” the way chronic disease and multiple 
conditions are managed in Australia (124). Central to the report recommendations, 
and underlining the importance of this thesis, is patient-centred care and shared 
decision-making in primary care settings. The report recommends changes to current 
health management and funding models, placing greater emphasis on patient-centred 
care and shared decision-making in primary care settings (54). In the May 2016 federal 
budget, the Australian Government announced they would commit $21 million to trial 
the recommended changes outlined in the report (124). Further contributing to this 
agenda is the new National Strategic Framework for Chronic Conditions, to be 
finalised and released later this year (2016). This Framework, unlike its previous 
iterations, is expected to address multiple conditions (125). The release of these 
policies is timely, reinforcing the importance of addressing multimorbidity care in 
primary care settings. 
Practice level 
Leading researchers, along with other key stakeholders including the PHCAG and the 
RACGP, argue the complexities of providing multimorbidity care requires a focus on 
patient-centred care that emphasises patients’ priorities and preferences for care 
(13,25,54,59,126-129). Patient-centred care is a philosophy of care that has long been 
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a cornerstone of family medicine but is difficult both to operationalise and measure 
(125). Challenges in practice arise as clinicians and patients move beyond the 
traditional biomedical paradigm, to negotiate the different preferences and goals for 
care that each bring to the consultation (21,28,130,131). Care based on the traditional 
biomedical model, which focuses on single body systems and diseases, can lead to 
tensions between clinicians’ and patients’ preferences and goals for care 
(21,131,132). While clinicians may focus on the physical or biological aspects of 
disease, patients’ preferences for care, are informed by their lived experience and 
centre on improving their quality of life and maintaining normalcy (21,28,131,133). A 
cross-sectional study investigating self-rated health among 3,189 primary care 
patients with multiple conditions, found the restrictions on patients’ ability to participate 
in normal activities had a stronger association with poor self-rated health than the 
diagnosis (134). Kleinman (64) in making his classic distinction between illness and 
disease argues this is because people experience and respond to illness rather than 
disease. Illness encompasses how people feel, think, or behave based on their 
perceptions of a condition, whereas disease is the physiological issue clinicians’ treat 
or manage (64). 
Hearing and responding to the patient voice within the clinical encounter, to ensure 
their priorities and preferences for care are considered and integrated, appears central 
to the provision of high quality multimorbidity care (135,136). Acknowledging that 
patients’ goals and preferences may differ from those of their clinicians, possibly 
leading them to disengage with treatment advice (70,135), Stewart et al. (137) argue 
effective care requires clinicians and patients to find “common ground” between their 
respective disease and illness informed perspectives. In order to find common ground 
(137) clinicians and patients must engage in shared decision-making to work through 
these tensions; however, with limited evidence and support on how to manage multiple 
conditions or incorporate patients’ preferences (16,62,79,123), clinicians must rely on 
their medical judgement and draw on existing tools for assistance where possible. 
These primary care practice tools include clinical practice guidelines, and care plans, 
but as tools developed to support the management of single chronic conditions their 
relevance and usefulness in the management of multiple conditions is unclear.  
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1.4 Research question 
The central question addressed in this thesis is: Are primary care practice tools 
developed to support the management of chronic disease in Australian primary 
practice, transferable to the management of multimorbidity care? In answering this 
question the thesis considered the following: 
 What is known about living with multiple chronic conditions? (Chapter two) 
 What is known about providing multimorbidity care in primary care? (Chapter 
two) 
 What primary care practice tools are currently in use to support chronic disease 
management? (Chapter three and four) 
 What are the strengths and limitations of these primary care practice tools for 
supporting core components of multimorbidity care (Chapters five, six & seven) 
 What are the implications of these findings for policy and practice? (Chapter 
eight) 
1.5 Contribution of the research 
Enhancing methods of health care delivery for people with multiple long-term 
conditions is a priority for most health systems around the world (10,12,13,16,138). 
There is an urgent need for new innovations and approaches to appropriately respond 
to the rising numbers of people presenting with multiple chronic conditions in primary 
care (12,15,16,139). Researchers argue that such approaches should be patient- not 
disease-centred (10,12,13,59,138-141), embedded in primary care settings 
(10,12,13,59,138-140), and where possible work within existing resources 
(34,54,142).  
Effective multimorbidity care requires more than the actions of individual clinicians. 
Systematic attention is required across primary care (12,61,139,140). Primary care 
practice tools have previously contributed to practice wide change for those managing 
single chronic conditions (41,42) and therefore may contribute to shifting Australia’s 
primary care system towards a more multimorbidity approach. This thesis examines 
the transferability of primary care practice tools to support the provision of 
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multimorbidity care. In doing so, the contribution of this research is to determine 
whether Australia’s primary care practice tools, developed to address chronic disease 
in the clinical consultation, are well positioned to contribute to multimorbidity care.  
1.6 Thesis structure 
 
Figure 1.2 - Overview of thesis structure 
Chapter two provides a foundational understanding of the challenges patients and 
clinicians face when managing multiple conditions. The chapter starts with a reflection 
on the distinction between the concepts of disease and illness. Building, on this 
discussion the chapter then explores chronic illness from the patients’ perspective. 
Having explored the patient perspective, the chapter turns to examine the clinicians’ 
perspective. A critical argument arising from this chapter is the need to involve patients 
in decisions and reach a shared understanding between patients and clinicians 
perspectives. The chapter looks to shared decision-making, as one way of facilitating 
this for those managing multiple conditions.  
Chapter three describes the processes used to identify relevant primary care practice 
tools that aid clinicians and patients in the management of chronic disease. These 
primary care practice tools are then described, laying the foundation for an 
examination of the applicability of these tools to the provision of shared decision-
making and multimorbidity care.  
Chapter four outlines the thesis research question and methods. A three-stage 
document analysis methodology was applied to the three tools identified for review: 
clinical practice guidelines, care plans and patient decision aids (PDAs). The three 
stages were: 1) the identification of relevant documents; 2) collection of the data; and 
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3) analysis of the data. The framework approach (143) was used to direct data analysis 
in step three. 
Chapters five, six and seven present the evaluation of clinical practice guidelines, care 
plans, and PDAs respectively. Each chapter is a self-contained piece of research that 
includes an introduction, methods, results and discussion section. As a similar method 
of analysis was used for evaluating each of the three tools, there is some inevitable 
repetition of content across the three chapters.  
Chapter eight presents and integrates the findings of the three studies presented in 
chapters five, six and seven. Implications of the study are discussed, focusing on how 
the strengths of current primary care practice tools might be drawn together to support 
multimorbidity care and facilitate shared decision-making. The strengths and 
limitations of the study are also discussed together with implications for future 
research, policy and practice.  
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 Chapter 2 Chronic conditions in primary care practice 
2.1 Introduction 
The following chapter provides a foundational understanding of multiple chronic 
conditions from the perspective of patient and clinician and seeks to consider the 
unique challenges posed by their management. In unpacking this broad aim, the 
chapter is presented in four sections. Section one starts with a consideration of the 
notions of “disease” and “illness” (64). The distinction between disease and illness 
emerged in the 1970s through the seminal work of Kleinman and colleagues (64) who 
sought to illustrate the different points of reference that underlie the perspectives of 
patients and clinicians.  
Drawing from this work, the second section moves to explore patients’ experiences 
and perspectives of chronic illness. Beginning with an understanding of the “illness 
trajectory” and the common stages a person moves through as they adapt to a 
changing health profile and engage in “illness work” (144). The discussion then moves 
to consider the added “treatment burden” faced by patients managing multiple 
conditions, and the subsequent need to set and re-set priorities (95). A central finding 
to emerge from this discussion is the importance of involving patients in the process 
of identifying and setting priorities that guide their care. 
Having explored the patient perspective, the third section turns to examine the 
clinicians’ perspective of managing multiple chronic diseases. In considering this 
perspective, recognition is given to professional, practice and health systems level 
factors that enhance and inhibit clinicians’ ability to provide effective multimorbidity 
care.  
The final section of the chapter seeks to identify the foundations upon which “common 
ground” between patients’ and clinicians’ can be found (137). In navigating this 
pathway the chapter explores the notion of patient-centred care, as the foundation for 
multimorbidity care. Acknowledging that the application of patient-centred care may 
be difficult to achieve in practice, the chapter argues for shared decision-making as a 
means of operationalising patient-centred care in primary care practice.  
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2.2 Disease and Illness 
Arthur Kleinman, a psychiatrist and anthropologist, is widely credited with drawing a 
distinction between the concepts of disease and illness (64). His seminal article: 
“Culture, illness and care: Clinical lessons from anthropologic and cross-cultural 
research” (64), compiled with Eisenberg and Good, delineates illness, identified as the 
patient’s lived experience, from disease: the physical or mental malfunction health 
professionals treat. 
The notion of disease, synonymous with the biomedical model, and more recently 
evidence-based medicine, emerged as the dominant approach to medical care in the 
19th century following the work of leading scientists, including Louis Pasteur and 
Robert Koch, who identified the relationship between germs and disease, which 
validated germ theory (145). This ground-breaking work emerged at a time when acute 
and infectious diseases were most prevalent (65,145,146). The biomedical model, 
underpinned by reductionism, stems from the belief that complex phenomena originate 
from a single source (65,147). This allows  diseases to be considered in isolation, as 
separate entities, which are thought to appear and progress in the same way, 
regardless of the context or circumstances of the afflicted individual (64,132,147). The 
personal, cultural and/or social context of the individual is generally not used to inform 
diagnosis, treatment or management of the disease (64,65,132,148). 
Illness, according to Kleinman, Eisenberg and Good (64), is an individual’s reaction to 
disease, in short, their lived experience. The physiological symptoms and impact of 
disease generally affects people in similar ways, but the experience of illness, 
including the behaviours, attitudes, and beliefs that emerge as a result of the 
experience may differ substantially across individuals, populations and cultures 
(64,149-151). A person’s illness experience will inform the decisions they make 
regarding their health and health care (64,132,152-154). Individuals will respond, 
assign meaning, or make sense of their illness, within the context of an “illness 
narrative”: a term Kleinman coined in 1988 (155) to describe the individual’s story of 
illness. These narratives are generally culturally and socially bound, and are used by 
individuals, communities and populations to comprehend, assign meaning and make 
sense of the illness experience (146,155). 
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In examining the notions of illness and disease, this section has not only illustrated the 
divergence of clinical and lay perspectives it also establishes a baseline from which to 
examine the consequences of this distinction for care. The following sections move to 
consider the notions illness and disease within the context of chronic conditions. It 
begins with key definitional aspects, again reflecting on the distinction between illness 
and disease, it then moves to examine the broad body of literature investigating the 
patient’s experience of chronic illness and the clinician’s experience of managing 
chronic disease. 
2.3 Defining Chronic Conditions 
Kleinman (155) was again an early contributor to understandings of chronic illness 
through his work on illness narratives. Within the context of his investigations he 
described chronic illnesses as those: “that never entirely disappear” (155). In line with 
Kleinman’s focus, the Chronic Illness Alliance (156), which supports individuals living 
with chronic illness and the organisations that represent them, developed a definition 
of chronic illness to reflect the ways in which they dominate the person’s life: 
… an illness that is permanent or lasts a long time. It may get slowly worse 
over time. It may lead to death, or it may finally go away. It may cause 
permanent changes to the body. It will certainly affect the person’s quality of 
life (156). 
In contrast to this approach, more frequently cited definitions include those that identify 
the causes, longevity and incurable nature of chronic disease, as the following from 
the Australian Institute of Health and Welfare (AIHW) (157) illustrates:  
Chronic diseases are caused by multiple factors, including a person’s 
genetic make-up lifestyle and environment. They are long-term conditions 
and cannot be directly spread from one person to another (157). 
Under the umbrella of chronic conditions sit a collection of conditions with varying 
impacts ranging from mild through to life-threatening (144,158). Advances in medical 
care and technologies have also seen conditions that were once associated with short-
term survival become conditions with which people may live for many years (e.g., HIV) 
(52).  
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In Australia, priority chronic condition areas, based on prevalence and impact, have 
been identified in the National Chronic Disease Strategy (2). These priority areas 
include: asthma; cancer; diabetes; heart, stroke and vascular disease; and 
osteoarthritis, rheumatoid arthritis and osteoporosis (2). The National Strategic 
Framework for Chronic Conditions set to be released in late 2016 will provide a 
national approach to guide planning, design and delivery of policies, strategies, actions 
and services to reduce the impact of chronic conditions in Australia (125). The 
Framework will supersede the National Chronic Disease Strategy 2005 which has 
provided national policy direction through its recognition of the synergies across the 
prevention and management of many chronic conditions (125). 
2.4 Chronic Illness: The patient experience  
The following section provides a broad overview of the research investigating the 
patient’s experience of chronic illness. It steps through the seminal works of Strauss 
and Corbin, particularly their notions of illness trajectory and illness work. The 
discussion then moves to consider the individual’s experience of multiple chronic 
conditions: “the most common chronic condition” (25) and the treatment burden that 
arises from the complex interplay of multiple conditions. The final phase of this section 
draws from this discussion to explore how individuals work through complexity by 
establishing different processes of priority setting.  
Illness trajectory  
The longevity and variable nature of chronic conditions have significant implications 
for patients’ lives (159). Anselm Strauss, a medical sociologist, pioneered much of 
today’s understanding of people’s experiences of chronic illness. In the ground 
breaking book, “Chronic Illness and the Quality of Life” (160), Strauss provided 
accounts of living with chronic illness placing the focus squarely on subjective 
experience. The work was among the first to identify chronic disease as a health policy 
challenge, arguing that while disease may present in similar ways physiologically, an 
individual’s illness experience can vary substantially (160). In later works Corbin and 
Strauss (160) introduced the concept of the ‘illness trajectory’ to describe this 
experience: 
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… not only to the physiological unfolding of a patient’s disease but the total 
organisation of work done over the course of illness and the impact on those 
involved with that work and its organisation (160) 
For acute conditions, the patient’s illness trajectory is relatively linear and predictable, 
but in the context of chronic illness, the longevity, uncertainty and unending 
management means patients experience a more complex illness trajectory 
(144,151,161-172). In acknowledging the unique nature of the patient’s experience, 
Corbin and Strauss (144) documented a number of common phases that occur over 
the course of illness including: “trajectory onset”, “stable”, “unstable”, “acute”, “crisis”, 
and “dying”. Subsequent studies have observed similar phases (151,161,163-176). 
Trajectory onset begins with the person noticing symptoms, seeking medical 
assistance and, depending on the timing and manner of their illness, receiving a 
diagnosis (144). For some, diagnosis can provide relief legitimising the illness 
experience (144,169), but for many receiving a diagnosis is associated with a sense 
of losing control in the face of an unknown condition (144,164,172,177). This 
experience is most clearly illustrated by a participant in Whittemore and Dixon’s (177) 
United Kingdom (UK) study of the ways people integrate their chronic illness 
experience: 
I realised that I am not in the driver’s seat of my life anymore and that the 
diseases are and they control me. You know, I don’t control my life. You lose 
control and that is the biggest issue that I find (177) 
As individuals move through the trajectory onset phase they enter the stable phase 
and begin to gain some sense of stability and control (144). During this phase new 
strategies are adopted to maintain ‘normalcy’ and overcome the limitations imposed 
by the condition (144,172). The ‘work’ of individuals adapting to and managing chronic 
illness was first described by Corbin and Strauss (178,179) and has had a lasting 
influence on the field as illustrating the investment required by the individual. Corbin 
and Strauss (178) identified three types of work: “illness work”, “everyday life work” 
and “biographical work” (see Table 2.1)  
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Table 2.1 - Types of work 
Work type Description 
Illness work Managing symptoms, handling complex medication regimens, attending medical 
appointments, and avoiding and working through acute or crisis points (178). Illness 
work enables some patients to become experts (178) who operate in partnership with 
their clinican (173. This is not the experience of all as cultural, social, economic and 
generational factors impact a person’s ability to participate (180). 
Everyday 
life work 
Day-to-day activities, such as eating, going to work, maintaining relationships, looking 
after the children or cleaning the house (178), all of which may be impacted by the 
person’s condition (161,168,181,182).  
Biographical 
work 
Adaption or reconstruction of the individual’s life in accordance with the limitations 
imposed by the conditions (178). Adaption centres on achieving and maintaining 
normalcy in the context of the social and physical limitations imposed by illness 
(161,163,181,183-185). Through this work people may view themselves as two people 
- their past self (pre-diagnosis) and present self (post diagnosis) (186). The two can 
be difficult to reconcile as (163,167,171,181,184,186) the following quote, drawn from 
a participant in Asbring’s study of women with chronic fatigue and fibromyalgia (187), 
illustrates:  
Having lived a little over 2 years with a ‘me’ that is no longer the 
‘real me’, because it is a completely new person. As time passes 
I can find certain things that I recognize from before but the rest is 
actually new and it’s not me and I don’t recognise myself. And still, 
I must socialize with this person (187). 
Overall, Corbin and Strauss’ (144) notion of work provides insight into the illness 
experience and clarifies the effort required across all aspects of life to achieve 
normalcy. Through work, the individual may be able to maintain themselves in the 
stable phase for some time, but at different points they may also experience an 
unstable phase (144). 
Periods of instability stem from negative reactions to medication, natural progressions 
in the condition, diagnosis of additional conditions, or changes in social context 
(144,188). To regain stability re-adjustments to medications, lifestyle or social activities 
may be required (144,172). The clinician can play a substantial role in the person’s 
responses and adaptations during this phase (135,188,189) by reducing complexity 
(e.g., eliminating unnecessary medications or identifying synergies between 
conditions) and ensuring the prescribed treatment is feasible and fits within the 
patients’ context (190). Without assistance the person’s health may deteriorate 
causing them to enter an ‘acute’ or ‘crisis’ phase. 
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In more severe instances of instability, people can experience acute or crisis episodes 
(144). Acute periods can arise from exacerbations of illness symptoms, or 
complications associated with condition progression (144). During these periods 
hospitalisation may be required to stabilise the condition. Until the patient has 
recovered, their biographical and everyday work may be reduced or cease (144). In 
more extreme situations or periods of crisis, the person may experience a life-
threatening event necessitating emergency treatment and the discontinuation of 
illness work (144). Following hospitalisation or rest the person must again re-engage 
in work. This will often involve a significant investment as they come to terms with a 
new way of life and adapt to limitations manifested by their illness (144). 
Entering the later stages of the illness trajectory, the individual’s health will start to 
deteriorate as symptoms become more difficult to control and disability increases 
(144,172). Engagement in everyday activities may be significantly reduced, requiring 
further investment in biographical work. Finally, the patient enters the dying phase, as 
the body begins to shut down and the person is unable to participate in illness, every 
day and biographical work (144,172). 
In summary, research investigating illness trajectories and the experiences and 
challenges individuals face as they adapt and re-adapt, serve to reinforce the 
importance of understanding the person’s illness experiences (144). Moreover, Corbin 
and Strauss’ (178) notion of work highlights the investment individuals make, as daily 
managers of their health, and provides an understanding of why individuals are 
uniquely situated to recognise issues or gaps in prescribed care and identify the 
resources required to manage their health. 
Multiple conditions: the patient experience  
As the previous discussion has outlined, individuals must make substantial 
investments in the day-to-day management of a chronic illness, but for those with 
multiple conditions the challenges of living with chronic illness are amplified 
(16,111,191-194). Multimorbidity, “the most common chronic condition experienced by 
adults”, places significant demands on individuals, clinicians and the health system 
(25). Individuals must navigate an illness trajectory complicated by processes of 
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adaption and re-adaption linked to each subsequent diagnosis (135,182,194). Illness 
work in this context involves the management of conflicts and interactions between 
multiple conditions and their associated medications and treatments (25). As Sells et 
al. (182) argue, the experience of being diagnosed and living with multiple conditions 
becomes a “cascade of crises” where individuals are constantly challenged physically, 
psychologically and socially.  
Research investigating the experience of managing multiple chronic conditions has 
grown in prominence in recent years, as an increasing number of largely qualitative 
studies have examined the challenges people face (133,135,195-198). Much of this 
research has highlighted the additional work and investment associated with multiple 
conditions (25), but extending on this Gallacher and colleagues (199) argue work is 
not only generated by the day-to-day but also through the treatment decisions made 
by health practitioners. In line with this, they emphasize the notion of ‘treatment 
burden’ which incorporates: 
the ‘workload’ of health care that patients must perform in response to the 
requirements of their healthcare providers as well as the ‘impact’ that these 
practices have on patient functioning and well-being (200). 
Treatment burden arises from the need to learn about treatments, attend medical 
appointments, undergo tests or examinations, and adhere to complex medication and 
self-care regimens (95,199,201,202). For those managing multiple chronic conditions 
these demands are amplified in the face of unwanted complications and complexity 
(73,95,202,203). Investigating the time individuals spend on health related activities 
(e.g., travelling to health services; participating in support groups; and taking 
medications) Jowsey et al.’s (204) study of over 2500 individuals with multiple 
conditions found that the time spent increased with each condition. On average, 
people with two-four conditions spent 11.1 hours on health related activities (excluding 
exercise) per month, increasing to two-three hours per day for those with five or more 
conditions (200).  
Through investigations of the impact of treatment burden, researchers have identified 
a number of different types of burden (see Table 2.2). For example, a large scale 
Australian study involving participants with one or more chronic conditions, identified 
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financial burden as the most significant burden experienced by participants, followed 
by lifestyle, social, administrative and medication burden (205). Not surprisingly, 
researchers have also identified that as care becomes more complex, the level of 
burden also increases (205,206). This increasing burden is clearly illustrated by the 
findings of an Australian study involving elderly people with three or more conditions 
(56). Roughead et al. (56) found that most participants consulted their GP 12 times a 
year on average; interacted with seven or eight medical professionals; received more 
than 80 health services; visited a pharmacist approximately every ten days, and were 
dispensed around 60 prescriptions per year.  
Table 2.2 - Types of treatment burden 
Burden type Description 
Financial 
Burden 
The costs of medications, consultations and tests which can rise substantially as 
care becomes more complex (56,93,102,111,205-207).  
Administrative 
Burden 
Time spent scheduling appointments, travelling to and attending appointments and 
undergoing tests (205,206). This burden is compounded by lack of collaboration and 
coordination between providers, and provision of contradictory or incomplete advice 
(93,205,207-209). Care may be fragmented and incomplete as patients transition 
from one clinician to another (13,20,93,111,121,207-210).  
Medication 
Burden 
Arises from managing various medications, their side effects, and the associated 
stigma (205,206). The coordination of medications and the interactions between them 
is commonly flagged as a core burden (56,93,129,195,197,205,206,211). Multiple 
medications (Noel et al. (93) identified that some patients take up to 27 medications) 
are associated with confusion, a sense of being overwhelmed 





The demands associated with learning about the conditions and adapting and 
adhering to new lifestyle practices (e.g., diet and meal planning, exercise) (205). 
Such changes are often difficult to implement as individuals with multiple chronic 
conditions, experience greater disability and physical impairment than is generally 
associated with one condition (73,79,93,111-113,192,193,212).  
Social Life 
Burden 
The impact on social relationships, including interactions with children, needing 
assistance with housework, or having to take medication in front of people (205). This 
burden has been linked with psychosocial distress, feelings of powerlessness, 
stigma, loneliness, humiliation, anger, despair (73,93,106,193,213), elevated rates of 
depression (93,105), and reduced quality of life (79,214-216).  
In summary, patients with multiple chronic conditions experience added treatment 
burden embedded in the management of their complex and diverse health care needs. 
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Looking to simplify the complexity of managing multiple chronic conditions and the 
resulting treatment burdens, patients must frequently prioritise conditions, goals, 
medications and/or outcomes (28,73,93,133,135,189,196,206,217-223).  
Prioritising 
A critical challenge to emerge from the multimorbidity literature is the need to 
acknowledge and incorporate patient preferences for care, particularly in relation to 
determining treatment and management priorities (28,73,93,133,135,189,196,217-
223). Individuals with multiple conditions are tasked with managing complex treatment 
regimens, complicated by conflicting conditions, medications, treatments and 
outcomes (201). To reduce treatment complexity and minimise negative interactions 
individuals must set priorities (211,221). Bratzke et al.’s (221) narrative review of 
thirteen studies investigating priority setting and decision-making among patients with 
multiple conditions, found priorities were set based on the person’s beliefs and 
attitudes, with one condition often taking priority over others. Priorities were general 
established in accordance with four main factors: the predictability of the condition; 
whether the condition could be controlled by medication; whether the condition 
disrupted others; and the perceived severity of the condition and its impact on daily 
life (221). However, Bratzke and colleagues (221) also noted variability across the 
reviewed studies in how patients’ perceived or determined condition severity and 
impact on daily life. This perception was linked to: how ‘worrisome’ the condition was 
perceived to be; the physical symptoms; or the person’s ability to achieve ‘global’ 
rather than disease-specific outcomes (e.g., maintenance of physical function, 
symptom relief and quality of life) (221).  
Bratzke et al.’s (221) review illustrates that the establishment of priorities is not fixed; 
they change in accordance with the individual’s social and life circumstances or 
following the diagnosis of an additional condition. Providing further clarification of the 
reasons why priorities change, Morris and colleagues’ (135) found that individuals re-
prioritise at “pivotal points”. Pivotal points generally coincide with the diagnosis of an 
additional condition, which disrupts or aggravates the person’s other conditions and 
requires the acquisition of new skills or the rearrangement of old ones (135). Morris et 
al. (135) found that individuals who were diagnosed with a new concordant condition 
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were generally able to transfer existing self-management practices across conditions, 
whereas those diagnosed with a discordant condition often reached a “tipping point” 
as they struggled to accommodate changes in lifestyle, medication management 
and/or develop of new skills (135). At these points, patients will often seek additional 
support from clinicians to assist with the re-prioritising process, with the success of 
these interactions largely determining whether patients can easily accommodate the 
new condition or are overwhelmed and reach a tipping point (135). In support of these 
findings, Kerr et al.’s (189) study of nearly 2000 people with diabetes and a range of 
comorbidities, found that those with discordant conditions needed greater support or 
assistance when setting priorities than those with concordant conditions.  
Overall, research investigating priority setting illustrates the range of factors 
influencing how and why patients prioritise and highlights the points at which the 
individual may need to work with a clinician to establish priorities. However, discussion 
and negotiation of priorities is clearly not always straightforward as patients’ priorities 
may differ from their clinician (21,70,135,219,220), who’s focus often centres on 
individual conditions at the expense of interactions between conditions (21). To 
investigate these issues further, the following section examines the clinician’s 
experience of managing chronic disease and the way in which their perspective, 
grounded within a disease model and informed by an evidence-based approach, often 
drives a different priority setting agenda that may conflict with the patient’s illness 
based perspective.  
2.5 Chronic disease: the clinician experience 
The bulk of clinical care for multiple long-term conditions takes place in the primary 
practice setting (6,8,9,13-15). Yet, numerous studies highlight the challenges facing 
GPs who provide care for this growing disease profile (18,19,21,224). These 
challenges arise at the professional, practice and health system levels.  
At the professional and practice level, the notion of disease is a central driver informing 
the clinician’s approach to the management of chronic disease (132,155). As the 
preceding discussion of disease highlighted, clinicians’ training, practice and broader 
workforce culture is grounded within the biomedical model (132,155). More recently, 
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the biomedical model has been underpinned by evidence-based medicine which has 
emerged as the dominant paradigm directing medical decision-making. Evidence-
based medicine refers to: 
The conscientious, explicit and judicious use of current best evidence in 
making decisions about the care of the individual patient. It means 
integrating individual clinical expertise with the best available external 
clinical evidence from systematic research (225). 
As Sackett et al.’s (225) definition illustrates, the focus of evidence-based medicine is 
on making the best clinical decisions for the patient, but in practice evidence-based 
medicine has been criticised for its strong disease focus; rigid application of treatment 
and management protocols matched to individual diseases; and its inability to inform 
the care of ‘deviant cases’ who are often actively excluded from the research trials that 
generate evidence (130,226-228). Notably these deviant cases often include those 
experiencing multiple conditions (227,228).  
Thus despite the prominence of evidence-based medicine, its inability to 
accommodate those with multiple conditions in the process of generating evidence 
has resulted in a dearth of best practice methods to guide treatment (15,16). As a 
result, clinicians, like their patients, experience high levels of uncertainty in the 
presence of multiple conditions due to limited evidence on how conditions, 
medications and other treatments will interact or conflict 
(19,73,79,123,211,224,229,230). Consequently, clinicians are left with two options: 
apply multiple single-condition based interventions and risk prescribing harmful and/or 
conflicting treatment regimens that further magnify the patient’s treatment burden (62); 
or abandon evidence-based medicine and rely on their judgement to develop care 
decisions and treatment priorities (226,231-233). The latter option is supported by 
those clinicians who argue they are most able to develop care arrangements for their 
patients (226,231-233); however this option may also fall short if it is dominated by a 
disease model. Illustrating this concern, Bower and colleagues’ (21) examination of 
clinical priority setting found GPs prioritised individual diseases to ensure pressing 
medical concerns were addressed before the consultation ended; any remaining 
health concerns, which may have arisen from the interaction of conditions, were put 
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off until the next consultation. Overall, both options are limited in practice and their 
ability to provide optimum care is not without question, but the barriers posed by the 
health system appear to create further challenges that clinicians must also navigate.  
At the health system level, primary care clinicians operate within a system and policy 
context that can support or undermine their capacity to deliver effective multimorbidity 
care. Many of the key barriers GPs face including: time constraints (17-21); restrictions 
imposed by fee for service arrangements (23,24,54,157); and fragmented rather than 
coordinated care (19,20,224) are most visible in the clinical setting, but stem from 
health system arrangements designed to support acute and single long-term 
conditions, rather than the complex management of multiple conditions 
(19,61,211,224). As Loeb et al. (234) argue, reliance on professional or personal 
strategies do not overcome the system barriers that prevent GPs from delivering 
optimal care.  
In summary, the preceding sections of this chapter have endeavoured to navigate the 
experience of patients and clinicians living with and managing multiple chronic 
conditions. The discussion has identified that patients and GPs experience numerous 
barriers associated with the management of multiple chronic conditions, but at the 
patient level, the process of prioritising and re-prioritising emerges as a potential 
response to address some of these barriers. As the gatekeeps of care, GPs appear 
best placed to work with patients to set priorities, but the goals and priorities 
established through the clinical consultion may not always align (21,70,135,219,220): 
a challenge that has potentially signficant consequences for management. Patients 
whose priorities and goals align with their clinician report greater satisfaction with their 
health care (137,235-237), but those who do not report higher levels of non-adherence 
and adverse outcomes (132,137,179). Acknowledging and incorporating patient 
priorities and preferences and navigating “common ground” (137) between clinical and 
lay perspectives clearly warrants further investigation to ensure the aims of 
multimorbidity care can be achieved.  
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2.6 Reaching common ground and developing shared 
understanding 
Understanding the distinction between disease and illness has important implications 
for approaches to management and treatment as clinicians and patients seek to 
explain poor health; identify what is important; determine how they will behave or act; 
and construct responses (64,132,152-154). From a clinical perspective, emphasis is 
placed on diagnosing and treating disease (64,65). To do this, the clinician may draw 
on a range of sources of information including: clinical tests, published evidence, 
medical records and their knowledge of the condition to inform management as Figure 
2.1 illustrates (137). However, the clinical determination of disease and its 
management may differ from, or even conflict with, the patient’s perspective. As 
Kleinman et al. (64), and others argue (64,149,150,193), it is not the physiological 
aspects of the disease, but the broader social and emotional experience of illness that 
is central to the patient. As Figure 2.1 highlights, the person’s social and cultural 
context, experiences, preferences, and feelings are fundamental to their 
understanding of disease and how it must be managed (137).  
 
Figure 2.1- Factors informing the clinical and patient perspectives 
In reflecting on the contributions of the clinician and patient, it is clear that both 
explanatory models are legitimate: neither should be given primacy nor considered in 
isolation as the implications for management and care are potentially detrimental 
(132,137,179). A substantial body of empirical research, conducted over the last forty 
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years, particularly within primary care settings, has found that care focused solely on 
single body systems and diseases can lead to tensions between clinicians’ and 
patients’ preferences and goals for care (21,64,65,131,132). At heart of the challenge 
then, is the need for patients and clinicians to find, what Stewart and colleagues (137), 
identified as “common ground”. Stewart et al. (137) proposed that effective care 
requires clinicians and patients to find common ground and develop a shared 
understanding between their respective disease and illness informed perspectives 
(see Figure 2.2).  
 
Figure 2.2 - Reaching a shared understanding between clinician and patients perspectives 
Understanding patients’ illness experiences is particularly important for primary care 
clinicians as they are generally responsible for managing a person’s health over long 
periods of time and act as advocates and care coordinators for their patients. As such, 
there is a strong imperative for primary care clinicians’ to treat or manage the disease 
with due consideration of the unique illness perspectives of individual patients 
(64,65,132,137). Disagreements or conflicts arising from differing perspectives need 
to be identified and discussed to reach agreement (137). Without this common or 
shared understanding, care may be compromised, patients may not adhere to the 
prescribed treatment or feel their voice has not been heard, fostering a negative 
clinician-patient relationship (132,137,179). Patients are more likely to benefit if they 
are engaged in care decisions to reach a shared understanding with their clinician 
(137,235-237). At the centre of this approach is the notion of patient-centred care. 
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2.7 Patient-centred care 
Patient-centred care has been defined as: 
Healthcare that establishes a partnership among practitioners, patients, and 
their families (when appropriate) to ensure that decisions respect patients’ 
wants, needs, and preferences and that patients have the education and 
support they need to make decisions and participate in their own care (238)  
In essence, patient-centred care aligns closely with the notion of illness but seeks to 
actively engage the patients’ voice in the delivery of care, particularly for those 
experiencing multiple long-term conditions.  
The Picker Institute, an international non-profit organisation devoted to furthering the 
study and application of patient-centred care, outlines eight dimensions of patient-
centred care (239). The “Picker Principles”, acknowledge the breadth of engagement 
required to establish the patient voice, and were developed from a comprehensive 
review of the literature and focus groups with patients, family and carers, clinicians 
and non-clinician hospital staff (239,240) (see Box 2.1). 
1. Involvement of patients in health care decisions and respect for their values and preferences 
for care 
2. Provision of coordinated, effective and integrated care 
3. Clear communication and provision of information to patients to support self-management 
4. Acknowledgement of the patients’ physical and environmental needs 
5. Support and respect for patients’ emotional needs 
6. Involvement of the patients’ family and/or carer 
7. Support continuity of care and patients’ transition between providers and settings 
8. Ensure patients’ have access to fast and reliable healthcare 
Box 2.1 - The Picker Principles: Dimensions of Patient-Centred Care (239) 
In principle there is active support for the notion of patient-centred care and the 
overarching ideals have been widely embraced (130,137,241,242); however as with 
evidence-based medicine the application of these ideals in clinical practice are less 
straight forward and have drawn criticism (130,241,242). In particular, patient-centred 
care appears to represent a less structured approach, which requires additional time 
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and has no clear methods for measuring effectiveness (242). Notably it also involves 
a redistribution of power within the clinical consult, which may be considered a threat 
by some clinicians who have established a predominant role in their relationship with 
the patient (242). The most prominent critique relates to a widely held view that patient-
centred care is something of a “fuzzy concept” (130). In line with this Stewart suggests 
it is: “most commonly understood for what it is not—technology centred, doctor 
centred, hospital centred, disease centred” (243).  
In acknowledging the inherent difficulties associated with operationalising patient-
centred care in the clinical setting some have argued, shared decision-making may 
provide an active patient-centred method to engage patients and clinicians in care 
(244). In line with this, Barry and Edgeman-Levitan (244) argue shared decision-
making may provide the practical steps clinicians and patients need to develop a 
shared understanding between their distinct perspectives (see Figure 2.3).  
In line with this, shared decision-making will be used throughout this thesis as a proxy 
for the broader concept of patient-centred care. The following discussion provides an 
overview of the literature describing and investigating the evidence informing the use 




Figure 2.3 - Role of patient-centred care and shared decision-making on clinician-patient 
relationship 
Shared decision-making 
Shared decision-making is defined as:  
a consultation process where a clinician and patient jointly participate in 
making a health decision, having discussed the options and their benefits 
and harms, and having considered the patient’s values, preferences and 
circumstances (245) 
As a central component of patient-centred care (137), shared decision-making 
assumes even greater salience in multimorbidity care because there is often not a 
single correct treatment option (244,246). Often when faced with a decision, patients 
and clinicians may discuss two or more available options (140, 209). In some 
instances, one option may far outweigh the others, while others might be preference-
sensitive (244,246). Preference-sensitive decisions, are those for which there is limited 
evidence informing the options; the benefits and harms of the provided options are 
similar; or the evidence does not favour one option over another (141,247-252). In 
these situations the preferences and priorities of the patient need to be considered, as 
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the value placed on the expected benefits, harms and/or outcomes may differ across 
clinicians and patients, across patients faced with the same decision, and within 
patients over time (244,246,251,253).  
Charles et al. (246,254) argue that for shared decision-making to occur, both 
participants (i.e., the primary care clinician and the patient) must work through three 
components (see Table 2.4). 




Involves both participants sharing and exchanging information (140, 218). At this 
stage clinicians would present the treatment or management options, for which a 
decision needs to be made. Knowledge of disease progression, known risks and 
benefits, along with their preferences or perspectives on the various options is also 
shared (140, 218). In response, patients may share information regarding their 
lifestyle, social context, beliefs or fears regarding their disease(s) or treatment options. 
At this point patients should be encouraged to share their preferences and goals for 
care, along with any information or prior knowledge regarding the presented options 
(140, 218).  
Deliberation Involves both participants deliberating and discussing the exchanged information 
(140, 218). Patients and clinicians preferences for care can differ. For example, 
clinicians may view the benefit of a particular option as outweighing the potential risks 
or side effects whereas patients may place greater importance on avoiding the side 
effect. These differences, if not addressed, can foster a negative clinician-patient 
relationship (97, 100, 111). This process is about working through the information 
exchanged and exploring both the patients’ and clinicians’ preferences for care, to 




Involves the clinician and patient reaching an agreement and deciding on a particular 
option (140, 218). After having shared the relevant information and deliberated around 
it, the final decision should reflect both participants’ agreement based on their shared 
knowledge and preferences for care (140, 218).  
Subsequent authors (141,247,248,255) have identified similar components or steps, 
but central to all of these works is the focus on engaging and involving patients in 
decision-making processes. Of note is the emphasis on sharing information in order 
to achieve shared decision-making. While it is often assumed these steps occur 
symbiotically, this is not always the case (256). For shared decision-making to occur, 
participating persons must share their relevant knowledge and preferences. This 
process of sharing information, before jointly deliberating and agreeing on a decision 
is what differentiates the shared decision-making model from other approaches such 
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as the paternalistic model, which places the patient in a passive role alongside 
dominant clinician, and the informed model, which locates the patient in a dominant 
position while the clinician functions in the more passive role of information provider 
(246,256).  
Shared decision-making seeks to find a balance between these approaches through 
emphasising the importance of both parties sharing information in order to participate 
in shared decision-making. Clinicians need to share their knowledge on the patients’ 
diseases and the evidence informing treatment or management and patients’ need to 
share their preferences, priorities and expectations regarding care. In line with this, 
Charles et al. (246) suggests:  
shared decision-making is seen as a mechanism to decrease the 
informational and power asymmetry between doctors and patients by 
increasing patients’ information, sense of autonomy and/or control over 
treatment decisions that affect their wellbeing.  
Shared decision-making is increasingly considered an “ethical imperative” (257), and 
a characteristic of good clinical care (245,258). Despite, the increasing emphasis on 
shared decision-making, its benefits have not been extensively examined (259,260). 
Most literature examining the benefits of shared decision-making centres on patient 
decision aids (PDAs) (245). The most recent of a series of systematic reviews, 
concluded the use of PDAs results in patients having an increased knowledge of 
options, improved risk perceptions, lower decisional conflict, and selection of options 
more in line with their preferences (251). In addition, a longitudinal study into medical 
decision-making for 203 women with breast cancer, found those who were more 
engaged in choosing their treatment had significantly higher overall quality of life than 
those who were passively involved (236).  
In Australia, share decision-making is encouraged in clinical practice guidelines, policy 
documents and by consumer health organisations (44,258). However, there is no clear 
strategy for implementing shared decision-making in primary care practice 
(44,245,258), although, this may change with the newly released ‘Better outcomes for 
people with chronic and complex health conditions’ report (54) and the soon to be 
released National Strategic Framework for Chronic Conditions (125). Presently, the 
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tools and infrastructure needed to support shared decision-making are lacking 
(44,245,258). According to Hoffman et al. (245),  
Australia is drastically lagging behind many other countries in all aspects of 
shared decision-making — policies, lobbying, advocacy, research funding, 
training, resources and implementation (245)  
Consequently, they call for greater system support of shared decision-making in 
primary care practice (245).  
A systematic review of 38 studies investigating health professional’s perceptions of 
shared decision-making identified three core facilitators to uptake of shared decision-
making by clinicians (261). These included: clinician motivation; the belief that shared 
decision-making would lead to improve patient outcomes; and the belief that shared 
decision-making would lead to improved clinical processes (261). This suggests 
primary care clinicians recognise the importance of participating in shared decision-
making (261), but encounter challenges in practice. Known barriers include: short 
consultation times; limited training for clinicians on how to participate in shared 
decision-making; threat to power relationships; and limited availability of resources or 
tools to support shared decision-making (262,263). Consequently, clinicians (40, 192, 
195), along with the RACGP (33) and the PHCAG (54) have called for methods to 
support shared decision-making and work through potential differences in priorities. 
Working through the shared decision-making components, outlined by Charles et al. 
(246), is one way clinicians and patients could achieve shared decision-making and 
support multimorbidity care within the clinical encounter. To support this work, the tools 
informing primary practice should also assist clinicians and patients to meet these 
steps. In Australia primary care practitioners draw on a range of tools, but it is unclear 
to what extent these tools enhance or limit clinicians’ ability to participate in shared 
decision-making for patients with multiple conditions. This thesis seeks to address this 
question but first the tools supporting clinical care need to be identified.  
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2.8 Conclusion 
The aim of this chapter was to contextualise lay and clinical perspectives, as they map 
with the notions of illness and disease, to inform an understanding of the management 
of chronic conditions. Building on this discussion the chapter explored the experience 
of living with multiple chronic conditions and the many challenges patients and 
clinicians experience when managing these conditions. A critical argument arising 
from this discussion was the need to engage patients in care decisions to ensure they 
are supported in priority setting processes and are able to participate in the 
development of a shared understanding with clinicians. The chapter proposes shared 
decision-making, a central component of patient-centred care, as one way of 
facilitating this process. On the basis of this discussion, the following chapter seeks to 
identify and describe the current primary care practice tools that could be used to 
assist patients and clinicians to achieve shared decision-making. 
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 Chapter 3 Primary care practice tools 
3.1 Introduction 
Chapter two provided a foundational understanding of chronic illness and disease from 
the perspectives of patients and clinicians. Arising from this discussion was the need 
to ‘reach a shared understanding’ between patients and clinicians whose perspectives 
may differ. Shared decision-making was argued as one approach to facilitate this 
process and achieve multimorbidity care. However, as noted in Chapter two, shared 
decision-making is not consistently practised across primary care settings. Identified 
barriers include: short consultation times; inadequate training of clinicians in practising 
shared decision-making; and limited availability of resources or tools to support shared 
decision-making (262,263). Clinicians (19,224,230), along with the RACGP (33) and 
the PHCAG (54), have called for tools to support shared decision-making in primary 
care, particularly when managing multiple conditions.  
Building on this discussion, the purpose of the present chapter is to identify and 
consider current primary care practice tools and their ability to contribute to shared 
decision-making and multimorbidity care. As such, the chapter is comprised of three 
sections. The first section briefly revisits the discussion, presented in Chapter one, 
describing what is meant by the term ‘primary care practice tool’ and why they are the 
focus of this thesis.  
Having reiterated the importance of these tools, the second section outlines the 
methods used to identify the three primary care practice tools which are the focus of 
this thesis. Clinical practice guidelines and care plans emerged as two tools, 
instrumental in providing chronic disease care in Australian primary care practice. 
These tools were validated by expert stakeholders, who also identified an additional 
tool - PDAs. Extending on this discussion the final section of this chapter provides a 
brief description of each of the three tools, including their purpose, benefits in a single 
disease context, and relevance for patients with multiple conditions.  
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3.2 Primary care practice tools 
Primary care clinicians draw on a range of tools to support care provision, from 
diagnostic tests, to evidence-based clinical practice guidelines, to care plans (32). For 
the purposes of this thesis, primary care practice tools are those that support the 
clinical consultation between primary care clinicians and patients through the 
standardisation of information or processes. Development of such tools typically 
springs from the need to support practice wide change, or establish uniformity in care 
provision, due to clinician need, gaps in care provision, new research or policy debates 
(30,32). Regardless, of their individual purpose, all of these resources and tools inform 
and influence the way clinicians choose to provide care (4,30,32,264). As such, some 
can and have been used as mechanisms to influence system wide change in care 
provision (30,32,41,42). Recognising this role, this thesis chose to focus on primary 
care practice tools rather than on the practice or actions of individual clinicians. This 
research takes the viewpoint that primary care practice tools have previously 
contributed to practice wide change (30,32,41,42) and therefore could support a shift 
towards better care for those with multiple chronic conditions. In taking this viewpoint 
the thesis applies the theory of incrementalism to data analysis and interpretation (37).  
The theory of incrementalism advocates “an evolutionary rather than revolutionary 
process” (140) to policy decision-making. This contrasts most prominently with 
rational-comprehensive theory, which espouses a process of policy decision-making 
whereby decisions are made following a comprehensive examination of all choices 
and their impacts (36-38). Although considered the ‘ideal’ the rational-comprehensive 
approach is rarely achieved in practice, as policy makers are seldom able to identify 
or reach a consensus with all stakeholders on the core objectives to be achieved 
and/or the methods to attain them, due to limitations in time, evidence and resources 
(36-38). Consequently, Lindblom (37) proposed the theory of incrementalism as a 
more realistic and achievable approach to real-world policy decision-making. Although 
numerous other theories exist, incrementalism features prominently in Australian 
public policy and numerous examples demonstrate that this is what drives change in 
health policy and practice (39,40,265-268).   
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Within the context of this research incrementalism offers a framework for considering 
how policy relating to primary care for chronic disease had been developed in Australia 
and how changes might be made in the future. Specifically, applying incrementalism 
led the thesis to be framed around the question of what changes, if any, to existing 
primary practice tools are required to support a shift toward multimorbidity care rather 
than a question focused on large-scale comprehensive system reform.  
Clinical practice guidelines and care plans are two examples of primary care practice 
tools used extensively in Australia to drive care provision.  
 Guidelines, as mentioned earlier, are considered the epitome of evidence-
based medicine, and as such are viewed not only as a means of guiding the 
provision of quality care but also as a means of evaluating it (264,269). Clinical 
practice guidelines, were identified in both the chronic illness literature and 
policy discussions as core tools directing care provision in primary practice and 
the health system more broadly (2,30,32,33,54,233,270).  
 Care plans facilitate coordinated multidisciplinary care, which actively involves 
the patient and is structured to their individual needs (4,39,271-273). Care plans 
have been a core part of primary care practice in Australia for almost two 
decades (4,39,271-273). They are widely supported in the chronic illness 
literature, health policy, clinical practice guidelines and care models as a means 
of individualising chronic disease care (33,54,136,159,272-276). 
Given their significance as core tools aiding and informing chronic disease 
management in primary care settings, both clinical practice guidelines and care plans 
were included for analysis in this research. To validate the importance of these tools 
and to ensure no other relevant tools had been missed, leading primary care 
researchers were identified.  
3.3 Expert stakeholder consultation 
A purposive sample of primary care clinicians, with expert knowledge regarding 
primary care practice tools currently available to support the management of chronic 
conditions, was identified and questioned. Purposive sampling involves deliberately 
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selecting participants based on certain qualities and experiences the participants 
possess, which might be overlooked when using a convenience or random sample 
(277,278). The study sought participants with expert knowledge in health systems and 
policy aspects of primary care.  
Ten primary care clinicians were identified through ‘Research Profiles’ a searchable 
online platform. The platform was developed in 2003, by the Primary Health Care 
Research and Information Service (PCHRIS), and allows those involved in primary 
care research to share their achievements, research ideas, research outcomes and 
ongoing or future research projects (279). Emails were sent to ten primary care 
clinicians informing them of the current study and inviting them to participate in a short 
(approximately 5 minute) survey (appendix 1). The difficulties of engaging GPs in face-
to-face interviews are well documented, therefore a short online survey was 
considered more appropriate given the survey’s purpose, and the increased likelihood 
of a higher response rate (280,281). Considerable effort was placed on the format and 
content of the questions to ensure they would not exceed five minutes, as research 
suggests primary care clinicians are less likely to participate in studies which require 
more of their time (280,282). An information sheet (appendix 2) was included in the 
text of the email and potential participants were advised that clicking on the link to 
answer the questions via ‘Survey monkey’ would indicate consent to participate in the 
study The University of Queensland’s School of Population Health Research Ethics 
Committee approved the study (appendix 3). 
The questions asked of the expert stakeholders are shown in Figure 3.1 below. The 
questions related directly to the professionals opinions and did not ask for information 
on specific patients, as research suggests clinicians are often reluctant to participate 
in studies which disrespect their patient’s confidentiality (282). 
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Figure 3.1 - Screenshot of the 'Survey Monkey' survey sent to expert stakeholders 
Six GPs responded to the survey. All the responses to free-text questions were 
ordered and the process of thematic analysis was used to guide analysis (283,284).  
Clinical practice guidelines and care plans were confirmed as core tools used in the 
management of multiple chronic conditions in primary practice. Clinical practice 
guidelines received an average rating of 3.2 out of 5 for their usefulness in the 
management of multiple conditions, and care plans received a rating of 3.8 out of 5. 
Two additional tools were identified: prevention guidelines, and PDAs. As this thesis 
aimed to investigate primary care practice tools which assist with the management, 
not prevention, of multiple conditions prevention guidelines were excluded. PDAs were 
included for analysis.  
In summary, three primary care practice tools: clinical practice guidelines, care plans, 
and PDAs were identified and validated through consultation with expert stakeholders. 
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The following section provides a brief description of each of these tools starting with 
clinical practice guidelines.  
3.4 Clinical practice guidelines  
In the 1990s, the Institute of Medicine released a series of reports on clinical practice 
guidelines, which they defined as a “systematically developed statement to assist 
practitioner and patient decisions about appropriate health care for specific clinical 
circumstances” (285). Since this time the development and use of clinical practice 
guidelines has continued to rise, with guidelines now being considered a core 
component of quality care translating evidence into practice (227,269,286,287). Wolff 
(269) attributes the growing interest in clinical practice guidelines to three major 
factors: rising health care costs; variations in clinical practice; and the provision of 
inappropriate care. Clinical practice guidelines are viewed as a means of overcoming 
these issues by drawing clinicians’ attention to ineffective, wasteful and potentially 
harmful practices, thereby improving consistency of care (288). Although, initially 
developed based on consensus among experts in the field, clinical practice guidelines 
have shifted to being based on systematic research evidence in line with the evidence-
based medicine movement (227). As a result they are generally created for the 
‘average patient’ from population based trials with narrow inclusion criteria (227). In 
essence, clinical practice guidelines provide health care providers and patients with 
evidence-based recommendations on the best methods for treating and managing 
certain health concerns (108,289,290).  
Clinical practice guidelines have demonstrated their effectiveness in guiding the 
management of single chronic conditions, by improving the consistency of care and 
drawing clinicians’ attention to ineffective and potentially harmful practices (288,291-
294). A systematic review of 59 studies investigating the effect of clinical practice 
guidelines found all but four reported improved adherence to the recommended 
procedures. Of the 11 studies that examined the outcomes of the recommended care, 
nine showed statistically significant improvements (291). Similarly, a systematic 
review of 20 studies examining the use of Dutch guidelines found their use significantly 
improved the structure of care in 17 of the 19 studies examining this outcome (293). 
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In addition, of the nine studies which look at patient health outcomes, six showed 
significant improvements as a result of guideline use (293). 
Relevance in a multimorbidity context 
In considering the relevance of clinical practice guidelines to support multiple chronic 
conditions, a number of limitations have been observed including: the quality of 
guidelines; their consideration of multiple conditions; and their accessibility. Each of 
these is considered in more detail below, starting with guideline quality.  
Guideline quality 
For guidelines to improve health care, they need to be of sufficient quality (295). Tools 
such as the Appraisal of Guidelines, Research and Evaluation (AGREE II) instrument 
have been developed to evaluate the quality of guidelines (296). The AGREE 
instrument uses twenty-three items across six domains (see Box 3.1), to assess the 
method of guideline development and how well these methods were reported (296). 
Domain 1. Scope and Purpose is concerned with the overall aim of the guideline, the specific health 
questions, and the target population (items 1-3).  
Domain 2. Stakeholder Involvement focuses on the extent to which the guideline was developed by 
the appropriate stakeholders and represents the views of its intended users (items 4-6).  
Domain 3. Rigour of Development relates to the process used to gather and synthesize the evidence, 
the methods to formulate the recommendations, and to update them (items 7-14).  
Domain 4. Clarity of Presentation deals with the language, structure, and format of the guideline 
(items 15-17).  
Domain 5. Applicability pertains to the likely barriers and facilitators to implementation, strategies to 
improve uptake, and resource implications of applying the guideline (items 18-21).  
Domain 6. Editorial Independence is concerned with the formulation of recommendations not being 
unduly biased with competing interests (items 22-23). 
Box 3.1 - The six domains of the Appraisal of Guidelines, Research and Evaluation (AGREE II) 
instrument (297). 
Currently there is no ‘gold standard’ process for developing guidelines and as a result, 
methodologies can differ. Many organisations have attempted to standardise guideline 
development by creating handbooks, which require guideline developers to meet 
certain methodological standards (295,296,298,299). In Australia, to receive approval 
from the National Health and Medical Research Council (NHMRC), guideline 
developers must meet the standards set out in the “NHMRC procedures and 
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requirements for meeting the 2011 NHMRC standard for clinical practice guidelines” 
(286). However, organisations are free to develop and disseminate guidelines without 
meeting quality standards and as a result clinicians are exposed to numerous, often 
conflicting guidelines of varying quality (295). 
An Australian study investigating the quality of guidelines for older people with 
comorbidities, assessed using the AGREE instrument1, found the quality of guidelines 
varied widely (295). Guidelines that did not receive approval from the NHMRC 
generally had poor descriptions of the methods used for collating evidence and 
creating recommendations, in comparison to those guidelines that had received 
NHMRC approval (295). Without a clear account of the methods used to develop 
guideline recommendations, clinicians are unable to determine the strength and 
quality of the recommendations and their applicability to patients (295). 
Consideration of multiple conditions 
A common criticism of guidelines is that they focus too much on single chronic 
conditions (12,27,62,295,300,301). While, this mirrors the way evidence is collected, 
it does not reflect the realities of primary care practice where the number of patients 
presenting with multiple conditions is increasing (301). 
An Australian review of guidelines and their significance to older patients with multiple 
conditions found current guidelines have little relevance to this population group 
(139,295). Of the 17 guidelines reviewed, nine provided guidance for patients with one 
comorbid condition, two for patients with multiple conditions, and only one for elderly 
patients with multiple conditions (139,295). Similarly, a Canadian systematic review of 
guidelines addressing comorbidity, found their applicability to patients with multiple 
conditions was limited. Of the 20 guidelines identified only 14 gave specific 
recommendations for the treatment of comorbidities, with a mean of three comorbidity 
related recommendations per guideline (71). The majority of these recommendations 
addressed concordant conditions (46 recommendations) rather than discordant 
conditions (8 recommendations) (71). None of the recommendations provided 
                                            
1 The AGREE instrument was updated in 2010, subsequent to the article’s publication, and renamed 
the AGREE II.  
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guidance for patients with more than one co-existing condition (71). Hughes, McMurdo 
and Guthrie (302) examined the extent to which patient comorbidity was address in 
guidelines developed by the National Institute of Health and Clinical Excellence 
(NICE), the central guideline development organisation in the United Kingdom. They 
observed considerable variation in the consideration of comorbidity across the 
guidelines, with some discussing comorbidity extensively and others not at all. This 
suggests further guidance is need on how to address or consider multiple conditions 
in guidelines. 
Due to the lack of applicable guidelines addressing the management of multiple 
conditions, clinicians often resort to using disease specific guidelines. This may be 
detrimental to patient care, as the clinicians can apply any number of different 
guidelines to one individual, with limited consideration of their interaction 
(12,189,303,304). This is best illustrated by Boyd et al.’s (12) study of the feasibility of 
applying multiple treatment recommendations drawn from guidelines, for the 
management of a hypothetical 79 year old with five chronic conditions (12). The result 
was an overly complex, harmful regimen that included multiple conflicts in prescribed 
treatments (12). 
Accessibility of guidelines 
Clinicians appear to have positive attitudes towards clinical practice guidelines 
(71,290). In a survey of 79 Australian GPs, guidelines were considered by the vast 
majority to support decision-making (94%) and medical education (92%)(305). 
Similarly, in a systematic review of 30 studies examining clinicians’ perceptions, 
clinical practice guidelines were perceived by the majority of respondents as a helpful 
source of advice, good educational tool and intended to improve quality (290). 
Likewise, a survey of 264 primary care clinicians in the Netherlands found 97% of 
clinicians believed guidelines were a useful source of advice, 94% thought they were 
based on sound and sufficient evidence and 89% believed guidelines would result in 
improved patient care (306). 
Despite these positive attitudes, research suggests guideline uptake varies as 
clinicians identify a number of barriers with their implementation. These barriers can 
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be classified into three common themes: guideline characteristics, environmental 
characteristics and practitioner characteristics. 
Guideline characteristics: Clinicians perceive guideline characteristics relating to 
quality, length, and complexity and compatibility as barriers to their use. Issues of 
guideline quality were discussed above and are not repeated here. 
 Length - Studies suggest clinicians are more likely to adhere to guidelines, 
which are short and simple (226,231-233,305,307). Use of 2-3 page 
summaries, flowcharts, and/or single page checklists are supported by 
clinicians as methods for simplifying guideline content, making them more 
accessible at the point of care (305). However, this conflicts with the importance 
clinicians may place on understanding the methods used by the guideline 
developers to generate the recommendations. 
 Complexity and compatibility - Less complex guidelines and those which 
require fewer changes to the clinician’s existing practices were more likely to 
be followed (226,233,305).  
Environmental characteristics including lack of time and resources may also reduce 
guideline uptake.  
 Lack of time - Clinicians report lack of time as a major barrier to the use of 
guidelines (226,231-233). Finding appropriate guidelines can be timely as not 
all countries, including Australia, have a central organisation responsible for 
developing and disseminating guidelines. As a result clinicians can spend 
considerable time locating relevant guidelines (226,231). In addition, some 
guidelines are in the order of 200 pages in length and reading these documents 
can place an added burden on already time-poor clinicians (226,231).  
 Lack of resources - Lack of resources referred primarily to organisational 
restrictions such as limited information management systems, referral 
pathways and funding and resources to be able to carry out the guideline 
recommendations (226,231). 
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Practitioner characteristics include age, location, awareness, confidence and 
applicability.  
 Age - Older GPs are generally less likely than their younger counterparts to use 
guidelines (233,270). This may be because older clinicians have more 
experience and therefore believe they do not need guidelines or alternatively 
are reluctant to change their existing practices (233,270).  
 Location - Clinicians located in rural areas are less likely to adhere to guidelines 
compared to those in urban areas (233). This could be because clinicians in 
urban areas have greater access to resources and professional peers than 
those in rural areas. 
 Awareness - With an increasing number of guidelines developed and 
disseminated, somewhat paradoxically, clinicians report lack of awareness of 
the existence of guidelines (231,232,270). 
 Confidence - Lack of confidence in their ability to carry out recommendations 
was another barrier identified by a number of clinicians (231-233,270). Doubt 
or disagreement about the expected outcome of the guideline recommendation 
has also contributed to non-adherence among clinicians (226,231-233). If the 
clinician felt the guideline recommendation would not result in the expected 
outcome for their patient then they would not follow it (226,231-233).  
 Applicability – The applicability of guidelines was another major concern 
identified by clinicians (226,231-233). Clinicians were cautious of applying 
guidelines based on evidence drawn from population based trials with narrow 
inclusion criteria as they felt their patients did not fit the average or ideal patient 
for whom the guideline recommendations were designed, but rather had more 
complex problems (71,226,231-233,290,306). As such, clinicians believed 
using guidelines would conflict with their patient’s individual circumstances and 
preferences for care (71,226,231-233,290,306). This problem was emphasised 
for patients with multiple long-term conditions (71,226,231-233,290,306). 
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Issues such as these point to potential shortcomings in guideline development, 
including inadequate involvement of consumers and end user clinicians for whom the 
guidelines are designed. Research suggests a patient-driven approach centred on 
addressing the person’s preferences and overall health goals would be more 
appropriate for patients with multiple conditions (67,250,308,309). 
Incorporating patient preferences 
The notion of ‘preferences’ refers to “the desirability of a health-related outcome, 
process or treatment choice” (250). Krahn and Naglie (250) argue that the 
identification and incorporation of patient preferences in guideline development and 
implementation may improve the patient-centredness of clinical practice guidelines. 
They suggest that obtaining consumer input during guideline development may 
provide the foundation for greater systematic attention to patient preferences and 
support for patient decision-making in clinical consultations (250,310,311). 
Encouraging consumer participation in the guideline development process became 
popular from the early 1990s (312). Strategies to engage consumers include involving 
consumers in guideline-development groups, providing drafts for feedback, 
conducting surveys of consumers or running consumer focus groups or workshops 
parallel to the clinical guideline development groups (308,313-315). Some of these 
approaches have been criticised for being ‘passive’ or ‘tokenistic’ (314,315). Broader 
evidence assessing the impact of these approaches on guideline development is 
limited, with the exception of a recent study by Tong et al. (311). Tong et al. (311) 
found active consumer engagement led to the identification of additional patient-
centred recommendations which had not been flagged by health professionals. 
Involvement of consumers in guideline development should not replace, nor is 
intended to replace, the discussion of patient preferences in the clinical consult. Rather 
consumer input should assist to identify recommendations which might be considered 
preference-sensitive. Flagging preference-sensitive recommendations and 
incorporating the preferences of individual patients is particularly important in the 
presence of competing health outcomes (217). There may be few competing health 
outcomes for patients with one long-term condition as treatment is focused on 
obtaining a particular disease-specific outcome, such as maintaining a healthy blood 
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glucose level for those with diabetes (217). In contrast, research suggests patients 
with multiple conditions, change from disease-specific to ‘global’ cross-disease health 
outcomes such as maintenance of physical function, symptom relief and quality of life 
(217,316). Guidelines should encourage clinicians to discuss patients’ individual 
preferences when recommendations are labelled as preference-sensitive 
(250,316,317). However, research suggests guidelines do not frequently provide this 
information (317) and it is unclear whether clinicians in fact use guidelines in this way 
for patients with multiple conditions.  
In summary, clinical practice guidelines are core drivers of evidence-based medicine 
in primary care practice. However, their quality and relevance in a multimorbidity 
context has been questioned. GPs argue clinical practice guidelines are made for the 
‘average patient’ and do not consider the needs and preferences of individual patients, 
particularly those with multiple conditions. Use of consumer engagement processes, 
during guideline development could assist in making guidelines more patient-centred 
by identifying preference-sensitive recommendations for further discussion in the 
clinical consultation. Having briefly examined clinical practice guidelines, this section 
now turns to consider the second primary care tool - care plans.  
3.5 Care plans  
Care plans have long been part of the primary care landscape (32,318). They emerged 
in response to the rise in chronic illness, which subsequently required changes in the 
approach and organisation of care (273). As outlined in chapter two, the longevity and 
complexity of chronic conditions often necessitates patients to visit numerous health 
care providers and self-manage their care on a day-to-day basis (159,319,320). Care 
plans, a written articulation of clinician and patients’ combined strategy for managing 
a chronic condition, arose as a means of assisting both clinicians and patients to 
coordinate care according to the needs of the individual (321-323). Ideally, patients’ 
GPs will use care planning discussions, and the resulting care plan, to coordinate other 
health care providers around the patient and their individual needs. This ensures care 
continuity and responsiveness. Care plans are also intended to support patients to 
self-manage by outlining their individual health care needs, management goals and 
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the resources required to achieve them (235,271,321,324,325). The care planning 
process typically involves a number of key features.  
 First, health problem(s) are jointly defined by the clinician and patient, wherein 
the patient’s health concern(s) are acknowledged along with the clinician’s 
diagnosis of medical condition(s) (235,321,325).  
 Second, the patient’s goals and objectives regarding their condition(s) are 
identified. A care plan outlining the actions to be taken by the patient and care 
providers to obtain these goals and objectives is developed, in line with the 
patient’s context and preferences (235,321,325). A copy of the care plan is given 
to the patient. 
 Third, clinicians ensure patients have access to the necessary self-management 
resources, such as other health professionals, training seminars, consumer 
health organisations, and support services (235,321,325).  
 Finally, the clinician would organise for regular check-ups or follow ups to ensure 
the patient was still managing well, check on potential complications and if 
required, update the care plan (235,321,325).  
In Australia, care plans have been a part of primary care practice for almost 20 years. 
Introduced in 1999, as part of the ‘Enhanced Primary Care’ (EPC) Package, the care 
plans aimed to encourage and support a multidisciplinary approach to chronic disease 
management (326). For the first time GPs and allied health professionals could receive 
reimbursement from Medicare for time spent developing multidisciplinary care plans 
for patients with chronic and complex care needs (4,39,271). The EPC package was 
modified in 2005 to cover two types of care plans: Team Care Arrangements (TCA) 
developed by clinicians in collaboration with allied health professionals for patients 
with multidisciplinary care needs; and General Practice Management Plans (GPMP) 
developed by primary care clinicians for patients with chronic disease (271).  
Care plans have demonstrated success in improving clinicians’ adherence to 
recommended guideline for treatment. Adaji et al. (4) investigated whether having a 
GPMP or TCA improved clinicians adherence to recommended treatments outlined in 
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guidelines for patients with type I and II diabetes. They found a strong association 
between care planning and increased testing of processes recommended by diabetes 
guidelines in contrast to those without a GPMP or TCA (4). Similarly, a study 
examining the care of patients with type 2 diabetes before and after the use of a TCA 
plan found that following the development of a TCA patients’ received care more 
closely aligned with care recommended by diabetes guidelines. Care plans have also 
shown to improve patients’ knowledge of symptoms, reducing exacerbations and 
increasing adherence to self-management regimes (271,327-329). In addition, Lewis 
and colleagues (330) reported that patient participation in care planning led to 
improved identification of health needs and services to meet those needs. Patients felt 
they received better quality of care and had an enhanced understanding of their 
condition (330). Likewise, a UK study of care plans and care planning for patients with 
long-term conditions found most patients reported some benefit from participating in 
care planning discussions (321). Similarly, Shortus et al. (331) found that patients who 
obtained a care plan were more satisfied with the care coordination they received. 
However, an Australian study of 2296 people with long-term conditions, investigating 
the use of care plans and patients’ engagement in their development, found the degree 
to which patients contribute to the formation of their care plans remains low (275). 
Relevance in a multimorbidity context 
Care plans are intended to be individualised and patient-centred, incorporating the 
patient’s emotional, physical, financial and social circumstances (332). As a result, 
patients may be more likely to self-manage effectively, achieve their health goals and 
adhere to their care plans (235,328,332-334). A recent Cochrane review of 
personalised care planning for adults with chronic conditions called for research to 
investigate care planning for patients with multiple conditions, after they were unable 
to identify any studies explicitly examining this issue (335). Despite the limited 
literature informing this area, researchers have argued for the potential of care plans 
to address some of the gaps in care for people with multiple conditions 
(12,21,62,139,335).  
One notable and highly relevant exception is a recent Australian trial of a multiple 
condition care plan template conducted by Morgan et al. (136). The care plan template 
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was developed for patients with depression, diabetes, and/or coronary heart disease, 
as part of the TrueBlue study. Clinical practice guidelines were used to inform the care 
plan template, with prompts for health professionals being included to ensure 
guideline-recommended checks (e.g., eye check) were performed (136). The template 
also requested the patient’s goals and preferences be listed and reviewed every three 
months, along with any barriers or enablers to achieving these goals. Practice nurses, 
funded by Medicare, were primarily responsible for the development of care plans with 
the patient (136). Patients were scheduled for 45 minute consultations with the 
practice nurse, during which time the nurse would document the patient’s clinical 
information (e.g., pathology results, risk factors, medications), arrange referrals, and 
work with the patient to identify their priorities and goals for care. The study found 
guideline-recommended checks were more frequently performed by health 
professionals using the TrueBlue care plan. In addition, patient lifestyle goals were set 
by 96% of the 142 intervention patients (136). Based on their findings Morgan et al. 
(136) identified a number of factors that contributed to successful care planning for the 
management of multiple conditions, including the integration of multiple guidelines, 
tracking clinical concerns and needs across conditions, monitoring multidisciplinary 
referral processes, identifying patients’ goals and priorities and establishing systems 
to ensure their regular review. This study provides some evidence of how care plans 
may be part of a renewed approach.  
With an increasing number of patients presenting with multiple chronic conditions in 
primary practice (5), it is time to take stock and consider whether care plans meet the 
needs of patients and clinicians managing multiple conditions.  
3.6 Patient decision aids 
PDAs are not currently well used within Australian primary care practice (245,336). As 
such, it was somewhat surprising that this tool was identified through consultation with 
expert stakeholders. PDAs are advocated as a means of facilitating or operationalising 
shared decision-making (245,337). Their emergence in the last two decades coincides 
with increasing attention to engaging patients in care decisions (244,257,338).  
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PDAs are “tools designed to help people participate in decision-making about health 
care options” (339). They do this by providing information on the benefits and harms 
of the various options and assisting patients to determine the value they place on the 
provided benefits and harms (339). The term ‘decision aid’ was first used in an article 
by O’Connor and colleagues (340) in 1998, to describe an intervention designed to 
assist women considering hormone replacement therapy after menopause. Since then 
the development and implementation of PDAs has continued to expand (251,341). 
Elwyn et al. (342), who have made substantial contributions to the field, identify three 
categories of PDAs: 
1. Those intended for use by clinicians and patients in the clinical consultation, 
such as “balance sheets” or “option grids”. These PDAs generally use short 
statements or graphics to present information on the various options (342). 
They do not provide extensive information, as their purpose is to prompt further 
conversation between clinicians’ and patients’ on the various options (342). 
2. Those that can be used by patients independently of the clinical encounter. 
These PDAs are more common (342). They provide extensive information on 
the various treatments options, and while they can be used independently they 
are intended to augment rather than replace discussion with clinicians in the 
consultation (342). Typically, PDAs are provided after a consultation to be 
discussed further at the next consultation or prior to a consultation so patients 
come prepared to engage in decision-making (342). 
3. Those mediated by other social encounters. These PDAs are used outside of 
the clinical encounter, and are facilitated through mediums such as telephones, 
Twitter, or Facebook interactions. Unlike the first two categories of PDAs, PDAs 
mediated by other social encounters typically occur between patients and 
persons other than their primary care clinician. 
Use of PDAs which are more detailed, provide clear probabilities and processes to 
assist with clarifying the value patients place on the benefits and harms, result in 
improved knowledge, more accurate risk perceptions and choosing of options more in 
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line with their values (251). Despite this there is ongoing debate as to whether the use 
of these detailed decision aids facilitates genuine shared decision-making within the 
clinical consultation (341). Early findings from Elwyn and colleagues (343) the use of 
option grids (“a brief summary of options organised in tabular format, limited to one 
side of standard size paper”), suggest the use of shorter PDAs, while not providing 
extensive information, may facilitate greater shared decision-making or “decision talk” 
between clinicians and their patients (343).  
PDAs have emerged as a means of facilitating or operationalising shared decision-
making in the clinical consultation, particularly for those facing preference-sensitive 
decisions (337,344,345). Cochrane reviews have compared (346-348) the use of 
PDAs to usual care for people facing treatment or screening decisions. The most 
recent (251) included 115 randomised control trials and concluded there was strong 
evidence that use of PDAs results in increased patient knowledge of options and 
feelings of being informed and clear on the issue of importance to them (251). There 
was moderate evidence indicating patients using PDAs had improved risk perceptions, 
were more likely to participate in decision-making and select options more in line with 
their preferences (251). Although, they have proven effective in supporting patients 
and clinicians managing single conditions, the ability of PDAs to support shared 
decision-making for patients with multiple conditions remains untested. 
Despite the evidence for benefits, routine use of PDAs is low (263). Known barriers 
include: short consultation times; limited training for clinicians on how to use PDAs to 
facilitate shared decision-making; concern that use of PDAs might cause distress to 
patients; perceived threats to existing patient-clinician relationships; limited availability 
of PDAs; and concerns about PDA quality (262). Although, a number of minimum 
standards or criteria have been put forward (337,349,350), primarily for assessing 
quality, a consensus has yet to be reached on what “active components” (349) PDAs 
should include. For instance the use of patient stories, short descriptions of other 
patients’ experiences when making the same treatment choice, is highly debated, with 
many arguing that more research is needed to confirm their benefits (52, 54, 55). 
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Relevance in a multimorbidity context 
Attributes of PDAs, such as helping patients to understand the risks and benefits of 
treatment options, assisting patients to clarify the value they place on these benefits 
and harms and participate in shared decision-making (344), suggest potential in terms 
of supporting multimorbidity care. Nevertheless, PDAs have not yet been examined in 
a multimorbidity context. 
In summary, three primary care practice tools were identified as relevant to the aims 
of this thesis: clinical practice guidelines; care plans; and PDAs. Each was identified 
as having a particular purpose: guidelines to support evidence-based medicine; care 
plans to facilitate multidisciplinary and patient-centred care; and PDAs to 
operationalise shared decision-making. All three were shown to have positively 
influenced or informed care for the management of single chronic conditions, but 
questions arose regarding their suitability within a multimorbidity context. For 
guidelines, specific issues that arise are whether they are of sufficient quality, include 
patient preference recommendations, and involve consumers in guideline 
development. For care plans, questions relate to whether they are applicable in a 
multimorbidity context or how well care plans accommodate the different care needs 
of patients with multiple and often complex needs and how readily these are 
considered when constructing a care plan. For PDAs, there are wider questions about 
their applicability to the multimorbidity context and how might they be better integrated 
into Australian primary care practice.  
3.7 Conclusion 
The aim of this chapter was to examine primary care practice tools currently available 
to assist in the management of chronic disease. Consequently, the chapter has 
outlined how the three tools chosen for analysis in this thesis (clinical practice 
guidelines, care plans and PDAs) were identified and presented a brief description of 
each. This description highlighted that while all of these tools inform and influence 
decision-making in primary care their conceptual underpinnings and intended purpose 
differ. The benefits of each tool were explored in relation to the management of single 
chronic conditions, but in so doing questions were raised regarding their applicability 
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in a multimorbidity context. Building on this discussion the next section outlines the 
thesis research question and methods used.  
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 Chapter 4 Research question and methods 
4.1 Introduction 
Chapter three provided a brief description of three primary practice tools currently 
available to support chronic disease management. Each demonstrated benefits in the 
management of patients with a single chronic condition, but questions arose regarding 
their suitability or transferability to the management of patients with multiple chronic 
conditions. Expanding on this discussion this chapter now turns to outline the thesis 
research question and the methodology used to answer it. To avoid excessive 
repetition this chapter provides only a brief outline of the methods used, as detail will 
be provided in subsequent chapters.  
4.2 Research question and aims 
The central question addressed in this thesis is: Are primary care practice tools 
developed to support the management of chronic disease in Australian primary 
practice, transferable to the management of multimorbidity care? In answering this 
question the thesis considered the following: 
 What is known about living with multiple chronic conditions? (Chapter two) 
 What is known about providing multimorbidity care in primary care? (Chapter 
two) 
 What primary care practice tools are currently in use to support chronic 
disease management? (Chapter three) 
 What are the strengths and limitations of these primary care practice tools 
for supporting core components of multimorbidity care (Chapters five, six & 
seven) 




This thesis, used an applied policy research methodology to address the research 
question and drive analysis. Applied policy research differs from other theoretical 
research in that it aims to address specific information requirements, which result in 
clear recommendations or actionable outcomes (143,351,352). Although most applied 
policy research is quantitative, a consequence of policy-makers initially desiring 
empirical ‘facts’ to inform policy, the contributions of applied qualitative policy research 
is increasingly recognised (352,353).  
Applied qualitative policy research adheres to the aims of applied research, to answer 
clear informational needs and produce actionable outcomes, while also having the 
benefit of being able to provide a rich description or comprehensive understanding of the 
issue under examination (143,352). In using an applied qualitative policy research 
methodology the thesis incorporates features of interpretivist and pragmatist 
epistemologies (353). Aspects of interpretivism are demonstrated in the need to 
understand the context of the item or person under study (353). In developing this 
understanding, researchers aim to align their interpretations as closely as possible to 
participants accounts, but also recognise “that deeper insights can be obtained by 
synthesising, interlocking and comparing the accounts of a number of respondents” (353). 
Consequently, the researchers interpretations are synthesised and placed or situated 
within a broader context to assist understanding (353). Applied qualitative policy 
research also aligns with pragmatism, as choosing the most appropriate research 
methods for the research question under investigation is valued more than adhering 
to a particular epistemological position (353). 
The research involved two key phases: the identification of primary care practice tools 
currently used in primary care practice and the search for and subsequent analysis of 
these tools using a three-stage document analysis process, including data analysis 
using the Framework approach. Figure 4.1 depicts the two stages outlined in more 
detail below. Framework analysis is specifically designed for applied qualitative 
research (143,351,352). Consequently, the analysis is targeted at providing ‘answers’, 




Figure 4.1 - Thesis methods 
4.4 Identification  
Three primary care practice tools were identified and included for analysis: clinical 
practice guidelines, care plans and PDAs. The processes used to identify these 
primary care practice tools were described in Chapter three. In summary, clinical 
practice guidelines and care plans emerged during a review of the literature and their 
importance confirmed by a survey of expert primary care clinicians. The expert primary 
care clinicians also identified PDAs as an additional tool warranting evaluation. 
4.5 Document analysis 
Document analysis was the methodology chosen for this thesis. Document analysis is 
a “systematic procedure for reviewing or evaluating documents – both print and 
electronic (computer-based and internet-transmitted) material” (354).  
Documents can include but are not limited to diaries, catalogues, newspapers, 
guidelines, and reports (355). As with other qualitative analytical methods, document 
analysis seeks to provide meaning or greater understanding on the chosen topic 
(355,356). There are a number of advantages of using document analysis including: 
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 Less costly and time consuming then other qualitative research methods, as it 
does not require the information within the documents to be collected. Rather it 
requires the selection and analysis of data or documents (354).  
 Documents are generally in the public domain making them easier to access 
as researchers rarely have to obtain authors’ permission or seek ethical 
clearance (354,357).  
 A more stable and unobtrusive research method as the documents do not 
change or react as a result of the researcher’s presence as can happen with 
other qualitative research processes (354).  
There are also some limitations with using document analysis such as: insufficient 
detail, when the data contained in the documents is not sufficient to answer the 
research question (354); and irretrievability, when some documents are unable to be 
collected (357,358). However, these were not perceived as outweighing the 
abovementioned benefits given the research questions in this thesis. Moreover, the 
benefit was that this method, which effectively involves secondary analysis, enabled 
a more comprehensive and detailed analysis of a large set of materials to be 
undertaken. Accordingly, document analysis was considered appropriate, given the 
aim of the thesis was to assess primary care practice tools, which are documentary 
sources. The document analysis process outlined by Sarantakos (359) was used for 
this thesis. The process involved three stages: 1) search for relevant documents; 2) 
collection of the data; and 3) analysis of the data. 
Stage 1: Search for relevant documents 
A separate bibliographic database search was conducted for each of the three primary 
care practice tools as shown in Table 4.1. Additional searches were conducted by 
hand searching key journals and published articles. Unpublished or grey literature 
searches were also conducted using relevant websites and online sources.  
Initially, Australian primary care practice tools developed to support patients with 
multiple conditions were sought, but when this produced little to no results, the search 
was broadened. The modified search strategy examined tools developed to support 
those with single chronic conditions, but which acknowledged comorbid conditions 
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(i.e., medical conditions additional to the index condition (12)). For example, if a clinical 
practice guideline for diabetes also discussed depression it was included. By focusing 
on primary care practice tools for single chronic conditions, but which included 
comorbidities, a balance was achieved between too few documents (i.e., including 
only those addressing multiple conditions) and too many documents (i.e., including all 
those which addressed single chronic conditions). To be included the primary care 
practice tools had to address one of the chronic conditions classified under Australia’s 
National Health Priority areas (360) including: cardiovascular health; stroke; cancer 
(colorectal, lung, breast and prostate); diabetes; depression; chronic kidney disease; 
asthma and chronic obstructive pulmonary disease; and arthritis and musculoskeletal 
conditions. Additional criteria included primary care practice tools relevant to a primary 
care setting; and applied to people aged 18 years and over.  
This thesis focused on Australian primary care practice tools and as such, all of the 
identified tools were sought from Australian sources, with the exception of PDAs. None 
of the included PDAs were identified through Australian sources. Therefore an 
additional search was conducted through the ‘Ottawa Hospital Research Institute’ an 
international inventory of PDAs.  
Table 4.1 - Stage 1 of the document analysis process 
Stage Primary care practice tools 





private & non-profit 
websites & key journals 
Databases, Government 
and non-profit websites 
Databases, Government, 
private & non-profit 
websites. Ottawa Institute 
Stage 2: Collection of data 
Copies of all relevant documents, 13 clinical practice guidelines, 16 care plan 
templates, and 21 patient decision aids were collected. All of the documents were 
available in the public domain and therefore ethics approval was not required to 
conduct the study. Although each of the tools were analysed to inform the broader 
research question, it was evident from the literature review and  the initial scan of the 
documents that the primary care practice tools could not be assessed in the same way 
or using the same research question. Each primary care practice tool is designed for 
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a different purpose and therefore the way they contribute to chronic disease care 
differs. As a result, the research questions posed and the specific purpose of the 
document analysis was different for each of the three tools (see Table 4.2). 
 The document analysis of clinical practice guidelines assessed the extent to 
which they: incorporate patient-preference recommendations; use consumer-
engagement processes during development (and, if so, how and with what 
outcomes); and meet standard quality criteria for guidelines.  
 The document analysis of care plans assessed whether care plans meet the 
needs of patients and clinicians managing multiple conditions. Drawing on key 
themes from the literature the study examined whether care plan templates 
support: the identification of patients’ preferences; priority setting; the 
identification of conflicts and synergies in care; and the review of patients’ goals 
and priorities.  
 The document analysis of patient decision aids investigated the ways they 
acknowledge or consider multiple conditions in decision-making and their ability 
to contribute to or support the shared decision-making components outlined by 
Charles et al. (246). 
Table 4.2 - Stage 2 of the document analysis process 
Stage Primary care practice tool 
Clinical practice guidelines Care plans Patient decision aids 
Collection 
of data and 
research 
question 






processes; do these 
consumer engagement 
processes produce more 
patient-preference 
recommendations 





priorities; identifying conflicts 
& synergies; & setting dates 
for care plan review 
21 Patient decision aids  
How do they acknowledge 
multiple conditions and 
contribute to the shared 
decision-making components 
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Stage 3: Data analysis 
Quality – AGREE II 
The analysis of guideline quality was assessed using the AGREE II instrument 
(295,298,361,362). The AGREE II is a validated tool that assesses guideline quality 
according to 23 items listed under six domains: scope and purpose; stakeholder 
involvement; rigour of development; clarity of presentation; applicability; and editorial 
independence. For each domain, items are scored on a 7-point scale from seven 
(strongly agree) to one (strongly disagree). An overall domain score is calculated from 
the sum of individual items standardised as a percentage for each domain. There are 
currently no standardised instruments for assessing the quality of care plans and 
PDAs. Although a number of minimum standards or criteria have been proposed for 
PDAs, such as the International Patient Decision Aid Standards (IPDAS), a consensus 
has yet to be reached on what should be included (349). 
Framework Approach 
The qualitative data analysis was directed by the framework approach (143). The 
framework approach includes five steps: familiarisation; identifying a thematic 
framework; indexing; charting; and mapping and interpretation (143). 
1. Familiarisation. First the researcher becomes familiar with the documents to 
“get a feel of the data” as a whole, while simultaneously taking notes on key 
points or repeating themes (143,351,352).  
2. Identifying a thematic framework. The notes taken during the familiarisation 
stage are used to develop an index thematic framework by which the data can 
be examined and referenced (143,351,352).  
3. Indexing. The index framework is systematically applied to all the collected 
data. This is done by annotating the data with numerical codes from the index 
for future recovery and comparison (143,351,352).  
4. Charting. The annotated data is extracted and placed in charts according to the 
appropriate part of the thematic framework to which they relate (143,351,352). 
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Therefore, charts are developed for each key theme with entries from various 
data sets (143,351,352). 
5. Mapping and interpretation. Interpretation of findings involves using the charts 
to define concepts, map the range and nature of various phenomena and find 
associations between themes with a view to providing explanations for the 
findings (143,351,352). The process of mapping and interpretation is influenced 
by the research objectives as well as by the themes, which emerge from the 
data.  
Framework analysis is specifically designed for applied qualitative research in which 
the objectives of the research are clearly established and shaped by specific 
information requirements (143,351,352). Although the process starts rather 
deductively, with pre-determined questions and objectives asked of the data, but still 
uses a grounded or inductive approach, as new themes or categories are continuously 
added to the thematic framework to reflect the data (351). The framework approach 
tends to be more structured than other qualitative methods, with the indexing and 
charting of themes allows for easy retrieval and comparison of data (143,351). The 
framework approach is most frequently used in health care settings, to investigate a 
range of research questions and document types (143,363). Of particular interest to 
this thesis, was a study by Hegarty and colleagues (298), who used the framework 
approach to investigate how depression guidelines could be made more relevant and 
applicable to primary care. 
 Table 4.3 - Stage 3 of the document analysis process 
Stage Primary care practice tools 
Clinical practice guidelines Care plans Patient decision aids 
Data analysis AGREE II instrument & 
Framework analysis 
Framework analysis Framework analysis 
4.6 Conclusion 
This chapter outlined the aims of this thesis and the research methods used. The aim 
of this thesis was to evaluate the ability of primary care practice tools, developed to 
address chronic disease, to contribute to effective patient-centred multimorbidity care. 
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This chapter described the two-phase process used to address this aim: 1) the 
identification of primary care practice tools currently being used in primary care 
practice and 2) the search and analysis of these tools using a three-stage document 
analysis process. The three stages of the document analysis process were outlined, 
including a brief overview and rationale for use of the framework approach. The next 
chapter presents the first part of the thesis results in the form of a published research 
paper examining the first tool: clinical practice guidelines. 
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 Chapter 5 Clinical practice guidelines 
The previous chapter provided an overview of the methods used to find and analyse 
clinical practice guidelines, care plans, and PDAs. This chapter examines the first tool: 
clinical practice guidelines. The chapter presents a paper I co-authored during my 
thesis, titled “Incorporating patient preferences in the management of multiple long-
term conditions: is this a role for clinical practice guidelines?” The paper was published 
in the Journal of Comorbidity. In line with the University of Queensland’s requirements, 
the article has been reproduced in standard formatting. In addition, the referencing 
has been changed to ensure consistency throughout the thesis and all references are 
now presented at the end of the thesis.  
5.1 Abstract 
Background: Clinical practice guidelines provide an evidence-based approach to 
managing single chronic conditions, but their applicability to multiple conditions has 
been actively debated. Incorporating patient-preference recommendations and 
involving consumers in guideline development may enhance their applicability, but 
further understanding is needed. Objectives: To assess guidelines that include 
recommendations for comorbid conditions to determine the extent to which they 
incorporate patient-preference recommendations; use consumer-engagement 
processes during development, and, if so, whether these processes produce more 
patient-preference recommendations; and meet standard quality criteria, particularly 
in relation to stakeholder involvement. Design: A review of Australian guidelines 
published from 2006 to 2014 that incorporated recommendations for managing 
comorbid conditions in primary care. Document analysis of guidelines examined the 
presence of patient-preference recommendations and the consumer-engagement 
processes used. The Appraisal of Guidelines for Research and Evaluation instrument 
was used to assess guideline quality. Results: Thirteen guidelines were reviewed. 
Twelve included at least one core patient-preference recommendation. Ten used 
consumer-engagement processes, including participation in development groups 
(seven guidelines) and reviewing drafts (ten guidelines). More extensive consumer 
engagement was generally linked to greater incorporation of patient-preference 
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recommendations. Overall quality of guidelines was mixed, particularly in relation to 
stakeholder involvement. Conclusions: Guidelines do incorporate some patient-
preference recommendations, but more explicit acknowledgement is required. 
Consumer-engagement processes used during guideline development have the 
potential to assist in identifying patient preferences, but further research is needed. 
Clarification of the consumer role and investment in consumer training may strengthen 
these processes. 
Key words: multimorbidity, comorbidity, primary care, patient preference, consumer 
participation, clinical practice guidelines 
5.2 Introduction 
Clinical practice guidelines targeting specific long-term conditions provide an 
evidence-based approach to treatment and management and can lead to improved 
patient care (364). However, the ability of guidelines to support complex care regimes 
for patients with multiple long-term conditions is the subject of some debate 
(27,62,295,301,303). The use of multiple disease-specific guidelines for individual 
patients is impractical and potentially hazardous (27,62,301,303). 
Alternative approaches to addressing multiple conditions using clinical practice 
guidelines have been proposed and considered (301,365). These include the 
development of meta-guidelines, which address common clusters of co-occurring 
conditions (365) and greater cross-referencing between guidelines that are available 
electronically (301). Some single-condition-specific guidelines include 
recommendations addressing comorbid conditions (27); but the extent to which these 
guidelines also consider patient preferences is unclear. 
While the debate about the adaption of clinical guidelines continues, a strong theme 
in the literature is the need to foster a patient-centred approach to the management of 
multimorbidities and take greater account of what patients want and value 
(67,250,308,309). Patient preferences – “the desirability of a health-related outcome, 
process or treatment choice” (250)– are considered important for the management of 
multiple and competing health conditions as the patient’s focus is shifted from disease-
specific goals to more global cross-disease outcomes, such as maintenance of 
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physical function, symptom relief and quality of life (217,366). In essence, some 
recommendations may be acceptable to most patients, but others may be “preference-
sensitive” and dependent on the patient’s views about outcome, process or choice 
(250). Researchers argue that incorporating patient preferences may mitigate the 
common criticism that guidelines developed to address single conditions are created 
for the “average patient” and do not acknowledge the complexity of individuals’ 
circumstances and preferences (67,367). 
Krahn and Naglie (250) argue that the identification and incorporation of patient 
preferences in guideline development and implementation may improve the patient- 
centredness of clinical practice guidelines. They suggest that obtaining consumer 
input during guideline development may provide the foundation for greater systematic 
attention to patient preferences and support for patient decision-making in clinical 
consultations (250,310,311). Strategies to engage consumers in guideline 
development include providing drafts for feedback, involving consumers in guideline-
development groups, conducting surveys of consumers or running consumer focus 
groups or workshops parallel to the clinical guideline development groups (308,313-
315). Some of these approaches have been criticised for being passive or “tokenistic” 
(314,315), but broader evidence assessing their impact on guideline development is 
limited, with the exception of a recent study by Tong et al. (311), which found that 
active consumer engagement led to the identification of patient-centred 
recommendations not flagged by health professionals. 
The widely used Appraisal of Guidelines for Research and Evaluation (AGREE) 
Instrument (368) acknowledges the importance of consumer input by way of an item 
assessing whether the views and preferences of the target population (patients, public, 
etc.) have been sought. In Australia, for clinical practice guidelines to receive approval 
from the National Health and Medical Research Council (NHMRC) (286), they must 
“be developed by a multidisciplinary group that includes relevant experts, end users 
and consumers affected by the clinical practice guideline”. 
 While consumer engagement is strongly advocated, it is unclear how such 
engagement takes place or whether it leads to greater inclusion of patient-preference 
recommendations in clinical guidelines. More broadly, the extent to which clinical 
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practice guidelines encourage patient-centred care through the inclusion of patient 
preferences also requires further investigation.  
5.3 Objectives 
The objectives of this study were to review clinical practice guidelines that include 
recommendations for comorbid conditions to determine the extent to which they: (1) 
incorporate patient-preference recommendations; (2) use consumer-engagement 
processes in their development phase; and (3) meet standard criteria for guideline 
quality, particularly in relation to the stakeholder-involvement processes; and to 
consider whether consumer-engagement processes in guideline development result 
in greater integration of patient-preference recommendations. 
5.4 Methods 
Inclusion criteria 
The study examined Australian clinical practice guidelines developed to support single 
chronic conditions, but which included recommendations for comorbid conditions (i.e., 
medical conditions additional to the index condition (12)). 
All guidelines developed to support the National Health Priority areas were included: 
cardiovascular health; stroke; cancer (colorectal, lung, breast and prostate); diabetes; 
depression; chronic kidney disease; asthma and chronic obstructive pulmonary 
disease; and arthritis and musculoskeletal conditions (360). Additional selection 
criteria included: application in primary care settings; and applied to people aged 18 
years and over. Guidelines are updated approximately every 6 years; therefore, the 
search, which began in 2012, focused on guidelines published between 2006 and 
2012. The search was later extended to include publications up to January 2014. 
Search strategy 
Ovid MEDLINE, Web of Science (ISI), Embase, Cinahl, PsycINFO, Cochrane and 
PubMed, were searched using the terms: “guideline”, “Australia”, and “primary care”. 
Additional searches were conducted on Australian websites, including the Department 
of Health, NHMRC, National Institute of Clinical Studies, Royal Australian College of 
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General Practitioners and relevant non-profit organisation websites. The Medical 
Journal of Australia and the Internal Medicine Journal, key journals publishing clinical 
guidelines, were also searched. 
Study selection 
Figure 5.1 summarises the guideline selection process. In all, 4,866 citations were 
identified: 4,835 of these were excluded, based on title and summary. The full text of 
31 guidelines was reviewed. Eighteen were excluded because they: did not provide 
recommendations for comorbid conditions; focused on prevention and detection; 
addressed out-of-scope conditions; targeted young people; were not applicable to 
primary care; or were outdated versions of an included guideline. Clinical updates or 
addenda were assessed in conjunction with the original guideline. Thirteen guidelines 
were included in the final analysis. 
 
Figure 5.1 - Search strategy. AGREE, Appraisal of Guidelines for Research and Evaluation 
Reproduced from Young C et al. J Comorbidity 2015; 5(1):122-31 under the Creative Commons BY-
NC 4.0 License 
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Data analysis 
Data analysis was conducted in three stages in accordance with the three main aims 
of the study. Stages 1 and 2 involved document analysis and Stage 3 involved a quality 
assessment using AGREE II. Ethics approval was not required as all data were drawn 
from published materials available in the public domain. 
Stage 1  
Document analysis of the guidelines was conducted to identify recommendations that 
incorporated patient preferences. Clinical practice guidelines vary in complexity and 
size, ranging in length from ten to several hundred pages and frequently provide a list 
of core recommendations or essential points, which are then further explained 
throughout the document by “supporting evidence statements”. The core 
recommendations and supporting evidence statements were analysed to identify 
recommendations that focused on patient preferences. 
Analysis was directed by the framework approach (352), which involved five steps 
(familiarisation; identifying a thematic framework; indexing; charting; and mapping and 
interpretation). Detailed review of the guidelines ensured familiarity with content and 
enabled the identification of key themes that aligned with the notion of patient 
preferences. An index framework that defined key themes including and consistent 
with patient preferences (e.g., “actively involved” recommended patients be engaged, 
involved or given the opportunity to participate in the decision-making process) was 
developed and used to code content. Relevant passages from each guideline were 
extracted in accordance with the themes and placed in charts to assist with mapping 
and interpreting the data. 
Three guidelines provided recommendations and evidence statements for both 
children and adults (369-371). Recommendations and evidence statements that 
focused only on children were excluded from the analysis. 
Stage 2 
Document analysis using the framework approach was also conducted to assess the 
consumer-engagement processes used during guideline development. Explanation of 
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guideline-development processes, including consumer engagement, was typically 
described at the beginning or end of the guideline, or occasionally in a separate report. 
All of this material was reviewed. A thematic framework was developed from key 
themes identified in the document analysis and from the literature (e.g., “training and 
education”). This framework was used to code guideline content. 
Stage 3 
An assessment of guideline quality was conducted using the AGREE II instrument 
(368). AGREE II is a validated tool that assesses guideline quality according to 23 
items listed under six domains: scope and purpose; stakeholder involvement; rigour 
of development; clarity of presentation; applicability; and editorial independence 
(27,368). For each domain, questions are scored on a 7-point scale from seven 
(strongly agree) to one (strongly disagree). An overall domain score was calculated 
from the sum of individual items standardised as a percentage for each domain (368). 
Guidelines were assessed as “good quality” (27) if they scored above 60% on all of 
the AGREE II domains. Two reviewers (C.E.Y. and K.S.B.) independently scored each 
guideline. The AGREE II concordance calculator (372) confirmed an acceptable level 
of agreement between the reviewers. 
In line with the study aims to examine consumer-engagement processes, particular 
attention was paid to the stakeholder domain in the AGREE II, which includes three 
items: 1) guideline development includes individuals from all relevant professional 
groups; 2) the views and preferences of the target population (e.g., patients, public) 
have been sought; and 3) the target users of the guideline are clearly defined (368). 
5.5 Results 
Thirteen guidelines met the inclusion criteria: four guidelines for cardiovascular health 
(373-376); one guide- line for stroke (377); one guideline for prostate cancer (378); 
two guidelines for diabetes mellitus (369,370); two guidelines for musculoskeletal 
health (379,380); two guidelines for respiratory conditions (371,381); and one 
guideline targeted multiple chronic conditions focusing on the prevention and 
management of chronic kidney disease for people with type 2 diabetes (382). Eleven 
guidelines were developed by non-profit organisations (369-371,373-378,381,382) 
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and two guidelines by the Royal Australian College of General Practitioners (379,380). 
Five guidelines were approved by the NHMRC (369,377,379,380,382). The guidelines 
ranged in length from19 to 288 pages. 
Incorporating patient preferences 
Across the 13 guidelines, a total of 1,076 core recommendations were reviewed, of 
which 49 (4.5%) were identified as patient-preference-related recommendations (see 
Table 5.1). The number of total core recommendations ranged from 18 to 335 for 
individual guidelines and the number of core patient-preference-related 
recommendations ranged from 0 to 16 (0–12.2 % of the total core recommendations). 
A further 108 statements, directing clinicians to consider patient preferences, were 
identified in the supporting evidence statements (range 0–25). 
Examination of both the guideline recommendations and supporting evidence 
statements revealed four key themes: patient preferences; care plans; actively 
involved; and risks and benefits (Table 5.1). General introductory comments or 
“blanket statements” (67) emphasising the need to consider individuals’ views were 
also identified. 
Twelve guidelines explicitly asked for patient preferences to be considered by the 
clinician in relation to treatment, interventions, or outcomes (369-371,373-381). For 
example, the guideline on type 1 diabetes stated, “Choice of device should be made 
on the basis of ease of use, patient preference/suitability and overall cost” (369). 
Care plans, also referred to as management, action and treatment plans, were 
highlighted by all but two guidelines (376,382) as a means of working collaboratively 
with patients to identify their preferences and goals for care. Care plans were the most 
frequently flagged core patient-preference-related recommendations (range 0–13) 
and were also commonly discussed in the supporting evidence statements (range 2–
6) (see Table 5.1). For example, the guideline for rheumatoid arthritis stated the 
following: “general practitioners should aim to engage patients with RA [rheumatoid 
arthritis] in individualized care plans that include treatment goals and objective 
measures of disease” (379). 
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Seven guidelines (369-371,376,377,379,381) called for patients to be actively involved 
or engaged in decision-making and as a member of the healthcare team, as illustrated 
by this example from the guideline for type 2 diabetes, “Encourage patients to 
participate and take an active role in the management of their diabetes” (370). 
Five guidelines (371,375,377,378,380) suggested outlining the risks and benefits of 
recommended treatments to enable patients to make an informed decision based on 
their treatment preferences, as demonstrated by the guideline for prostate cancer:  
Toxicities should be considered in the context of what is important to each 
individual patient, as for some patients impairment of sexual function may 
have a significant impact on their quality of life and overall adjustment, as 
well as affecting adversely those close to them (378). 
Eleven guidelines provided blanket statements (369-371,374-380,382). These were 
statements provided at the beginning of the document, instructing clinicians that all 
recommendations should be individualised to consider the needs, preferences and 
context of each patient. For example, the chronic kidney disease in type 2 diabetes 
guideline, the only guideline that did not include any core patient-preference-related 
recommendations, began with the following overarching statement:  
This document is a general guide to appropriate practice, to be followed 
subject to the clinician’s judgement and the patient’s preference in each 
individual case. The guidelines are designed to provide information to assist 
decision-making and are based on the best evidence available at the time 
of development (382). 
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Table 5.1 - Appraisal of the included guidelines according to the patient-preference framework. 
*Received National Health and Medical Research Council (NHMRC) approval. ES, evidence statements; PPR, patient-preference-related recommendations. 




PPR (% total) PPR (ES) 








Acute coronary syndromes (374) 44 2 (4.5) 1 (1) 1 (2) 0 (0) 0 (0) 
Asthma (371) 158 3 (1.9) 0 (7) 3 (13) 0 (3) 0 (2) 
Chronic heart failure (376) 80 1 (1.2) 1 (3) 0 (0) 0 (3) 0 (0) 
Chronic kidney disease in type 2 diabetes* (382) 18 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Chronic obstructive pulmonary disease (381) 34 2 (5.9) 0 (4) 1 (6) 1 (0) 0 (0) 
Coronary heart disease (375) 44 1 (2.3) 1 (0) 0 (3) 0 (0) 0 (1) 
Early rheumatoid arthritis* (379) 30 2 (6.7) 0 (3) 1 (4) 1 (1) 0 (0) 
Hip and knee osteoarthritis* (380) 34 2 (5.9) 0 (1) 2 (2) 0 (0) 0 (1) 
Hypertension (373) 25 3 (12.0) 0 (2) 3 (5) 0 (0) 0 (0) 
Locally advanced and metastatic prostate cancer 
(378) 
57 7 (12.2) 2 (2) 0 (2) 0 (0) 5 (3) 
Stroke* (377) 335 16 (4.8) 1 (3) 13 (6) 0 (6) 2 (4) 
Type 1 diabetes* (369) 132 8 (6.0) 2 (3) 4 (3) 2 (0) 0 (0) 
Type 2 diabetes (370) 85 2 (2.4) 0 (2) 1 (5) 1 (2) 0 (0) 
Total 1,076 49 (4.5) 8 (31) 29 (51) 5 (15) 7 (11) 
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Guideline quality 
The AGREE II domain scores for each guideline are presented in Table 5.2. Across all 
guidelines, the applicability domain (i.e., “the guideline outlined potential barriers and 
facilitators to its implementation in practice, strategies to improve uptake, and resource 
implications”) received the lowest domain scores, while clarity of presentation (i.e., “are the 
recommendations specific and easily identifiable, and are the various options clearly 
presented”) received the highest domain scores (368). Clarity of presentation was the only 
domain for which all guidelines scored above 60 %. The five guidelines approved by the 
NHMRC consistently scored higher across all domains (369,377,379,380,382). Within this 
group, the guideline for stroke was the only guideline to score above 60 % in all domains 
(377). Of particular interest was the stakeholder involvement domain. Six guidelines scored 
above 60 % for this domain (369,377-380,382). Closer examination of the individual items 
within this domain revealed that 11 guidelines scored better (average between the two 
reviewers above 4.2 (60 %) on a 7-point rating scale) for the first item: “included individuals 
from all relevant professional groups in the development group” (369,371,373,374,376-
382); and the third item: “clearly defined target users” (369-371,374-380,382). In contrast, 
only four guidelines scored above 60 % (369,377,378,382) on the second item “the views 
and preferences of the target population (patients, public, etc.) have been sought”. To score 
highly on this item, guideline developers needed to outline the strategies used to gain 
consumer perspectives, report the outcomes of this process and describe how this was 
used to inform the guideline. 
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  (%) (%) (%) (%) (%) (%) 
Acute coronary syndromes (374) 2006 67 58 19 69 25 33 
Asthma (371) 2006 44 50 20 67 29 0 
Chronic heart failure (376) 2011 53 50 14 72 13 79 
Chronic kidney disease in type 2 diabetes* (382) 2009 89 86 75 72 42 38 
Chronic obstructive pulmonary disease (381) 2011 53 50 17 75 27 4 
Coronary heart disease (375) 2012 31 39 11 69 27 63 
Early rheumatoid arthritis* (379) 2009 86 78 72 83 31 25 
Hip and knee osteoarthritis* (380) 2009 81 78 68 81 21 46 
Hypertension (373) 2010 0 25 5 86 23 38 
Locally advanced and metastatic prostate cancer (378) 2010 64 81 78 83 23 54 
Stroke* (377) 2010 83 86 74 78 71 88 
Type 1 diabetes* (369) 2011 92 81 76 78 54 46 
Type 2 diabetes (370) 2012 53 47 8 72 40 0 
%, overall score of the two reviewers calculated according to the AGREE II scoring system. Maximum AGREE II score 100%; COPD-X, chronic obstructive 
pulmonary disease and exacerbations. *Received National Health and Medical Research Council (NHMRC) approval. 
Reproduced from Young C et al. J Comorbidity 2015;5(1):122-31 under the Creative Commons BY-NC 4.0 License
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Consumer-engagement processes 
The thematic framework developed for this phase of the analysis covered four key themes: 
consumer involvement in the development group; clarification of this role; provision of drafts 
for public review; and training and education. Across the guidelines, only two methods of 
engagement were reported: involving consumer representative(s) in guideline-development 
groups; and providing drafts for public review. Seven guidelines used both methods 
(369,377-382), three provided drafts for public review only (373,375,376), and three did not 
report their methods of engagement (370,371,374) (see Table 5.3). 
Most guideline-development groups included one or two consumer representatives 
recruited from relevant non-profit organisations, with the exception of the guideline for stroke 
(377), which included three consumers, and the guideline for chronic kidney disease in type 
2 diabetes (382), which included five consumers, one for each of the five smaller expert 
advisor y groups forming the guideline-development group (see Table 5.3). None of the 
guidelines reported training and education of consumers. Seven guidelines reported the 
broad role of the development group (369,377-382); only one provided a specific 
explanation of the consumer’s role (382).  
Consumer representatives were selected and appointed by Diabetes Australia for 
each EAG [Expert Advisory Group] to ensure the consideration of people with type 
2 diabetes with respect to their acceptability of the proposed guideline 
recommendations (382). 
Ten guidelines provided drafts for public review (369,373,375-382), but the extent to which 
this engaged consumers was not always possible to ascertain. Four guidelines provided an 
explanation of the results of the public-review processes, outlining how comments were 
incorporated or changes made (369,377,378,382). The comments addressed a range of 
issues including guideline structure, chapter size, editing, and clarification of 
recommendations and supporting evidence statements. Six guidelines did not clarify the 
extent or nature of the feedback process (373,375,376,379-381). For example, the guideline 
on osteoarthritis stated, “Feedback collected from the survey and independent submissions 
were collated and addressed by the Working Group” (380). 
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The study also considered whether consumer-engagement processes in guideline 
development resulted in greater integration of patient preferences. There was some 
suggestion that more extensive use of consumer-engagement processes (i.e., both 
provision of drafts for public review and inclusion of consumers in the development group) 
was associated with greater incorporation of patient-preference recommendations. Six of 
the seven guidelines that produced the greatest proportion of core patient-preference 
recommendations (as shown in Table 5.3) used both consumer-engagement (369,377-
381). However, the guideline that reported the most comprehensive consumer-engagement 
processes (i.e., provided a specific explanation of the consumers role, included five 
consumers in the development group, and stated how the public review feedback was 
incorporated) (382) did not explicitly include recommendations targeting patient 
preferences. Rather a blanket statement was provided at the beginning of the document 




Table 5.3 - Appraisal of the included guidelines according to the consumer-engagement framework. 
Guideline 
Consumers included 
in development group 
(n) 
Role description 
Provision of drafts  
for public review 
Training and 
education 
Acute coronary syndromes (374) NR NR NR NR 
Asthma (371) NR NR NR NR 
Chronic heart failure (376) NI NR Yes NR 
Chronic kidney disease in type 2 diabetes* (382) 5 Broad group and consumer specific Yes NR 
Chronic obstructive pulmonary disease (381) 1 Broad group description Yes NR 
Coronary heart disease (375) NI NR Yes NR 
Early rheumatoid arthritis* (379) 1 Broad group description Yes NR 
Hip and knee osteoarthritis* (380) 1 Broad group description Yes NR 
Hypertension (373) NI NR Yes NR 
Locally advanced and metastatic prostate cancer (378) 3 Broad group description Yes NR 
Stroke* (377) 2 Broad group description Yes NR 
Type 1 diabetes* (369) 2 Broad group description Yes NR 
Type 2 diabetes (370) NR NR NR NR 
*Received National Health and Medical Research Council (NHMRC) approval. NI, not included; NR, not reported. 
Reproduced from Young C et al. J Comorbidity 2015;5(1):122-31 under the Creative Commons BY-NC 4.0 License 
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5.6 Discussion 
All 13 of the reviewed guidelines acknowledged patient preferences, either explicitly or 
indirectly through related themes, but their location and prominence varied, appearing as 
core recommendations, supporting evidence statements and/or blanket statements. Ten 
guidelines reported some form of consumer engagement during their development. The 
guidelines that employed the most extensive consumer-engagement processes (e.g., both 
provision of drafts for public review and inclusion of consumers in the development group) 
were among those with the greatest proportion of patient-preference recommendations. 
Overall, the quality of guidelines was mixed; the lack of evidence of strategies to incorporate 
the views and preferences of consumers saw many fall short on stakeholder involvement. 
Quantifying the extent to which guidelines incorporate patient preferences was not always 
straightforward, as some recommendations and supporting evidence statements were less 
explicit in their request that patient preferences be considered. Similarly, patient preferences 
were more frequently presented in supporting evidence statements than in core 
recommendations. Presenting patient preference information in supporting evidence 
statements may undermine the potential of guidelines to support a more systematic 
discussion of patient preferences in primary care as it risks this information being overlooked 
by time-poor clinicians. In practice, clinicians and patients frequently identify differences in 
their preferences, priorities and goals for care when managing multiple conditions; if not 
discussed and worked through, these differences can lead patients to disengage from 
clinical advice (135). Clearer and more frequent flagging of patient-preference-related 
recommendations in guidelines is needed to draw attention to patient preferences in clinical 
consultations. Consistently identifying these recommendations and facilitating their 
discussion is one way in which guidelines might support a more systematic approach to 
patient-centred care (250,311). 
Overall, more extensive use of consumer-engagement processes in guideline development 
was linked to a greater proportion of core patient-preference recommendations; however, 
closer consideration of the consumer-engagement processes used across the guidelines 
highlights shortfalls in practice. Ten guidelines engaged consumers in public-review 
processes. These typically passive methods have been criticised for limiting consumers’ 
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ability to actively engage and provide valuable input (311,314,383). Seven guidelines 
engaged consumers in development groups, but there was little evidence of the provision 
of training or specific role descriptions for consumers. 
Research suggests that unless guideline developers provide consumers participating in 
development groups with education and training, a clear explanation of their role, and 
sufficient support (e.g., more than one consumer representative), their involvement is likely 
to be tokenistic and relatively ineffective (313-315). In support, Tong et al. (311) found that, 
when adequately assisted and engaged, consumers were able to contribute meaningfully 
to guideline development by identifying topics and outcomes (e.g., day-to-day management 
and overall illness experience) not identified by health professionals. This experiential input 
is the cornerstone of consumer engagement: it extends the clinicians’ focus from disease 
to incorporate the patients’ social context, experiences, and feelings (384). In short, without 
effectively engaging consumers, guideline developers risk producing guidelines that may 
not fully address the topics and outcomes of importance to patients, particularly those 
experiencing multiple conditions (311,314,384). 
Our findings, like those of Vitry and Zhang (295), demonstrate the role of NHMRC standards 
in contributing to the development of higher quality guidelines in Australia. Currently, the 
inclusion of a consumer representative in guideline development groups is a NHMRC 
standard (286), but our findings are consistent with other research suggesting this approach 
may be of limited value when used in isolation and without proper support of consumers 
(314,315). Further clarification of consumer-engagement processes and their purpose could 
be driven by a revision of the NHMRC standards for clinical practice guidelines (286). 
The limitations of this study need to be acknowledged. An extensive search was conducted, 
but it is possible that eligible guidelines were missed as, unlike other countries, such as the 
UK (385), there is no centralised guideline-development organisation in Australia. The 
analysis conducted for this study was based on all publicly available information including 
published guidelines and their supporting documents. It is possible that more extensive 
consumer-engagement processes were conducted, but not reported. Since standardised 
quality-assessment practices, such as AGREE II, rely on published materials, there is a 
clear need for guideline developers to provide full information that accurately reports all 
elements of the development process. 
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5.7 Conclusion 
Clinical practice guidelines appear to be taking important steps towards supporting 
clinicians and patients through the incorporation of patient-preference recommendations, 
but there is scope for more explicit acknowledgement. Consumer-engagement processes 
used to develop guidelines have the potential to contribute to the identification of patient 
preferences, but further research is needed to investigate the contribution and impacts of 
these processes. Clarification of the consumer role and investment in consumer training 
may help to strengthen these processes and further support a systems-based approach to 
patient-centred care for people with multiple chronic conditions. 
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 Chapter 6 Care plans 
The previous chapter presented a research paper examining the first primary care practice 
tool: clinical practice guidelines. This chapter will present research examining the second 
primary care practice tool: care plans. The chapter presents a paper I co-authored during 
my thesis, titled “Are care plans suitable for the management of multiple long-term 
conditions?” The paper has been submitted to the Journal of Comorbidity and is currently 
under review. In line with The University of Queensland’s requirements, the article has been 
reproduced in standard formatting. In addition, the referencing has been changed to ensure 
consistency throughout the thesis and all references are now presented at the end of the 
thesis.  
6.1 Abstract 
Background: Care plans have been part of the primary care landscape in Australia for 
almost two decades. With an increasing number of patients presenting with multiple chronic 
conditions, it is timely to consider whether care plans meet the needs of patients and 
clinicians. Objectives: To review and benchmark existing care plan templates that include 
recommendations for comorbid conditions, against four key criteria: patients’ preferences; 
setting priorities; identifying conflicts and synergies; and setting dates for review. Design: 
Document analysis of Australian care plan templates published from 2006-2014 that 
incorporated recommendations for managing comorbid conditions in primary care. Results: 
Sixteen templates were reviewed. All of the care plan templates addressed the patient 
preference criteria, but this was not done comprehensively. Only three included priority 
setting processes. None assisted in the identification of conflicts and synergies between 
conditions. Fifteen required dates for reviewing the plan be provided. Conclusions: Care 
plans are a well-used tool in primary care practice but their current format perpetuates a 
single-disease approach to care, which works contrary to their intended purpose. 
Restructuring care plans to incorporate shared decision-making and attention to patient 
preferences may assist in shifting the focus back to the patient and their care needs. 
Key words: multimorbidity, comorbidity, primary care, patient preference, consumer 
participation, patient care planning 
 84 
6.2 Introduction 
Care plans, widely advocated as mechanism to individualise chronic disease care (335), 
are intended to engage primary care clinicians and patients in an examination of clinical 
evidence and a consideration of patients’ preferences, needs and values to inform and 
facilitate care planning and shared decision-making (318,335). Empirical evidence indicates 
care plans can: enhance self-management practices (386); increase adherence to guideline 
recommendations (4); improve processes and clinical outcomes (387); and reduce or delay 
hospitalisation (388). However, the effectiveness of care plans relies on the care planning 
processes used and the clinician’s and patient’s desire and ability to participate in these 
processes (210,276,321). 
Care plans in Australia 
Care plans have been used across Canada, Germany, the United Kingdom, the United 
States, and Australia (335). In Australia, the introduction of the Enhanced Primary Care 
(EPC) package in 1999 signalled a shift to care planning and a significant change in 
approach to chronic disease management (4,39). For the first time primary care clinicians 
could be reimbursed by Medicare, Australia’s universal health insurance scheme, for time 
spent developing multidisciplinary care plans for patients with chronic and complex care 
needs (4,39). In 2005, the EPC was expanded and renamed the Chronic Disease 
Management (CDM) items, but care plans remained central to the policy (4,39). 
Care plan templates designed to meet the minimum requirements set by Medicare (see Box 
1) and assist with the development of General Practice Management Plans (GPMP) (i.e., 
care plans involving GPs) and Team Care Arrangements (TCA) (i.e., care plans led by the 
GP with involvement from a multidisciplinary team of health professionals) have been 
developed by governments, non-profit, and professional organisations (389). The use of 
templates is not mandatory, clinicians can develop their own plan format, but Bolger-Harris 
et al. (389) found most clinicians prefer templates because they are quick, adaptable, 
increase the chance of reimbursement by Medicare, and provide prompts and checklists for 
care.  
A General Practice Management Plan (GPMP) must describe: 
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- the patient’s health care needs, health problems and relevant conditions; 
- management goals with which the patient agrees; 
- actions to be taken by the patient; 
- treatment and services the patient is likely to need; 
- arrangements for providing this treatment and these services; and 
- arrangements to review the plan by a date specified in the plan. 
A Team Care Arrangements (TCAs) must describe: 
- treatment and service goals for the patient; and 
- treatment and services that collaborating providers will provide to the patient; and 
- actions to be taken by the patient; and 
- arrangements to review by a specified date 
Box 6.1 - Medicare requirements for General Practitioner Management Plans and Team Care 
Arrangements (324) 
Despite this preference for care plan templates GPs are critical of their ability to “cater for 
patients with multiple chronic diseases” (389). Adding weight to these concerns, the Royal 
Australian College of General Practitioners (RACGP) (60) questions the ability of care plans 
to meet the needs of patients and GPs managing multiple chronic conditions. The RACGP 
argues the predominant focus on the provision of single-disease care is the most serious 
gap in Australia’s primary health care system, and suggests the chronic disease 
management items only add to this issue, as the “needs of complex patients with advanced 
disease or multiple diseases are not acknowledged” (60). 
Care plans in a multimorbidity context 
Empirical evidence informing the development and application of care planning for patients 
with multiple conditions is needed (335). A recent Cochrane review of 15 randomised trials 
examining personalised care planning for adults with chronic conditions, found no studies 
that explicitly examined whether care plans led to improved physical, psychological, or 
subjective health, or improved capabilities for self-management for patients with multiple 
conditions (335). Acknowledging the limited evidence informing multimorbidity care (16,62), 
researchers have increasingly argued in favour of approaches that move beyond a focus 
on disease (12,141,248,250,309). These arguments are grounded within a patient-centred 
approach, but also stem from empirical work identifying the impractical and potentially 
hazardous outcomes that can arise when disease-centric interventions that target single 
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conditions (such as clinical practice guidelines) are applied across multiple conditions 
(62,303). Care plans have been emphasised as a mechanism for enhancing the provision 
of multimorbidity care by supporting patient-centred care (12,21,62,141,248,335), although 
in practice patients report diverse experiences and different levels of engagement in care 
planning processes (275,321,390,391). To achieve greater consistency in care planning 
and the resultant care plan broader system level interventions are required (136,392).   
A recent study by Morgan et al. (136) trialling care planning for patients with depression, 
diabetes, and/or coronary heart disease, demonstrates the potential utility of care plans in 
a multimorbidity context. The trial involved significant investment, with multiple system level 
changes including: merging evidence-based guidelines; training primary care practice staff 
in goal setting and problem solving; changes to practice based information technology; and 
automating recall for review (136,392). A multiple condition care plan template, informed by 
clinical practice guidelines, was developed to support clinicians and patients to record and 
track changes across clinical data for all their conditions. The template required extensive 
review of the patient’s goals and preferences along with barriers to achievement; the 
development of multidisciplinary care arrangements; and established prompts for guideline-
recommended checks (136). In comparison with usual care, patients achieved significant 
clinical improvements in depression and cardiovascular disease risk (136). Guideline-
recommended checks were also more frequently performed, multidisciplinary care 
arrangements and communications were well structured and managed, and patients’ goals 
were comprehensively monitored (136). 
Morgan et al. (136) concluded that many factors contributed to the success of the trial, but 
the identification of patients’ goals and priorities, and establishing systems to ensure regular 
review appeared central (136). These findings provide preliminary evidence for a patient-
centred approach that draws on care planning to enhance multimorbidity care 
(12,141,248,393), while also highlighting the level of system level investment required to 
support such an approach (136). Systems level investment to support the management of 
multiple conditions is clearly essential, but at a time of fiscal constraint this is a significant 
challenge. Major health system reform is difficult and costly to achieve, with most reform 
arising from incremental change to existing practice (39,40). Examining whether current 
tools that support practice, such as care plan templates, are fit for purpose in the context of 
multimorbidity care is timely. 
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Examining the potential of Care plan templates 
An examination of care plans and their potential utility for multimorbidity care requires 
careful consideration of key criteria integral to patient-centred care and shared decision-
making. Identifying an empirical evidence base informing appropriate assessment criteria is 
an obvious challenge, but a number of leading agencies and authors in the field, such as 
the American Geriatric Society Expert Panel (AGS) (141), Muth et al. (248) and others 
(190,393,394) have proposed key principles to guide the management of multiple conditions 
within primary care. These principles, developed through extensive literature reviews and 
in consultation with expert stakeholders (141,248), emphasise the need for: establishing 
patients’ preferences, setting priorities, identifying conflicts and synergies and establishing 
review processes. In the absence of a solid evidence base, these components provide a 
preliminary basis for evaluating whether care plans support the management of multiple 
chronic conditions. 
Patients’ Preferences 
Understanding the health issues, treatments, and agreed actions of significance to the 
patient, that is, his or her ‘preferences’ (250) acknowledges there is rarely a single correct 
treatment option when managing multiple conditions (244). Moreover it recognises that in 
managing multiple conditions a patient’s focus often shifts from disease-specific goals to 
more global cross-disease outcomes, such as maintenance of physical function, symptom 
relief and quality of life (394). Emphasis on shared decision-making and establishing 
patients’ preferences stems from the need to manage the misalignment that can arise 
between the preferences and goals of patients and those of their clinician 
(135,141,219,248,250). This misalignment may lead patients to disengage from clinical 
advice thereby undermining shared decision-making processes (135). Despite the 
increasing emphasis on shared decision-making, and taking greater account of what 
patients want and value (44,54), its benefits have not been extensively examined (260).  
Setting priorities or goals 
Overly complex management regimens, conflicts between medications and conditions, and 
excessive treatment burden are key challenges arising from the management of multiple 
conditions (19,21,224). Patients overwhelmed by the burden of treatment may not adhere 
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to prescribed treatments (190). In response, The AGS (141) and Muth et al. (248) suggest 
a patient-centred approach acknowledges that priorities or goals must be set in line with the 
patient’s preferences (141,248). In doing so, recognition must also be given to whether 
patients wish to participate in care decisions (9,395). 
The challenges associated with setting priorities are well documented, with clinicians 
frequently citing limited resources and the narrow evidence base informing the management 
of multiple conditions as central to this problem (19,394). Clinical practice guidelines, the 
main drivers of evidence based care in primary practice, do not account for multimorbidity. 
Therefore the information needed to inform goal setting discussions, such as numbers 
needed to treat (NNT) and harm (NNH), is often absent or conflicting for patients with 
multiple conditions (12,62,141,393). Despite this, evidence suggests patients with multiple 
conditions can still engage in shared priority or goal setting discussions with their clinician, 
by ranking which broad cross disease goals are of most importance to them (394). 
Identifying the goals of most importance to the patient is a first step to directing guideline-
based disease-specific care (141,248,393).  
Conflicts and synergies 
The identification of conflicts and synergies is a central part of care planning for patients 
with multiple conditions designed to help patients accommodate and avoid being 
overwhelmed by new conditions (135). When managing multiple chronic conditions, 
clinicians often adopt an “additive-sequential model”, in which they examine conditions 
individually with the most pressing addressed before the consultation ends and the 
remainder held over until the next consultation (21). This process, perpetuated by current 
Medicare funding arrangements and clinical practice guidelines, reinforces the centrality of 
individual diseases rather than consideration of conflicts or congruence between them. This 
can undermine the clinical management of multiple conditions, as it may fail to support 
patients who place greater importance on function than disease (122). Opportunities to take 
a more personalised and holistic view of the patient’s care (83) and reduce patient burden 
through processes such as de-prescribing, may also be lost (396).  
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 Regular review 
The AGS (141) and Muth et al. (248) highlight the need for constant review of patients’ 
goals, priorities and preferences. This is in keeping with the view that care plans should be 
living, dynamic documents that change over time and at pivotal points (such as the 
diagnosis of a new condition (135)), to reflect and support the needs of patients (54,335). 
Regular review of patients’ goals, priorities and preferences ensures care continues to be 
targeted at the issues of importance and relevance to patients (136). Review also serves as 
a means to monitor goals and ensure patients are supported to work through any barriers 
that undermine progress (136). Setting a date for review of the care plan is a Medicare 
requirement (see box 1), but the scheduled fee for reviewing a GPMP plan is significantly 
lower ($72.05) than that for preparing one ($144.25) [44]. 
In summary, recent evidence (136) suggests care plans may have the potential to move 
beyond the management of single conditions and support the provision of multimorbidity 
care, but this process must be underpinned by key criteria integral to patient centred care 
and shared decision-making. The purpose of this study is to review and benchmark existing 
care plan templates, which include recommendations for comorbid conditions, against these 
four criteria: patients’ preferences, setting priorities, identifying conflicts and synergies and 
establishing review processes. 
6.3 Methods 
OvidMedline, Web of science (ISI), Embase, Cinahl, PsycINFO, Cochrane and Pubmed, 
were searched for care plan templates using the following terms: ‘patient care planning’, 
‘case management’, ‘care plan’, and ‘Australia’. An extensive search of the grey literature 
was also conducted using Australian websites including: the Department of Health, 
Department of Veterans Affairs, Primary Health Networks, Royal Australian College of 
General Practitioners (RACGP) and relevant non-profit organisations websites. 
The study sought disease-specific (i.e., they include prefilled data related to the specified 
condition) and generic (i.e., they include general headings but no prefilled information) care 
plan templates. To be included a template needed to acknowledge comorbid conditions 
(e.g., if a care plan template for diabetes also discussed depression it was included). 
Templates which acknowledged comorbid conditions were the focus as they were more 
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likely to recognise and support the needs of patients with multiple conditions. Disease-
specific templates were also restricted to those that addressed a chronic condition classified 
as Australia’s National Health Priority areas (360): cardiovascular health; stroke; cancer 
(colorectal, lung, breast and prostate); diabetes; depression; chronic kidney disease; 
asthma and chronic obstructive pulmonary disease; and arthritis and musculoskeletal 
conditions. Additional criteria included: care plan templates for development in primary care 
practice settings; and applied to people aged 18 years and over. 
Figure one summarises the template identification process. After combining the results of 
all searches and deleting duplicates, 1757 citations remained. Citations were screened 
individually based on title and summary; 1720 were excluded at this point. The full text 
versions of 37 care plan templates were screened for eligibility. Twenty-one were excluded 
because they did not consider co-occurring conditions or were not designed for use in 
primary care. 
 
Figure 6.1 – Search strategy care plan 
Data analysis 
Document analysis guided by the framework approach was used to review the care plan 
templates. The framework approach, which involves five steps (familiarisation; identifying a 
thematic framework; indexing; charting; and mapping and interpretation) (352), was chosen 
because of its emphasis on applied research that seeks to provide ‘answers’ to clearly 





391 duplicates removed 
1720 excluded on title/abstract 
- Not a care plan (1706) 
- Not an included condition (10) 
- For people aged <18years (4) 
16 included in final report 
21 excluded on full analysis 
- Does not consider co-occurring 
conditions (19) 
- Not developed by GP (2) 
1757 references screened on title and abstract 
37 references selected for full analysis 
2148 references identified by search 
- Database (1884) 
- Online search (264) 
 91 
To assess the ability of care plan templates to support the management of multiple chronic 
conditions, the four criteria relevant to care planning for patients with multiple conditions 
(patient preferences; priority setting; identification of conflicts and synergies between 
conditions; and review) were used to construct a data-extraction index or thematic 
framework (Table 6.1). The thematic framework was used for coding, with relevant 
passages from each care plan template extracted in accordance with identified themes and 
placed in charts to assist with mapping and interpreting the data.  
Table 6.1 - Care plan framework themes 
Theme Description 
Patient preferences  Health issues identified by patients, patients’ preferences for management 
goals, process or treatment choice. 
Priority setting Processes to assist clinicians and patients to prioritise health issues/conditions, 




Identification of: conflicts between conditions, medications and management 
strategies; barriers to following the care plan; commonalities between 
conditions, medications and management strategies; and enablers to following 
the care plan. 
Review  A date for reviewing patient goals and priorities. 
6.4 Results 
Sixteen care plan templates (397-412), thirteen designed for specific diseases (397-
403,406,408-412) and three generic ones (404,405,407) developed to cover a range of 
conditions met the inclusion criteria. Of the thirteen disease-specific templates: four were 
for cardiovascular health (397,402,408,410); four for musculoskeletal conditions (399-
401,403); two for diabetes (411,412); one for depression (398); one for COPD (409); and 
one for mental health (406). Seven care plan templates were GPMPs 
(398,400,401,404,406,408,412), four were TCAs (399,403,405,410), four were combined 
GPMPs and TCAs (397,402,409,411), and one was for the Coordinated Veterans Care 
(CVC) Program (407). The CVC Program is an initiative of the Department of Veterans’ 
Affairs, which provides reimbursement to primary care clinicians who develop care plans for 
veterans and eligible relatives with one or more chronic conditions or complex care needs 
(413). Ten care plan templates were developed by Primary Health Networks (formerly 
Medicare Locals) (397-403,409-411); three by the Department of Health (404-406); one by 
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the Department for Veterans Affairs (407); one by the Royal Australian College of General 
Practitioners (412); and one by the Heart Foundation (408). 
All of the disease specific templates (397-403,408-412), with the exception of the GPMP for 
Mental Health (406), included some pre-filled information (see Table 6.2). This information, 
drawn from clinical practice guidelines, was provided under each of the care plan headings 
or components for the specific condition. For example, the GPMP for Depression (398) 
included pre-filled information on the patient’s problems, goals, required treatments and 
services including patient actions, and arrangements for treatments/services for depression. 
Pre-filled data on the patient’s health issues, corresponding goals, and treatments and 
agreed actions was organised under similarly labelled subheadings across the disease 
specific templates: general, lifestyle, biomedical, medication, and psychosocial. The generic 
templates (404,405,407) did not include pre-filled information, they provided the headings 
(e.g., health issues, goal, required treatments and agreed actions) under which primary care 
clinicians and patients can record information (see Table 6.3). The GPMP for Mental Health 
was the only disease-specific template, which did not include pre-filled data (406). The 
template includes many of the same headings included in the generic templates (i.e., patient 
need, goals, treatments), and headings related specifically to mental health (i.e., results of 
mental state examination, crisis/relapse) (406). 
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Table 6.2 - Extract from a disease-specific care plan template (398). 
GP MANAGEMENT PLAN – MBS ITEM NO. 721 (DEPRESSION / ANXIETY DISORDER) 
Patient problems/needs/relevant 
conditions 
Goals – changes to be achieved (if 
possible) 
Required treatments and services, 
including patient actions 
Arrangements for treatments/services 
(when, who, and contact details) 
1. General    
Patient’s understanding of depression/ 
anxiety 
Patient to increase their understanding of 
depression/anxiety and how it can be 
managed 
Patient education GP 
Nurse 
Allied health professional 
Symptoms Improve mood, sleep, energy, attention, 
concentration, motivation, sexual function 
Improve physical symptoms (e.g. fatigue, 
headache, muscle pains, weight loss) 
Increase self confidence 






– Psychotherapy  
– Relaxation training 
GP 
Allied health professional 
Psychiatrist 
Causes/stressors and precipitants Identify stressors and precipitants, such as 
relationship and family problems, negative 




– Problem solving 
– CBT 
– Interpersonal therapy 
– Marital/family therapy 
– Loss/grief counselling 
GP  
Patient 
Allied health professional 
Psychiatrist 
Maintenance/relapse prevention Avoid relapse/decrease severity of relapse Regular review 
Address stressors and known risk 
factors for relapse 
GP  
Patient 
Allied health professional 
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Increase awareness of 
stressors/circumstances that could trigger a 
relapse 





Table 6.3 - Extract from a generic care plan template (404). 
PREPARATION OF A GP MANAGEMENT PLAN (ITEM 721) 
Patient’s health problems/health 
needs/relevant conditions 
Management goals with which the 
patient agrees 
Treatment and services required, 
including actions to be taken by 
the patient 
Arrangements for providing 











   
Copy of GPMP offered to patient? YES / NO 
Copy/relevant parts of the GPMP supplied to other providers? YES / NO / NOT REQUIRED 
GPMP added to the patient’s records? YES / NO 
Review date for this plan: dd / mm / yy 
The referral form issued by the Department can be found at www.health.gov.au/mbsprimarycareitems or a form can be used that contains all of the 
components of the Department's form. 
 96 
 
Table 6.4 - Appraisal of the included care plans according to criteria 
 Patient preferences    






treatments and actions 
Priority 
setting 
Identification of conflicts 
and synergies between 
conditions 
Review 
GPMP; Generic (404) + ++ + - - + 
GPMP Diabetes (412) + + + - - + 
GPMP CHD (408) - ++ ++ - - + 
GPMP Depression (398) + + + - - + 
GPMP Osteoarthritis (400) + + + - - + 
GPMP Osteoporosis (401) + + + - - + 







TCA; Generic (405) - - + - - + 
TCA CHD (410) - + + - - + 
TCA Osteoporosis (399) - + + - - + 
TCA Osteoarthritis (403) - + + - - + 
CVC; Generic (407) + ++ ++ ++ - ++ 
GPMP & TCA diabetes (411) + + + + - - 
GPMP & TCA COPD (409) ++ + ++ - - + 
GPMP & TCA Cardiac (397) ++ + ++ - - ++ 
GPMP & TCA Hypertension (402) + ++ + + - + 
- does not address criteria; + somewhat addresses criteria; ++ addresses criteria  
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Data relating to the four criteria relevant to care planning for patients with multiple 
conditions (patient preferences; priority setting; identification of conflicts and synergies 
between conditions; and review) are outlined below. Table 6.4 presents a summary of 
the extent to which each of the assessed templates addressed the four criteria. 
Patient preferences 
Across the templates, the broad criterion of patient preferences was mapped against 
three subthemes: a description of the health issue(s); management goals; and 
treatments and agreed actions. Eleven care plans (397,398,400-
402,404,406,407,409,411,412) required the patient’s health issues or conditions be 
recorded. For example, the GPMP template for diabetes included the following 
heading: “patient’s problems/needs/relevant conditions”, under which clinicians and 
patients could respond (412). Two templates (397,409), both combined TCA/GPMPs, 
extended this request for information by encouraging primary care clinicians and 
patients to independently record the health issues. Of the five templates 
(399,403,405,408,410) that did not request information on the health issue(s), four 
were TCA templates (399,403,405,410), which are not required by Medicare, to record 
patients’ health issue(s).  
Fifteen care plan templates (397-404,406-412) provided a heading under which goals 
for care could be recorded, for example, the TCA template for Osteoarthritis flagged: 
“goals to be achieved” (403). Six templates (402,404,406-408,411) stipulated patients 
should agree to the goals for care, as the following example from the generic GPMP 
template illustrates “management goals with which the patient agrees”(404). The 
generic TCA template (405) did not record patients’ management goals but focused 
on treatment and service goals. 
All of the care plan templates recorded the treatments and/or agreed actions (397-
412). For example, the GPMP for Depression flagged: “treatment and services 
required, including actions to be taken by the patient” (398). Four templates (397,407-
409) stipulated that the primary care clinician should agree to these treatments or 
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actions and patients as the GPMP/TCA template for Chronic Obstructive Pulmonary 
Disease demonstrates: “agreed action by health professionals and patients” (409). 
Setting priorities or goals 
The priority-setting theme included processes to assist clinicians and patients to 
prioritise patient preferences. Only three care plan templates included priority-setting 
processes (402,407,411). Two templates, the GPMP for Diabetes and the GPMP/TCA 
for Hypertension, addressed this criteria in a rudimentary way simply recording the 
“primary diagnosis/main issue” (402,411). The third template, for the CVC program, 
asked the patient to identify and rate their problems (8 point scale: zero = ‘not at all’ - 
eight = ‘a lot’) (407). The template also asked patients to identify a goal and rate their 
progress in achieving the goal (8 point scale: zero = no success, eight = complete 
success) (407). Notably the template only included space for one problem statement 
and one goal statement, but additional statements could be added elsewhere (407).  
Conflicts and synergies  
Processes for identifying conflicts and synergies between conditions were not flagged 
by any of the care plan templates.  
Regular review 
In line with the minimum requirements set by Medicare all of the care plan templates 
(397-410,412), with the exception of the GPMP/TCA for diabetes (411), requested a 
review date for the care plan, but only two templates requested a review of the patient’s 
management goals. 
6.5 Discussion 
Sixteen care plan templates were identified to assess their ability to support shared 
decision-making and enhance the management of multiple conditions. None of the 
care plan templates addressed all of the criteria (patient preferences; priority setting; 
identification of conflicts and synergies; and review), but most addressed one or more 
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to some extent. Patient preferences, linked to three subthemes (health issue(s); 
management goals; and treatments and agreed actions) was the most commonly 
addressed criterion, while substantially less emphasis was placed on priority setting 
and the review of individual management goals. None of the care plan templates 
identified conflicts and synergies.  
Thirteen of the reviewed care plans were pre-filled disease specific templates. The 
inclusion of pre-filled data in care plan templates, while important for bringing 
evidence-based medicine to the point of practice, runs the risk of overshadowing 
genuine care planning discussions. Care planning is intended to involve both primary 
care clinicians and patients reflecting on clinical evidence and the patient’s 
preferences, to inform and facilitate shared decision-making, resulting in the 
development of a joint care plan for managing the person’s condition(s) (335). In 
contrast, the pre-filling of templates can direct care-planning discussions to focus on 
the issues, goals, treatments and agree actions recommended by disease-specific 
clinical practice guidelines. In essence, the discussion remains one sided with the 
emphasis being placed on clinical decision-making and “medical agendas” (391), 
rather than supporting genuine care planning discussions and consideration of 
patients’ preferences for care. This is particularly concerning for patients with multiple 
conditions who are known to have contraindications to the treatments recommended 
in guidelines (62). 
In line with the single disease approach for which clinical practice guidelines are often 
criticised (62,303), the care plan templates guided clinicians to consider co-occurring 
health issues in a sequential manner. Isolating the management of conditions in this 
way may not reflect the way patients think or prioritise care (21,135,394). When 
considering trade-offs between competing conditions, medications and treatments, 
patients often shift focus from disease-specific outcomes to more global health 
outcomes such as maintenance of physical function, symptom relief and quality of life 
(16,394), with some patients preferring not to acknowledge individual conditions (9). 
Fried et al. (394) suggest having patients identify or prioritise the global health 
outcomes of importance to them and organise care planning around these outcomes. 
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Pre-filled information sees the direction and focus of care at least partially pre-
determined while “data field” requirements under current GP Medicare funding 
arrangements may present a further barrier to shared decision-making between 
clinicians and patients. Swinglehurst et al. (390) and Blakeman et al. (391) made 
similar observations when examining the use of care plan templates in UK primary 
care practices. Disease-specific care plan templates directed care-planning 
discussions towards “medical agendas”, while completing specified “data fields” to 
meet set quality indicators, impeded the clinician’s ability to engage in genuine care 
planning processes. These findings in combination with our own suggest care plans 
have drifted from their intended purpose, of fostering patient-centred care, to driving 
clinicians to meet policy requirements. Pre-populated care plans have a place in 
current primary care practice as indicated by the expressed preferences of clinicians 
(389). However, our findings support calls for pre-populated disease-specific, 
information to serve as a means of achieving the broader health goals identified by the 
patient, and not as a goal in itself (248,393,394).  
Few of the care plan templates reinforced the need to engage patients in the 
development of care plans or included processes to assist clinicians and patients to 
set priorities. Some patients may not wish to participate in care decisions, but this 
should be an informed rather than an imposed choice (414). When faced with 
managing numerous potentially conflicting conditions, often with limited time and 
resources, some patients and clinicians will set priorities but these can differ (135,219). 
Working through differing priorities can assist to increase patients’ adherence with 
prescribed care (190), reduce the complexity or treatment burden faced by patients 
(190) and ensure the care plan addresses the issues of importance to patients (219). 
Yet seeking “agreement” with patients was not comprehensively encouraged or 
supported by the templates. Similarly, templates did not seek to reduce the complexity 
of care management through the identification of conflicts and synergies. Research 
suggests primary care clinicians rarely initiate priority setting discussions with their 
patients (415), but it is unclear whether this is due to limited availability of priority 
setting tools (19,224,262) or the culture of current practice (262). Clinicians have 
called for methods to support shared decision-making and resolve potential 
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differences between their priorities and those of their patients with multiple conditions 
(19,224). By not encouraging priority setting and regular review of patients’ priorities 
and goals for care, care plans are missing a valuable opportunity to assist both 
clinicians and patients to manage multiple conditions.  
Overall, our findings suggest current care plan templates may inadvertently impede, 
rather than foster shared decision-making, but there is scope for care plans to support 
the management of multiple conditions. This was demonstrated by the generic CVC 
template, which addressed the majority of the criteria, and included comprehensive 
methods for setting priorities. The generic CVC template encouraged patient 
ownership of the plan using headings such as “Identified issues (including self-
management)”; “What I want to achieve?” and “Steps to get there’” The template also 
encouraged the review of individual goals and the documentation of the patients’ 
progress towards that goal, allowing for potential barriers or enabler to care to be 
identified. The CVC template offers a clear example of how templates might be 
improved to better facilitate shared decision-making and multimorbidity care. Care 
plans are but one component of the wider system in which multimorbidity care takes 
place. To make meaningful and sustainable change, modifications to improve their 
relevance in a multimorbidity context, must be underpinned by, broader system level 
interventions. Some of these system level changes are already underway. The recent 
Primary Health Care Advisory Committee (PHCAG) report recommends changes to 
Australia’s current health management and funding models, placing greater emphasis 
on patient-centred care and shared decision-making in primary care settings (54). 
Care plans are explicitly identified as a means of facilitating patient-“work with and 
support their patients to set shared goals and make shared decisions about the 
inclusions of their care plan that are aligned and appropriate to their needs, 
circumstances, preference and context” (54).  
The report also cautions against the use of “expressly automated” care plans, targeted 
more “towards satisfying requirements for payment rather than the needs of the 
patient” (54). In the May 2016 federal budget, the Australian Government announced 
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a $21 million commitment to trial the recommended changes outlined in the report 
(124).  
The limitations of this study need to be acknowledged. An extensive search was 
conducted, but it is possible eligible Australian care plan templates were missed. No 
formal or tested criteria currently exist for evaluating care plan templates in a 
multimorbidity context. The evaluation criteria used in this study were drawn from 
current evidence, but it is possible that relevant questions or criteria were not 
considered. In addition, due to the limited evidence base for multimorbidity 
interventions and management (16,335), we do not know if adopting care plan 
templates based on the domains suggested will impact patient outcomes. 
Nonetheless, the findings highlight a number of issues that are potentially important in 
shaping the management of multiple conditions. This study evaluated care plan 
templates and not the manner in which they are used by clinicians or patients.  It is 
possible that clinicians engage in priority setting discussions and the identification of 
conflicts and synergies without these being flagged in current templates. However, 
current research suggests this is not generally the case. This study focused on care 
plan templates developed for use in Australian primary care practice and as a result, 
the care plans assessed were structured towards meeting the requirements set by 
Medicare and Australian clinical practice guideline recommendations. However, our 
findings are consistent with those reported by Swinglehurst et al. (390) and Blakeman 
et al. (391), suggesting they may have broader implications for the design of care plan 
templates beyond the Australian context.  
6.6 Conclusion 
Care plans are a well-used tool in primary care practice but their current format 
perpetuates a single-disease approach to care, which works contrary to their intended 
purpose. Policy constraints, medical agendas and clinical practice guidelines strongly 
influence the use of care plans in current practice. Restructuring care plans to 
incorporate shared decision-making and attention to patient preferences may assist in 
shifting the focus back to the patient and their care needs. 
 104 
 
Conflicts of interest 
The authors declare that they have no competing interests. 
Funding 
This study was not funded. 
 105 
 
 Chapter 7 Patient Decision Aids  
7.1 Introduction 
This chapter begins the discussion of how current primary care tools could be used 
collectively to contribute to multimorbidity care. It brings together the findings of the 
preceding chapters, in concert with a review of PDAs, to map the ways in which 
primary care practice tools can be used to facilitate shared decision-making and 
support multimorbidity care. To address this aim, the chapter is presented in two 
sections. Section one of the chapter draws on the findings from the expert stakeholder 
consultation to examine PDAs, a contemporary primary care practice tool not currently 
in widespread use in Australia. PDAs have been designed to support shared decision-
making and provide space for the patient voice; however their contribution to the 
management of multiple chronic conditions has not previously been examined. This 
section offers a brief overview of PDAs, before providing a more detailed analysis of 
PDAs designed to work through disease specific decisions but which acknowledge 
other conditions within the decision-making process. These PDAs are mapped against 
the SDMCs, outlined by Charles et al. (246) in chapter two, to identify where they are 
most suitably able to contribute to shared decision-making and supporting 
multimorbidity care.  
Section two seeks to merge the results of the current review of PDAs and the reviews 
of clinical practice guidelines and care plans, to outline the contribution these tools 
make to the SDMCs. This discussion moves beyond the limitations of the current tools, 
examined in detail in earlier chapters, to identify where their contribution may be most 
appropriately directed to support a multimorbidity care approach.  
Patient decision aids 
PDAs are electronic or paper-based tools that facilitate shared decision-making 
(337,344,345) and are widely used in the United States and the United Kingdom 
(251,416). They are designed to facilitate shared decision-making by supporting 
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patients and clinicians to participate in decision-making about health care options 
(336,337,344,345). Consensus has yet to be reached on the “active components” that 
PDAs must include (349) but, Trevena et al. (336) have identified a number of common 
steps decision aids should work through, including: outlining available options; 
identifying the risks and benefits of options; and ensuring patients’ preferences are 
elicited and incorporated (336).  
PDAs fall under three classifications of use: by clinicians and patients in the clinical 
consult; by patients independent of the clinical encounter; and decisions mediated 
through other social encounters (342). Unlike the first two classifications, PDAs 
mediated by other social encounters typically occur outside the clinical setting and 
involve participants other health professionals. This research focuses on the first two 
PDA classifications, given their application to patient-clinician interactions, which is the 
focus of this thesis. 
A number of Cochrane reviews conducted over the last 15 years have compared the 
use of PDAs to usual care for people facing treatment or screening decisions and 
demonstrated positive outcomes (251,346-348). The most recent review, involving 
115 randomised control trials concluded the use of PDAs results in patients having an 
increased knowledge of options, improved risk perceptions, lower decisional conflict, 
and selection of options more in line with their preferences (251).  
Despite this evidence-base, the ability of PDAs to support shared decision-making for 
patients with multimorbidity care remains untested. Attributes of PDAs, such as 
helping patients to understand treatment options, assisting patients to clarify how they 
feel about options and facilitating participation in shared decision-making (344), 
suggest promise in a multimorbidity context. In considering this, the objectives of this 
research were to investigate: the ways PDAs acknowledge or consider multiple 




7.2 Review of patient decision aids 
OvidMedline, Web of science (ISI), Embase, Cinahl, PsycINFO, Cochrane and 
Pubmed, were searched using terms including: ‘decision support techniques’, 
‘decision support systems, clinical’, ‘decision support systems, patient’, ‘information 
seeking behaviour’, ‘decision making’, ‘patient participation’ and ‘patient preference’. 
An extensive search of the grey literature was also conducted using the International 
Ottawa Hospital Research Institute A to Z Inventory of Decision Aids and Australian 
websites including the Department of Health, National Health and Medical Research 
Council, the Australian Commission on Safety and Quality in Health Care, Royal 
Australian College of General Practitioners and relevant non-profit organisations 
websites. This was important as PDAs may take the form of “grey resources” rather 
than appear in traditional published formats. None of the included PDAs were 
identified through database searches; all were identified by searching the grey 
literature. Figure 7.1 summarises the search and selection process.  
 
Figure 7.1 - Search strategy patient decision aids 
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This review targeted PDAs developed to support patients with chronic conditions. 
Recognising that PDAs typically focus on discrete decisions for particular conditions, 
the search focused on decision aids that acknowledged other conditions within the 
decision-making process, along with those classified as ‘generic’. Generic PDAs do 
not include pre-filled information; instead they outline a number of key steps for 
assisting clinicians and patients to work through decisions and as such they may be 
particularly useful in supporting the management of multiple conditions.  
Disease-specific PDAs were restricted to those that addressed a chronic condition 
classified as Australia’s National Health Priority areas (360): cardiovascular health; 
stroke; cancer (colorectal, lung, breast and prostate); diabetes; depression; chronic 
kidney disease; asthma and chronic obstructive pulmonary disease; and arthritis and 
musculoskeletal conditions. Additional inclusion criteria were: PDAs for use in general 
practice; and applied to people aged 18 years and over.  
Data analysis 
Document analysis, directed by the framework approach (352) outlined in chapter four, 
was conducted in two stages. Stage one investigated the ways comorbid conditions 
were acknowledged or considered in decision-making; and stage two examined their 
ability to support shared decision-making. Unlike clinical practice guidelines, there is 
no quality assessment tool available to examine the quality of PDAs. Minimum 
standards have been proposed to assess quality (252,349,417), but consensus has 
not been reached on what format PDAs should take, how much detail they should 
contain (251), or which “active components” (349) (e.g., best estimate charts or value 
clarification processes2) should be included. Ethics approval was not required as all 
data were drawn from published materials available in the public domain. 
                                            
2 Value clarification processes, such as rating exercises or patient stories, are those which aim to 
assist patients to clarify the value they place on the benefits and harms presented. Rating exercises 
ask patients to rate on a five point scale (five point scale: zero = not important, five = very important) 
how important the reasons for or against an option are for them. Patient stories, aim to assist patients 
to clarify their own feelings about the various options by providing the personal stories of other 




Document analysis of the PDAs was conducted to identify the way PDAs addressed 
or acknowledge the presence of other conditions during the decision-making process. 
Detailed review of the PDAs ensured familiarity with content and enabled the 
identification of key themes relating to other conditions (i.e., those not the focus of the 
PDA). An index framework (see Table 7.1) that defined key themes including and 
consistent with other conditions (e.g., “potential complications” flagged when other 
conditions might cause complications in the decision-making process) was developed 
and used to code content. Relevant passages from each PDA were extracted in 
accordance with the themes and placed in charts to assist with mapping and 
interpreting the data. 




The PDA flagged how other conditions might impact the treatment, process or 
choice. Themes identified include ‘pre-existing conditions’ and ‘ask your doctor’. 
Increase risk  The PDA discusses how the treatment might increase a person’s risk of 
developing comorbid conditions. 
Reduce risk  The PDA discusses how the treatment might reduce a person’s risk of developing 
comorbid conditions. 
Stage 2 
Document analysis using the framework approach was also conducted to assess the 
ability of PDAs to support shared decision-making. This was determined by examining 
their potential to contribute to the three components necessary for achieving shared 
decision-making, as outlined by Charles et al. (246). The SDMCs were used as criteria 
against which each PDA was reviewed to determine the extent to which the 
components were addressed. A thematic framework (see Table 7.2) was developed 
from key themes identified in the document analysis that aligned with the SDMCs (e.g., 
                                            
making is highly debated, with many arguing more research is needed to confirm their benefits and 
develop a definitive set of standards. 
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“processes to assist with value clarification”). This framework was used to code PDA 
content. 
Table 7.2 - Patient decision aid framework themes 
Theme Description 
SDMC 1: Information 
exchange 
The tool prompts the sharing of information by clinicians and patients. 
Themes identified include ‘benefits and harms’. 
SDMC 2: Deliberation The tool includes processes to assist the clinician and patient to deliberate 
regarding the shared information. Themes identified include: ‘processes to 
assist with value clarification’, ‘talk with your doctor’; ‘ask your clinician’ 
question prompts and ‘discuss other treatment options with your clinician’. 
SDMC 3: Deciding on 
treatment to 
implement 
The tool prompts the documentation and review of a decision, which has 
been jointly agreed to by clinicians and patients. Themes identified 
include: ‘check decision’. 
7.3 Findings 
Patient decision aid characteristics 
Twenty-one PDAs met the inclusion criteria: thirteen for musculoskeletal health (418-
430); three for diabetes (431-433); two for depression (434,435); one for chronic 
kidney disease (436); one for cardiovascular disease (437); and a generic decision aid 
(438). The PDAs had been developed by Government and non-government 
organisations in the UK, USA and Canada (see Table 7.3).  
Thirteen PDAs (420-430,433) were classified for use by patients and clinicians in face-
to-face clinical encounters (see Table 7.3). These PDAs were shorter (i.e., no more 
than four pages) providing only a brief summary of options which could be quickly 
examined and used to facilitate further discussion in the clinical consult. One PDA 
used a small comparison table to present information, which provided a brief 
tabularised summary of options, and two PDAs presented information as option grids 
(429,430), which are more detailed stand-alone comparison tables. Nine PDAs used 
best estimate charts (420-428), which are presented as a simple graphic that 
illustrates the likelihood of a risk or benefit occurring, per 100 people (see Figure 7.2) 




Figure 7.2 - Summary table (left) from a PDA for Osteoarthritis of the hip (430) and a best 
estimate chart (right) from a PDA for rheumatoid arthritis (423). 
Eight PDAs (418,419,431,432,434-437) were categorised for use by patients 
independent of the clinical encounter (see Table 7.3). These decision aids were longer 
ranging from 12 to 16 pages. Although these PDAs also used best estimate charts 
(two PDAs) (434,437) and/or comparison tables (four PDAs) (418,419,431,434) to 
present information, they also provided a comprehensive explanation of the options, 
along with background information on the condition being addressed. Three of the 
PDAs did not include either best estimate charts or comparison tables, presenting 
information in written format only.  
Eight PDAs targeted decisions related to medication initiation (420-426,433), five 
examined the use of multiple medications (419,431,434,436,437), and three 
considered medication versus other options (e.g., skin creams or surgery) 
(418,429,430). Of the remaining decision aids: two gave patients the option of initiating 
a non-pharmacological treatment (e.g., transcutaneous electrostimulation or 
ultrasound therapy for osteoarthritis) (427,428); one compared multiple non-
pharmacological treatment options (435); one provided information on methods for 
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measuring blood sugar and taking insulin (432); and one was generic (refer to Box 
7.1) (438). 
The generic PDAs provided only headings or data fields which guide the intended user(s) through 
four steps:  
Step 1: “Clarify your decision” –the patient must identify the decision which needs to be made; 
their reasons are for making the decision; when they need to make a decision; and how far along 
they are with making a decision (438). 
Step 2: “Explore your decision” - the patient must consider the benefits and risks of the various 
options in light of personal preferences (438). The patient is asked to list the available options and 
the main risks and benefits known. The patient is then asked to rate how much the listed benefits 
and risks matter to them on a scale from 0 (not at all) to 5 (matters a lot) (438) and then identify which 
option they prefer (438). They are also asked to list other persons who are involved in the decision-
making process and which option they prefer. The decision aid asks how this other person can 
support the patient and whether the person is pressuring the patient (438). This component 
concludes by asking the user which role they would prefer in making the choice: share the decision 
with [name person]; decide myself after hearing the views of [name person]; or someone else decides 
[name person] (438). 
Step 3: “Identify your decision-making needs” - assists patients’ to determine their decision-
making needs by considering the following: do you know the benefits and risks of each option (438)? 
Are you clear about which benefits and risks matter most to you (438)? Do you have enough support 
and advice to make a choice? Do you feel sure about the best choice for you (438)?  
Step 4: “Plan the next step based on your needs” - provides additional components or 
suggestions for the patient to work through based on earlier responses (438). For instance if a patient 
is unclear about which benefits and risks mattered most to them, then the PDA suggests the following 
to assist: review the stars in the balance scale to see what matters to you; find people who know 
what it is like to experience the benefits and risks; talk to others who have made the decision; read 
stories of what mattered most to others; and discuss with others what mattered most to you.  




Table 7.3 - Patient decision aid characteristics 
Name of Patient Decision Aid Disease Organisation Classification Decision 
Information 
presentation format 







Multiple medications Best estimate charts 
Medicines for Early Stage Chronic Kidney Disease A 
Review of the Research for Adults With Kidney 






Multiple medications Written format 
Medicines for Treating Depression: A review of the 
research for adults (434) 




Best estimate charts 
Comparison table 
Medicines for Type 2 Diabetes: A review of the 
research for adults (431) 
Diabetes AHRQ USA 
Independent of 
consult 
Multiple medications Comparison table 
Managing Osteoarthritis pain with medicines: A review 






Medication versus other options Comparison table 
Medicines for Psoriatic Arthritis: A review of the 






Multiple medications Comparison table 
Therapies for Treatment-Resistant Depression: A 
Review of the Research (435) 






Methods for Delivering Insulin and Monitoring Blood 
Sugar (432) 
Diabetes AHRQ USA 
Independent of 
consult 
Between methods for testing 
blood sugar and injecting insulin 
Written format 




Cochrane Group In consult Medication initiation Best estimate charts 




Cochrane Group In consult Medication initiation Best estimate charts 
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AHRQ, Agency for Healthcare Research and Quality; US, United States, OHRI, Ottawa Hospital Research Institute 
  




Cochrane Group In consult Medication initiation Best estimate charts 




Cochrane Group In consult Medication initiation Best estimate charts 




Cochrane Group In consult Medication initiation Best estimate charts 




Cochrane Group In consult Medication initiation Best estimate charts 
Should I have ultrasound treatment for osteoarthritis 
(OA) in my knee? (427) 
Musculoskeletal 
health 
Cochrane Group In consult Non-pharmacological initiation Best estimate charts 
Should I have transcutaneous electrostimulation 
(TENS) for osteoarthritis (OA) in my knee? (428) 
Musculoskeletal 
health 
Cochrane Group In consult Non-pharmacological initiation Best estimate charts 
I have never taken medication for rheumatoid arthritis 
before. Should I take methotrexate (Rheumatrex®) 
alone or with other disease-modifying anti-rheumatic 
drugs for rheumatoid arthritis? (420) 
Musculoskeletal 
health 
Cochrane Group In consult Medication initiation Best estimate charts 
Diabetes, Type 2: Should I Take Insulin? (433) Diabetes Healthwise USA In consult Medication initiation Comparison table 





In consult Medication versus other options Option Grid 





In consult Medication versus other options Option Grid 
Ottawa Personal Decision Guide (438) Generic 
OHRI & Uni of 
Ottawa, Canada 
In consult Generic Generic 
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Multiple chronic conditions 
Analysis of the PDAs revealed three key approaches to acknowledging other 
conditions in the decision-making process (see Table 7.4). The first, used by 
seventeen PDAs, involved flagging the potential complications additional conditions 
may pose in the decision-making process (418-431,433,435). For fourteen PDAs this 
involved identifying specific pre-existing conditions known to negatively impact the 
treatment or outcome (i.e., increasing risk of side effects) (420-431,433,435). For 
example, the PDA for osteoarthritis lists health factors which might complicate 
treatment options:  
What other health factors may affect your choice? Check any that apply and 
discuss your concerns with your doctor. I have had recent trauma to my 
knee. I have another condition that could be causing the pain in my knee. I 
have metal in my knee such as an artificial joint or prosthesis, I have a skin 
infection or open wound. I am in the active stage of any cancer. (427) 
Four decision aids suggested patients ask their clinician about the potential impact 
their other conditions may have on the provided options or index condition (418,434-
436). For example, questions raised in the decision aid for early stage chronic kidney 
disease include: “What should I talk about with my doctor? …What medicines you take 
for other conditions and how they might interact with a new medicine” (436). 
The second approach, used by ten PDAs, discussed how the treatments, medications 
or index condition might increase a person’s risk of developing a comorbid condition 
or severe side-effects (418-421,425,429,431,434,436,437), as illustrated by the PDA 
for Chronic Kidney Disease: 
[Why is CKD dangerous?] It can cause problems with your heart and can 
increase your risk of bone loss, broken bones, anemia (a low number of red 
blood cells, which carry oxygen throughout the body), complete kidney 
failure, and other serious problems. It can also lead to death (436). 
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The third approach, used by six PDAs, outlined how the relevant treatment and 
medication options might reduce a person’s risk of developing additional conditions 
(431-434,436,437), as this example from the PDAs for Type 2 Diabetes demonstrates: 
What are the benefits of using insulin? Insulin is the most effective medicine 
for lowering blood sugar levels. Keeping blood sugar under control reduces 
your risk for other health problems caused by diabetes, such as eye 




Table 7.4 - Appraisal of the included patient decision aids according to the multiple condition framework 







“ACE Inhibitors” and “ARBs” To Protect Your Heart? (437) - - + + 
Medicines for Early Stage Chronic Kidney Disease: A Review of the Research for Adults With Kidney 
Disease and Diabetes or High Blood Pressure (436) 
- + + + 
Medicines for Treating Depression: A review of the research for adults (434) - + + + 
Medicines for Type 2 Diabetes: A review of the research for adults (431) + - + + 
Managing Osteoarthritis pain with medicines: A review of the research for adults (418) - + + - 
Medicines for Psoriatic Arthritis: A review of the research for adults (419) - - + - 
Therapies for Treatment-Resistant Depression: A Review of the Research (435) + + - - 
Methods for Delivering Insulin and Monitoring Blood Sugar (432) - - - + 
Should I take etanercept (Enbrel) for rheumatoid arthritis? (421) + - + - 
Should I take tocilizumab (Actemra) for rheumatoid arthritis? (422) + - - - 
Should I take Risedronate (Actonel®) for osteoporosis? (423) + - - - 
Should I take Etidronate (Didronel®) for osteoporosis? (424) + - - - 
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Should I take abatacept (Orencia®) for rheumatoid arthritis? (425) + - + - 
Should I take alendronate (Fosamax®) for osteoporosis? (426) + - - - 
Should I have ultrasound treatment for osteoarthritis (OA) in my knee? (427) + - - - 
Should I have transcutaneous electrostimulation (TENS) for osteoarthritis (OA) in my knee? (428) + - - - 
I have never taken medication for rheumatoid arthritis before. Should I take methotrexate (Rheumatrex®) 
alone or with other disease-modifying anti-rheumatic drugs for rheumatoid arthritis? (420) 
+ - + - 
Diabetes, Type 2: Should I Take Insulin? (433) + - - + 
Osteoarthritis of the knee (429) + - + - 
Osteoarthritis of the hip (430) + - - - 
Ottawa Personal Decision Guide (438) - - - - 
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Shared decision-making components  
Twenty-one PDAs were examined in relation to ability to contribute to the three 
SDMCs outlined by Charles et al. (246). As tools designed to assist patients to 
participate in decision-making about health care options, their most significant 
contribution to the shared decision-making process appears to be linked to 
components one and two.  
Components 1: supporting both participants to share or exchange 
information 
PDAs are themselves a means of sharing or exchanging information, particularly 
related to the benefits and harms of treatment options. Through the use of PDAs 
clinicians can facilitate the first shared decision-making component (246). By 
participating in this step they are preparing their patients to participate in steps one 
and two.  
Benefits and harms 
All of the included PDAs (418-437), with the exception of the generic one (438), 
provided information on the benefits and harms of the provided options. However, 
there was considerable variability in how this information was provided. Nine PDAs 
(420-428) presented the benefits and harms using best estimate charts. Three PDAs 
(429,430,433) presented the benefits and harms in a table format. Five presented the 
benefits and harms using a combination of a comparison table and/or ‘best estimate 
image’ and plain text (418,419,431,434,437) and three PDAs did not use any 
comparison tables or best estimate charts, presenting the benefits and harms as text 
only (432,435,436). 
Component 2 – supporting both participants to deliberate to reach a shared 
understanding.  
Across the PDAs, the second shared decision-making component was addressed in 
four ways: the inclusion of processes to assist with value clarification, the provision of 
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reminders to talk to your clinician, the inclusion of questions to ask your clinician; and 
prompts to discuss other treatment options with your clinician (see Table 7.5).  
Processes to assist with clarifying preferences 
In addition to providing information on the benefits and harms of the various options, 
the PDAs also included processes to assist clinicians and patients to deliberate 
regarding the provided information (i.e., assist in clarifying preferences or the value 
placed on various benefits and harms). Eleven PDAs included processes to assist with 
eliciting patients’ preferences or values for care (420-428,433,438), thereby assisting 
patients to participate in component two. These included rating exercises and 
preparedness quizzes. The rating exercises asked patients to rate (five point scale: 
zero = not important, five = very important) reasons for choosing options. The 
preparedness quizzes assessed patients’ readiness to participate in decision-making 
by providing a short quiz regarding the information presented in the PDA to ensure the 
patient understood the provided information.  
One PDA included personal stories from other patients who had faced the same 
decision, to assist patients to clarify their own feelings about the provided options. As 
this example from the PDA for type 2 diabetes demonstrates: 
"My mom had diabetes. She had to give herself insulin shots, and it looked 
so messy and painful. I swore that it would never happen to me. Well, for 8 
years now I've had type 2 diabetes. I feel like I've done everything I can at 
this point. I don't really want to start insulin, but it's more important to me 
that I stay as healthy as I can. I know that insulin can help me. — Jeff, age 
48” (433). 
Talk with your clinician 
Ten PDAs (418,419,429-432,434-437) prompted patients to discuss or talk with their 
clinician regarding the information presented. For instance, the option grid for 
osteoarthritis of the knee included the following statement: “use this grid to help you 
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and your healthcare professional talk about how best to manage your knee pain and 
activity level” (429). 
Ask your clinician 
A further eight PDAs (418,419,431,432,434-437), all developed by the AHRQ, listed 
specific questions patients might pose to their clinician to prompt discussion and 
deliberation. The following example from the patient decision aid for diabetes 
demonstrates this approach:  
 “Ask your doctor 
 Do you think my blood sugar level is controlled well? 
 Is there anything I should change to better manage my diabetes? 
 Would a continuous monitor or insulin pump help me control my blood sugar? 
 What else can I do to keep my blood sugar at a healthy level?” (432). 
Discuss other treatment options with your clinician 
Thirteen PDA (420-430,433,435) prompted patients to discuss other treatment options 
not presented in the PDA, with their clinician as illustrated. This was usually presented 
as a generally worded prompt as in this example from the PDA for osteoporosis: “You 
may wish to discuss other treatment options with your doctor” (423). 
Component 3 – An agreement is achieved between both participants on the 
choice 
Ten PDA (420-428,438) asked patients to document their final choices. For instance, 
the PDA considering whether to take alendronate for osteoporosis, prompted patients 
to choose from the following choices at the end of the PDA: try alendronate; discuss 
other treatment options; or other, please specify. However, none of these PDA 
encouraged or suggested that a date be set for reviewing choice or decision, which as 




Table 7.5 - Appraisal of the included patient decision aids according to the shared decision-making framework 
















“ACE Inhibitors” and “ARBs” To Protect Your Heart? (437) + - + + - - 
Medicines for Early Stage Chronic Kidney Disease: A Review of 
the Research for Adults With Kidney Disease and Diabetes or 
High Blood Pressure (436) 
+ - + + - - 
Medicines for Treating Depression: A review of the research for 
adults (434) 
+ - + + - - 
Medicines for Type 2 Diabetes: A review of the research for 
adults (431) 
+ - + + - - 
Managing Osteoarthritis pain with medicines: A review of the 
research for adults (418) 
+ - + + - - 
Medicines for Psoriatic Arthritis: A review of the research for 
adults (419) 
+ - + + - - 
Therapies for Treatment-Resistant Depression: A Review of the 
Research (435) 
+ - + + + - 
Methods for Delivering Insulin and Monitoring Blood Sugar (432) + - + + - - 
Should I take etanercept (Enbrel) for rheumatoid arthritis? (421) + + + + - + 
Should I take tocilizumab (Actemra) for rheumatoid arthritis? 
(422) 
+ + - - + + 
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Should I take Risedronate (Actonel®) for osteoporosis? (423) + + - - + + 
Should I take Etidronate (Didronel®) for osteoporosis? (424) + + - - + + 
Should I take abatacept (Orencia®) for rheumatoid arthritis? (425) + + - - + + 
Should I take alendronate (Fosamax®) for osteoporosis? (426) + + - - + + 
Should I have ultrasound treatment for osteoarthritis (OA) in my 
knee? (427) 
+ + - - + + 
Should I have transcutaneous electrostimulation (TENS) for 
osteoarthritis (OA) in my knee? (428) 
+ + - - + + 
I have never taken medication for rheumatoid arthritis before. 
Should I take methotrexate (Rheumatrex®) alone or with other 
disease-modifying anti-rheumatic drugs for rheumatoid arthritis? 
(420) 
+ + - - + + 
Diabetes, Type 2: Should I Take Insulin? (433) + + - - + + 
Osteoarthritis of the knee (429) + - + - + - 
Osteoarthritis of the hip (430) + - + - + - 
Ottawa Personal Decision Guide (438) - + - - + + 
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7.4 Implications for practice 
Twenty-one PDAs were identified and reviewed. The majority focused on discrete 
medication related decisions and were intended for use in the clinical consultation. Key 
methods used by PDAs to acknowledge multiple conditions included flagging potential 
complications, prompting discussion between the patient and clinician and identifying how 
further illness could be prevented. In flagging multiple conditions and providing assistance 
to clinicians and patients to work through decision-making processes, PDAs have 
demonstrated some potential to contribute to the management of multiple conditions, albeit 
within the context of discrete decisions. In particular, generic PDAs warrant further 
investigation as a means of working through the complex and potentially infinite number of 
decisions associated with multiple conditions. 
The PDAs most strongly informed components one and two of the SDMCs: of the PDAs 
reviewed, all but the generic decision aid contributed to the first and second SDMCs. Just 
over half the PDAs contributed to the third SDMC, demonstrating scope for PDAs to support 
shared decision-making in a systematic and consistent way.  
Contribution of existing tools to the SDMC 
This thesis has consistently highlighted the necessity of shared decision-making as a 
foundation for effective multimorbidity care. Shared decision-making, a central component 
of patient-centred care (137,244), assumes even greater salience in multimorbidity care 
because there is often not a single ‘correct’ treatment option. Charles et al. (246) argue 
shared decision-making must involve at least two people, traditionally the clinician and 
patient, sharing or exchanging information, jointly deliberating, and agreeing on a treatment 
choice. In practice, shared decision-making is rarely achieved due to a range of barriers 
including: short consultation times; limited training for clinicians on how to participate; threats 
to power relationships; and limited access to, or availability of, resources or tools that can 
support shared decision-making (262,263,439,440). Acknowledging these barriers, and in 
recognition of the importance of shared decision-making, particularly in a multimorbidity 
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context, clinicians (19,224,230) and professional organisations (33,54) have called for 
methods or tools to support this process.  
Primary care practice tools such as clinical practice guidelines and care plans are designed 
to support primary care clinicians and patients to manage single chronic conditions. Broadly, 
these tools were developed to support practice wide change and enhance the uniformity of 
care provision (39,269) and they have been directly linked to improvements to care 
(271,288,291,330), but challenges arise when they are required to adapt to new situations 
inconsistent with their original purpose (62,303). In line with this, our findings indicate clinical 
practice guidelines and care plans in their current form have limited transferability from the 
management of single chronic conditions to the management of multiple chronic conditions. 
The question arises is to whether these tools might be adapted to support a multimorbidity 
care approach. Having argued the central place of shared decision-making in multimorbidity 
care, the remainder of this chapter briefly revisits clinical practice guidelines and care plans 
to map their contribution to the three SDMC outlined by Charles et al. (246) in order to 
demonstrate how these tools could be capitlised on (see Table 7.6).  
Clinical practice guidelines 
As chapter three outlined, clinical practice guidelines are designed to translate the best 
available evidence into recommendations for clinical practice (227). Through the translation 
of evidence into practice they have demonstrated effectiveness in guiding the management 
of single chronic conditions (288,291,292). This translational role allows guidelines to 
provide clinicians and patients with evidence-based information on the benefits and harms 
of decision options thereby contributing to the first SDMC: information exchange (246). 
However, in line with systematically conducted research, guideline recommendations are 
derived from research trials engaging participants who must meet narrow inclusion criteria 
(i.e., those experiencing single chronic conditions), thereby limiting their generalisability to 
patients with multiple conditions (227). As chapter five concluded, some guidelines have 
made steps towards acknowledging potential preference-sensitive decisions through the 
development of patient-preference recommendations but, more, guidelines remain 
inconsistent in how they present these recommendations and provide little guidance on how 
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clinicans should work through these recommendations. This is the foundational next step 
needed for guidelines to contribute to component two of the SDMCs: deliberation. As a 
consequence, their ability to assist both clinicians and patients to decide on a treatment to 
implement (component three) is limited. The clinical focus of guidelines, while critical to their 
purpose of informing clinicans, appears to undermine their ability to serve the dual purpose 
of translating evidence in a way that supports the patient voice, parituclarly for those 
managing mutliple conditions.  
Care plans 
As previously discussed in chapter six, care plans were introduced in Australia to encourage 
and support multidisciplinary approaches to chronic disease management (4,39). Care 
planning processes are intended to involve both clinicians and patients reflecting on clinical 
evidence and the patient’s preferences, needs and values to inform the development of a 
joint strategy for managing the patient’s chronic condition(s) (438). In line with this goal, care 
plans can play a key role in supporting component one of the SDMCs: information exchange. 
However, as our findings revealed, many care plan templates are pre-filled and disease-
specific, directing the organisation of care and treatment goals to support single disease-
specific outcomes rather than the cross-disease outcomes central to the management of 
multiple conditions (438). As a consequence, the current format of care plans available to 
primary care clincians in Australia do not appear to comprehensively encourage patient 
involvement in the care planning process, but are instead oriented to clinical decision-
making and meeting the Medicare requirements, further highlighting the need for 
congruence between policy and practice. The findings also indicate that currently available 
care plan templates do not provide guidance to clinicians and patients on how to work 
through preference-sensitive decisions and the conflicts in preferences and goals for care 
that can arise from competing health conditions. This restricts their contribution to 
component two of the SDMCs: deliberation, but as argued in chapter six is a feature of care 
plans that could be harnessed. Care plans do provide an avenue for decisions to be 
documented and reviewed, in accordance with component three of the SDMCs: decide on 
a treatment to implement, but the pre-filling of information undermines their ability to support 
this component as the direction and focus of care has to some extent been determined. 
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Restructuring care plans, to emphasis shared decision-making and the identification and 
review of patient preferences and priorities, rather than individual conditions, may assist to 
refocus care plans on the patient and their care needs. 
In summary, clinical practice guidelines and care plans are core contributors to the 
management of single chronic conditions, but their role in identifying and incorporating the 
preferences of patients with multiple conditions is inhibited by the primacy of their focus on 
disease and clinician decision-making. PDAs, as tools specifically designed to 
operationalise shared decision-making, could help fill this void.  
Table 7.6 - Summary of each of the tools mapped against the shared decision-making components 
SDMC  Primary care practice tool  
Patient decision aids Clinical practice guidelines Care plans 
1) Information 
exchange 
A form of information 
exchange themselves they 
provide information the 
benefits and harms of the 
various options 
Provide information on the 
benefits and harms. Flag 
patient-preference 
recommendations and the 
need to engage patients, but 
this is not consistently 
applied. 
Consideration of cross-
disease outcomes or 
engagement of patients in 
decision-making processes 
is not systematically 
encouraged. 
2) Deliberation Include processes to assist 
patients to engage in 
deliberations with their 
clinician including value 
clarification activities, 
knowledge quizzes, and 
provision of discussion 
questions. 
Do not provide guidance or 
processes to assist patients 
and clinicians to work 
through or deliberate about 
preference-sensitive 
recommendations. 
Limited guidance or 
processes to assist patients 
and clinicians to weigh up 
clinical evidence, individual 
preferences or priorities. 
3) Deciding on 
treatment to 
implement 
Are intended more as an aid 
to reaching agreement rather 
than as a means of 
documenting agreement. 
The focus in on clinician 
decision-making and single 
chronic conditions. 
Focus is on clinician 
decision-making and single 
disease-specific outcomes, 
but do they provide an 





The aim of this chapter was to consider the ways PDAs acknowledge or consider multiple 
conditions in decision-making and the ability of PDAs to contribute to or support the SDMCs. 
Extending on this discussion the chapter then explored the ability of clinical practice 
guidelines and care plans to contribute to the SDMCs. This highlighted that each tool has 
strengths and limitations and there is potential for greater integration across primary care 
practice tools to further support shared decision-making and multimorbidity care. The next 
and final chapter brings together the findings of the thesis and includes a proposed approach 
to integrating the three tools. The following chapter will outline how these tools could be 




 Chapter 8 Discussion 
The thesis has presented a detailed analysis of three existing primary care practice tools, 
examining their ability and transferability to address one of Australia’s most pressing health 
system issues: the delivery of care to patients with multiple conditions. The research was 
based on the proposition that effective multimorbidity care must incorporate patient 
preferences and shared decision-making to reflect the central tenets of patient-centred care 
and consumer engagement. By examining this topic, the thesis makes a timely contribution 
to the current policy agenda set out in the recently released Primary Health Care Advisory 
Committee (PHCAC) report “Better outcomes for people with chronic and complex health 
conditions” (54). The report establishes the urgent need to address multiple chronic 
conditions, through strengthening patient involvement and shared decision-making in 
primary care. Also underlined is the importance of capitalising on existing resources (54), 
further reinforcing the applicability of the theory of incrementalism that underpinned and 
guided this thesis. 
This thesis found that none of the existing tools commonly (or potentially) used in primary 
care practice systematically incorporate the key attributes, argued in the  thesis as being 
necessary, for achieving multimorbidity care. Each of the three tools reviewed captures 
elements of what is required to provide multimorbidity care, but each was also revealed to 
have particular limitations. The thesis argues that while these tools offer a sound basis to 
enhance multimorbidity care, adaptations or incremental changes are needed to improve 
the ability of each to contribute to patient-centred multimorbidity care. Furthermore, while 
these tools can contribute individually, much scope also exists for a more integrated 
approach to their use. There is potential to create synergies that could enhance shared 
decision-making and the incorporation of patient preferences, thereby supporting the 
provision of multimorbidity care.  
This chapter draws together the individual study findings to examine the ways in which these 
tools could be integrated to produce a synergistic approach to facilitate shared decision-
making and support multimorbidity care. Directions for future research and policy will be 
discussed as well as the strengths and limitations of this thesis.  
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8.1 Integrated primary practice tools 
To support the provision of effective multimorbidity care all the tools informing primary care 
should, ideally, facilitate shared decision-making between clinicians and patients. Yet, this 
thesis confirms that existing tools centre on managing single chronic conditions and are 
more strongly oriented to clinician decision-making, rather than shared decision-making.  
Figure 8.1 illustrates how each of the tools currently relates to shared decision-making. 
Clinical practice guidelines are predominantly disease-focused and designed to inform 
clinician decision-making. As noted in chapter five some guidelines have made efforts to 
support patient perspectives through the inclusion of patient preference recommendations, 
but this is far from consistent across guidelines. Care plans, as outlined in chapter six, were 
also shown to be geared to direct clinician decision-making. Despite being a tool designed 
to facilitate joint decision-making they do not, at present, readily incorporate the patient 
perspective. PDAs strongly inform patient perspectives but unlike guidelines and care plans, 
feature little in the Australian primary care landscape and are reliant on clinicians and/or 
patients to first recognise that a decision needs to be made.  
 
Figure 8.1 - Current contribution of primary care practice tools to shared decision-making and 
multimorbidity care  
Drawing on the findings presented in chapters five, six and seven, this thesis proposes how 
the identified primary care practice tools could be used in a more integrated manner to 
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support shared decision-making and multimorbidity care. As Figure 8.2 illustrates, the 
proposed integration of primary practice tools begins with clinical practice guidelines, 
developed using sound and effective consumer engagement processes. This is followed by 
the development of PDAs, designed to accompany and complement clinical practice 
guidelines, to work through patient-preference recommendations identified through 
consumer engagement processes during guideline development. PDAs are also relevant for 
use alongside care plans, which include processes to elicit and incorporate patient 
preferences and set priorities, to ensure the discrete decision is made within the patient’s 
broader goals and preferences for care.  
 
Figure 8.2 - Proposed method for integrating current primary care practice tools 
Clinical practice guidelines 
At the outset of the research, clinical practice guidelines were acknowledged as evidence-
based primary care practice tools designed to translate evidence and inform clinical 
decision-making; they are not designed to promote patient-centred care or shared decision-
making. However, their ability to inform clinical decision-making is not without question 
because many patients do not fit into the ‘average patient’ model upon which they are based. 
In shared decision-making, information exchange is bi-directional (246), but guidelines are 
predominantly uni-directional, with information on the benefits and harms transferring from 
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clinician to patient (441). Primary care clinicians have called for improvements that foster 
patient-centred management of multiple conditions and strengthen the patient voice 
(33,67,250,308,309). Efforts to shift guidelines into the patient space have been proposed, 
including the development of patient versions of guidelines (441). The use of consumer 
engagement processes and greater incorporation and flagging of preference-sensitive 
decisions key recommendations proposed in chapter five. 
The reviewed guidelines used consumer engagement processes, but these processes have 
been criticised as passive methods limiting consumers’ ability to actively engage and provide 
valuable input (311,314,383). Likewise, the guidelines did not provide training or establish a 
specific role description to consumers, elements considered essential for meaningful 
consumer engagement (311). These findings highlight the need not only for greater direction 
on how to successfully engage consumers in guideline development, but how to measure 
the effectiveness or outcomes of such processes. As consumer engagement continues to 
be encouraged in guideline development and health policy creation more broadly, there is a 
need for appropriate mechanisms to assess consumer engagement, otherwise it risks 
consumer engagement being tokenistic and having little relevance. If, as researchers argue, 
obtaining consumer input during guideline development lays the foundation for greater 
attention to patient preferences in clinical consultations (250,310,311), then conducting 
meaningful consumer engagement at a policy level is critical to ensure patients are 
supported and considered at an individual clinical consult level.  
Involvement of consumers in guideline development is not a substitute for the discussion of 
patient preferences in the clinical consult. Rather consumer input should assist to identify 
recommendations which might be considered preference-sensitive. Patient preferences 
were more frequently presented in supporting evidence statements than in core 
recommendations. This could undermine the potential of guidelines to support the patient 
voice in primary care practice as it risks this information being overlooked by time-poor 
clinicians. More systematic flagging of patient-preference recommendations across 
guidelines could help address this. This is particularly important because as the thesis 
argues, clinical practice guidelines have a core role in informing disease-specific care plans 
and PDAs. Therefore clearer and more frequent flagging of patient-preference 
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recommendations in guidelines could serve as a catalyst for greater attention to patient 
preferences and shared decision-making in clinical consultations and across primary care 
practice tools.  
This first stage of more active consumer engagement forms the basis for shared decision-
making by promoting a reciprocal exchange of information and setting the scene for further 
deliberation that enables patients to participate. Information exchange is necessary but not 
sufficient for shared decision-making in the clinical encounter. To capitalise on the important 
role of clinical practice guidelines in directing care decisions and to address some of their 
limitations, this thesis joins van der Weijden (227) in arguing for clinical practice guidelines 
to be developed in combination with PDAs. 
Patient decision aids 
After reviewing clinical practice guidelines and care plans, it became evident that more 
targeted mechanisms to support shared decision-making and incorporate the patient voice 
within the clinical encounter is needed. PDAs were identified as a potential solution, but their 
applicability to a multimorbidity context had not previously been considered. Accordingly, 
the present study investigated the ways PDAs acknowledged multiple conditions in decision-
making and their ability to contribute to the SDMCs. Key methods used by PDAs to 
acknowledge multiple conditions included flagging potential complications, prompting 
discussion between the patient and clinician and identifying how further illness could be 
prevented. The PDAs were found to contribute to the SDMCs, most prominently through the 
provision of information on the benefits and harms and the inclusion of value clarification 
processes; although there was scope for greater standardisation across PDAs.  
PDAs provide evidence-based information on a particular condition, the various treatment 
options, and the benefits and harms of those options. In flagging multiple conditions and 
providing assistance to clinicians and patients to work through decision-making processes, 
PDAs have demonstrated potential to support deliberation and thereby contribute to shared 
decision-making. Despite these benefits, PDAs are not currently widely used within 
Australian primary care practice (245,336). To address this gap and to overcome some of 
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the criticisms made of clinical practice guidelines, the thesis suggests developing clinical 
practice guidelines in combination with PDAs. 
PDAs could be developed alongside guidelines to ensure recommendations identified 
through consumer engagement processes are flagged as preference-sensitive. This could 
assist to increase uptake of PDAs, as clinical practice guidelines are widely used and 
respected tools within Australian primary care practice (233). Joint development of 
guidelines and PDAs could also help to overcome the criticism that guidelines are too 
disease centric and do not consider individual patient preferences (13,226,309) or include 
processes to assist with deliberation (12,67). 
Care plans and PDAs could also be used to augment one another. PDAs assist patients and 
clinicians to work through discrete screening, treatment and/or medication decisions, but do 
not appear to assist with broader decisional conflicts or processes such as prioritising 
conditions and goals for care; key decisions faced by clinicians and patients managing 
multiple conditions (135,217,415). Working through these broader decisional conflicts and 
prioritising conditions and goals for care is something that could be integrated in care plan 
development.  
Care plans 
Care plans have been part of the primary care landscape contributing to a multidisciplinary 
approach to chronic disease care in Australia for almost two decades. As jointly developed 
strategies which outline the patient’s preferences, needs and values for care, care plans are 
widely advocated as a means of individualising chronic disease care (159,274-276). As such 
they have a valuable role in assisting clinicians and patients to deliberate and reach an 
agreement on care decisions. However, the findings presented in chapter six revealed that 
care plan templates provide limited guidance to clinicians and patients on how to deliberate 
or set priorities within a multimorbidity context. In addition, the majority of available care plan 
templates reviewed were pre-filled. The inclusion of pre-filled data in disease-specific 
templates could result in care being decided with minimal collaboration and consultation 
between clinicians and patients. The inclusion of processes to facilitate the identification of 
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patients’ preferences and priority setting; identify conflicts and synergies in care; and review 
of patients’ goals and priorities are clearly needed in care planning.  
PDAs step clinicians and patients through the decision-making process and include 
processes to assist with value clarification. By including processes that support deliberation, 
PDAs are able to assist clinicians and patients to find common ground and reach a shared 
understanding of the decisions made. There is potential for care plans to draw on elements 
of PDAs, particularly the generic PDAs, to inform their design.  
Care plan templates provide an avenue for documenting the agreed decision(s) and dates 
for their review. Care decisions should be reviewed regularly to ensure they reflect the needs 
and preferences of the patient. In the event a decision needs to be reviewed, clinicians and 
patients can refer back to the relevant clinical practice guideline or PDA.  
In summary, consideration of multiple conditions and shared decision-making cannot be 
viewed as an added component within standard clinical consults. For patients and clinicians 
to be truly supported in the management of multiple long term conditions, these issues need 
to be considered at a policy or primary care practice level to ensure meaningful change and 
engagement at the clinic level. If all primary care practice tools were to in some way 
acknowledge and support the patient voice and shared decision-making, meaningful 
practice wide change could be achieved.  
8.2 Implications and implementation 
Major structural reform is generally difficult and costly to achieve. Consequently most health 
system reform, in line with Lindblom’s theory of incrementalism, occurs through incremental 
changes to existing practice (39,40). The mobilisation of primary care practice tools to better 
support multimorbidity care represents one step towards achieving a more systematic and 
routinised approach to multimorbidity care in primary care practice. However, it is well 
acknowledged that these tools are one small part of a much larger system, the elements of 
which influence their use and impact (140,442,443). This study has focused on the clinical 
context and primary care practice tools as potential drivers of the interaction between the 
clinician and patient. As part of a wider system, change cannot occur without systems 
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thinking that takes account of interconnected structures, elements and patterns 
(140,442,443). Contextual factors likely to impact the operationalisation of the proposed 
integration of primary care practice tools include financing, workforce, and information.  
Financing 
Australian primary care providers are paid on a fee-for-service basis (23,24,153). This 
payment method runs counter to the needs of patients with long-term conditions, as it 
encourages short consultation times (in 2013-2014 the median primary care consultation 
was 13 minutes (46)), and an “additive sequential” (21) approach involving a linear approach 
to managing individual diseases. Existing financing arrangements are not conductive to the 
proposed integration of primary care practice tools, which would require extended 
consultation times and alternative payment schemes to facilitate a multimorbidity approach 
to care. Calls to review existing payment schemes have been made by others including most 
recently the PHCAG (54). 
Workforce 
Providing a patient-centred care approach in primary care practice requires an adequately 
equipped workforce. Training, at the undergraduate, postgraduate, and continuing 
education levels, is required to promote the development of skills needed to manage the 
high levels of uncertainty and complexity associated with managing multiple conditions (28). 
This is reflected in the RACGP position statement for multimorbidity (33). Further 
development and strengthening of a workforce culture to ensure it values the perspectives 
of patients and supports their engagement in care decisions must also be a priority. 
Information 
 Access to relevant and timely information is essential for clinicians to be able to engage in 
shared decision-making and provide effective multimorbidity care (28,141). Information to 
guide the management of multiple conditions is limited and further research into patients’ 
and clinicians’ experiences of multiple conditions and their management in primary care is 
needed to strengthen the evidence-base. Developing and strengthening information 
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systems to better monitor patients across care providers, is also essential to ensure 
improved continuity of care for patients and the provision of data to inform policy and 
practice.  
8.3 Further research 
Areas for further research focusing on the development and applicability of each of the 
individual tools to address multimorbidity care have been identified earlier in chapters five, 
six and seven and are not repeated here. Rather, this section considers areas for further 
research based on the integrated thesis findings.  
Quality multimorbidity care 
Further research into patients’ experiences of quality multimorbidity care is needed. Existing 
quality indicators are often based on the assessment of individual disease or risk indicators 
(12). However, this approach seems contrary to a multimorbidity approach and inappropriate 
given effective multimorbidity care can at times necessitate an escalation of one condition 
to reduce the damage caused by another, or to align with the preferences of the patient. 
Hence, determining what constitutes quality multimorbidity care, from patients’ perspective, 
and how this could be measured in practice requires further consideration.  
Evaluation of models  
Rigorous evaluation of different models for providing multimorbidity care, including the one 
proposed earlier in this chapter, is needed. The proposed changes to the identified primary 
care practice tools and their potential benefits are at this point theoretical and require 
empirical testing to determine acceptability to clinicians and patients. This requires careful 
assessment of individual patient outcomes, examination of clinician and patient perceptions 
of care, along with assessment of the acceptability, feasibility and health system impacts, 
including cost.  
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The identification of core attributes for integrating primary care practice tools 
This thesis highlights how three existing tools, clinical practice guidelines, care plans, and 
PDAs, could be integrated to produce a synergistic response to multimorbidity care. This 
was done by examining the strengths and limitations of each of the tools and considering 
how the strengths of one could be used augment the limitations of another. In thinking about 
the broader implications of these findings, and how other primary care practice tools could 
be similarly mapped and integrated, a number of preliminary attributes or dimensions, upon 
which tools could be evaluated, have been identified. These attributes, illustrated in Figure 
8.3, could be considered along a scale from high to low attainment. Locating/mapping tools 
against these attributes could assist policy makers and clinicians to identify the strengths 
and limitations of existing tools and highlight opportunities for integration. For example, a 
tool that has a high evidence-base but low consideration or encouragement of patient 
preferences, would be flagged as needing to be partnered with a tool that better facilitates 
integration of patient preferences. These preliminary attributes, which emerged from the 
thesis as significant, require further detailed consideration and testing to determine their 
broader applicability and relevance.  
 
Figure 8.3 - Preliminary primary care practice tool attributes  
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Role of IT in supporting the integration of primary care practice tools 
Electronic and interactive versions of each of the tools are available, with most now being 
developed in this format to increase accessibility and usability at the point of care. This 
should allow for greater integration and cross referencing of tools. Further research is 
needed to identify how tools could be electronically integrated to produce a tool which 
supports patients and clinicians throughout the clinical consult. Consideration would need 
to be given to the potential risks of increasing clinicians’ engagement with electronic tools at 
the point of care. 
8.4 Thesis strengths and limitations  
The perspective taken for thesis was novel, no other study appears to have collectively 
examined primary care practice tools and how they may be adapted and integrated to better 
support multimorbidity care. This research provides new insights into how these tools could 
be adapted and better integrated to support a system level shift towards multimorbidity care 
and shared decision-making. 
The thesis focused on the applicability of primary care practice tools from a primary care 
practice level. It did not examine how primary care practice tools are used or perceived by 
clinicians and patients in the clinical consultation. The rationale for this approach was 
twofold:  
1) examining how primary care practice tools are used in clinical consultations for 
patients with multiple conditions, seemed superfluous if the tools themselves were 
ill equipped for this purpose;  
2) examining primary care practice tools and how they could be adapted (if 
necessary) was considered more likely to bring about practice wide change than 
focusing on the individual actions of individual clinicians. 
The thesis focused on the clinical encounter and the relationship between clinicians and 
patients. However, patients with multiple conditions are known to attend numerous health 
care providers (12,121,204). The role of practice nurses was not examined in this thesis 
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despite their increasing role in chronic disease management in primary care practices 
(41,444). The main rationale for focusing on the relationship between primary care clinicians 
and patients, was based on primary care clinicians’ significant role as the major providers of 
chronic disease care who typically have overall responsibility for the coordination of care 
across other health care providers (13). If the relationship between the patient and their 
primary care clinician is not operating effectively then the continuity of care between other 
health professionals is likely to be comprised. How well these findings apply to other practice 
arrangements has not been addressed. 
A rigorous approach was taken to the identification and analysis of the various tools. The 
study identified three primary care practice tools, all of which were validated through 
consultation with expert stakeholders as important to chronic disease care. It is important to 
note other tools, initiatives and resources are available to support primary care clinicians 
(e.g., HealthPathways (445)). These are provided by non-profit and private organisations, 
Primary Healthcare Networks (formerly Medicare Locals), and state and territory 
governments around Australia. However, these initiatives were not flagged by our expert 
panel and therefore were not included. 
An extensive search of published and grey literature was conducted to identify relevant 
documents (primary care practice tools) for analysis. Searching the grey literature was a 
necessary and important step as this is where the majority of primary care practice tools are 
disseminated. If the reviews had been restricted to focus solely on peer-reviewed 
publications identified through database searches, then critical documents would have been 
overlooked.  
Framework analysis is a well-regarded, systematic and comprehensive method for 
reviewing and evaluating data of the type included in this thesis (143). The quality, rigour 
and transparency of the data analysis, using the framework approach, relies heavily on the 
skill and experience of the researcher (277,446). Critical reflection and detailed discussion 
with supervisors, together with comprehensive index frameworks and detailed charts, 
occurred at all stages to enhance rigour and transparency.  
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The implications of this research extend beyond an Australian context. Multimorbidity is 
challenging health systems globally. Although, this thesis focused principally on primary care 
practice tools developed in Australia, for use in Australian primary care practice, these tools 
have been developed and used in primary care practices around the world. International 
studies have examined the use of clinical practice guidelines in a multimorbidity context 
(27,62,67,71,304,388). Adding to this literature, this research has identified how the 
strengths of guidelines could be harnessed and used in concert with other primary care 
practice tools to provide a systematic approach to multimorbidity care. Despite the long 
history of care plans, they have received surprisingly little review. Beyond Morgan et al. 
(136) who trialled a new care plan template for multiple conditions, literature examining the 
use of care plans for patients with multiple conditions is negligible. Although, previous 
studies have commented on the disease-specific nature of care plans templates (136,389), 
this thesis appears to be the only research which has formally analysed care plan templates 
to consider their relevance in providing multimorbidity care. Likewise, research examining 
the use of PDAs for patients with multiple conditions is scarce. This thesis appears to be the 
first to consider the use of PDAs within a multimorbidity context.  
8.5 Conclusion 
Health systems are ever evolving and need to adapt in line with changing disease profiles 
of the populations they serve. The limitations of an almost exclusive disease focus are well-
documented, as are the challenges of consistently delivering patient-centred care. A 
contemporary challenge is that of shifting focus from a single chronic disease to one that 
accommodates multiple chronic diseases. Hence, there is a need for a paradigm shift within 
Australia’s primary care system from one focused on single diseases to one that considers 
and supports multimorbidity care across primary care practice. Primary care practice tools 
have previously contributed to practice wide change for those managing single chronic 
conditions and therefore may hold one of the keys to shifting Australia’s primary care system 
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Appendix 1. Expert stakeholder invitation email and questions 
 
 
Public Health Building 
Herston Road, Herston 
Brisbane Qld 4006 
Telephone +61 7 3365 5345 
Facsimile +61 7 3365 5442 
Email:  Enquiries@sph.uq.edu.au 
Website www.sph.uq.edu.au 
Dear [Title Name],  
A study investigating ‘system tools currently available to guide GPs management of multiple 
long term conditions’ is being undertaken by PhD student Charlotte Young, under the 
direction of Dr Allyson Mutch (tel. 3346 4682) and Associate Professor Fran Boyle (tel. 3346 
4681) from the School of Population Health, University of Queensland. 
An aim of the project is to identify which tools are used in primary care to enable GPs to 
manage multiple chronic conditions. As an expert in primary care we would be grateful if you 
could assist us by answering the questions below. The questions relate directly to your views 
and will not require you to divulge information on specific patients. All personal information 
will be kept confidential. 
We would greatly value your participation, input and views. Please be assured that 
participation in this study, is entirely voluntary and you are free to withdraw at any stage.  
This study has been cleared by one of the human ethics committees of the University of 
Queensland in accordance with the National Health and Medical Research Council’s 
guidelines. You are of course, free to discuss your participation in this study with project staff 
(Ms Charlotte Young contactable on 0420307578). If you would like to speak to an officer of 
the University not involved in the study, you may contact the Ethics Officer on 3365 3924. 
If you are agreeable to taking part, please complete the questions below and return via email 
to c.young@sph.uq.edu.au or click on the following link to complete the questions via 
surveymonkey: https://www.surveymonkey.com/r/Q9HFGMQ. Returning your responses by 
email or completing the survey online is accepted as an indication of your consent to 
participate in this project. 
We would greatly appreciate your assistance.  
1.1.1.1.1.1            TECHNOLOGY & INNOVATION MANAGEMENT CENTRE 
 196 
 
Yours Sincerely,  
 
Charlotte Young  
School of Population Health |The University of Queensland | Public Health Building | 
Herston Rd | Herston Qld 4006 | Australia | Ph: +61 7 3381 1215 | Email: 
c.young@sph.uq.edu.au 
Question 1: Based on your experience how would you rate the following tools for use in the 
management of multiple long term conditions in primary care? Please rate on a scale of 1 (not 
useful) to 5 (very useful). 
Tools Rating Particular strengths or weaknesses 





Question 2: What additional Australian tools would you add to this list?  
 
Question 3: What do you believe are the essential features of a tool designed to support GPs 
in the management of multiple long term conditions in primary care? 
 
Question 4: What do you think is most needed to assist GPs in the management of multiple 






Appendix 2. Expert stakeholder information sheet 
 
 
Project Title: Critique of system tools currently available to guide GPs management of 
patient care from a multimorbidity perspective 
Thank you for taking the time to read this information sheet about a research project designed 
to investigate system tools currently available to guide GPs management of patient care from 
a multimorbidity perspective.  
Who is conducting the study? 
The study will be conducted by The University of Queensland PhD student: Charlotte Young, 
under the direction of: Dr Allyson Mutch, Senior Lecturer (tel. 3346 4682) and Associate 
Professor Fran Boyle (tel. 3346 4681) from the School of Public Health, University of 
Queensland. 
What is the purpose of the study? 
We are investigating GPs professional opinion regarding current tools available to support 
the management and care of patients with multiple conditions.  
What would your participation involve? 
We would ask you to participate by completing a short one-off questionnaire. Your 
participation in the study will cease upon return of the completed questionnaire.  
We would greatly value your participation in the above ways and have attempted to ensure 
that this process is minimally disruptive to your life. Please be assured that participation in 
this study, is entirely voluntary and you are free to withdraw at any stage. All information 
provided will be treated in confidence and will be available only to members of the research 
team for the purposes of the research project. 
If you are agreeable to taking part, please complete the attached informed consent form and 
return via email to c.young@sph.uq.edu.au or fax to 3365 5442.   
Who do I contact for more information? 
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This study has been cleared by one of the human ethics committees of the University of 
Queensland in accordance with the National Health and Medical Research Council’s 
guidelines. You are of course, free to discuss your participation in this study with project staff 
(Ms Charlotte Young contactable on 0420307578). If you would like to speak to an officer of 
the University not involved in the study, you may contact the Ethics Officer on 3365 3924. 
Thank you very much for your consideration in becoming involved in this research study.  I 
look forward to hearing from you.  
Yours sincerely, 
Ms Charlotte Young 
School of Public Health 








To Ms Charlotte Young 
From Lisa Fitzgerald 
Date 03 June 2014 
Re Ethics Approval CY030614 
CC Dr Allyson Mutch 
Associate Professor Fran Boyle 
Dear Charlotte, 
Thank you for your application for ethics approval for  your research: 
Research topic: What system tools support general practitioners 
management of multimorbidities? 
The School of Population Health Research Ethics Committee has reviewed the 




Chair, School of Population Health Research Ethics Committee 
School of Population Health, University of Queensland 
Public Health Building 
Herston Road, Herston 
Brisbane Qld 4006 
Telephone +61 7 3365 
5345/5280 
Facsimile +61 7 3365 5442 
Email:  
Enquiries@sph.up.edu.au 
Website www.sph.uq.edu.au 
 
 
 
